The interrelationship of strain diversity, virulence and patient ethnicity for tuberculosis in the Midlands, UK by Smith, Helen Elizabeth
   
 
 
 
 
 
The interrelationship of strain diversity, 
virulence and patient ethnicity for 
tuberculosis in the Midlands, UK 
 
 
Helen Elizabeth Smith 
 
 
A thesis submitted to the 
University of Birmingham 
for the degree of 
DOCTOR OF PHILOSOPHY 
 
School of Immunity and Infection 
College of Medical and Dental Sciences 
University of Birmingham 
January 2013 
 
 
 
 
 
 
 
 
 
University of Birmingham Research Archive 
 
e-theses repository 
 
 
This unpublished thesis/dissertation is copyright of the author and/or third 
parties. The intellectual property rights of the author or third parties in respect 
of this work are as defined by The Copyright Designs and Patents Act 1988 or 
as modified by any successor legislation.   
 
Any use made of information contained in this thesis/dissertation must be in 
accordance with that legislation and must be properly acknowledged.  Further 
distribution or reproduction in any format is prohibited without the permission 
of the copyright holder.  
 
 
 
   
Abstract 
 
This study examined the relationship between Mycobacterium tuberculosis global 
clades and patient origin. In the UK, the rate of tuberculosis is higher amongst 
patients who originated from the Indian subcontinent (ISC), where two dominant 
lineages are present, the Central Asian Strain (CAS) and the East African Indian 
(EAI) lineage. Mycobacterial interspersed units containing variable number of tandem 
repeats DNA fingerprinting of M. tuberculosis strains isolated from UK patients who 
originated from the ISC, as defined by novel software, identified that CAS was the 
most prevalent clade (39%) and EAI was the third most prevalent clade (15%). To 
further elucidate the relationship between host origin and strain lineage, two rigorous 
new models of infection were developed which assessed mycobacterial growth and 
host cell response. The monocyte-derived macrophage model was more appropriate 
for measuring cytototoxicity than the THP-1 cell model as in the absence of infection, 
50% of THP-1 cells died compared to 2% of macrophages. CAS strains caused 1.5 
fold more cell necrosis and their growth was four fold higher than EAI strains in the 
monocyte-derived macrophage model. Finally, the response of polarised monocyte-
derived macrophages from Asian and Caucasian donors to different M. tuberculosis 
lineages was compared. CAS strains grew preferentially better in M2 macrophages 
from Asian donors. The prevalence of CAS in the Midlands is likely to be due to a 
combination of specific strain importation and increased ability of this strain to 
transmit to the population present in the Midlands. 
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1 INTRODUCTION 
1.1 Tuberculosis 
Tuberculosis (TB) is an infectious disease that can affect every organ of the body, 
although the most common form of the disease occurs in the lungs. TB can occur in 
humans and animals; the disease is caused by bacteria belonging to the 
Mycobacteriaceae family. There are over 120 species of mycobacteria, most of which 
are saphrophytic organisms that inhabit water and soil (Tortoli, 2006). 
 
The species of mycobacteria that are capable of causing TB belong to the 
Mycobacterium tuberculosis complex, and include Mycobacterium tuberculosis, 
Mycobacterium bovis, Mycobacterium africanum, Mycobacterium microtti and 
“Mycobacterium canettii” (Nicol and Wilkinson, 2008; Aranaz et al., 2003). Members 
of the complex have comparable genomes, with 99.9% nucleotide similarity and 
identical 16S rRNA sequences (Brosch et al., 2002). Despite the nucleotide similarity 
shared by members of the complex, there are wide variations in pathogenicity and 
host range (Table 1-1) (Gordon et al., 2009). 
 
Skeletal abnormalities associated with TB disease have been identified in prehistoric 
human remains, indicating that TB affected ancient humans. This evidence has been 
corroborated by the detection and molecular characterisation of M. tuberculosis from 
9000-year-old skeletons (Hershkovitz et al., 2008). In 1700 approximately one tenth 
of deaths registered in the London Bills of Mortality were caused by TB and by the 
end of the 18th century TB was estimated to cause a quarter of all deaths in Europe 
(Porter, 1989). TB can be contracted through the ingestion of infected cow’s milk and 
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so the introduction of Pasteurisation helped to reduce the spread of the disease. 
Public health measures, including vaccination and contact tracing, improved 
diagnostic techniques and the introduction of antibiotic therapy have all been 
instrumental in reducing the incidence of TB. However, the disease has not been 
eradicated and by the 1980s the number of cases of TB had begun to increase. 
Table 1-1 Phenotypic differences between five members of the M. tuberculosis complex (Nicol 
and Wilkinson, 2008; Goh et al., 2001) 
Organism Habitat 
Primary route of 
transmission 
Usual colony 
morphology 
M. tuberculosis Humans 
Airborne transmission from 
person to person 
Rough, eugonic 
growth 
M. bovis 
Wide host range: 
humans, cattle, cats, 
badgers etc. 
Airborne transmission, 
ingestion of contaminated 
cow’s milk 
Intermediate 
rough, dysgenic 
growth 
M. africanum Humans 
Airborne transmission from 
person to person 
Rough, dysgenic 
growth 
M. microtti Rodents Airborne transmission Rough or smooth 
M  canetti Humans Airborne transmission 
Smooth, eugonic 
growth 
 
Cases of drug resistant TB due to poor compliance with treatment regimens (Shah et 
al., 2007) and the spread of human immunodeficiency virus (HIV) which leaves 
people susceptible to TB infection due to depletion of CD4+ T cells (Kaufmann and 
McMichael, 2005) have contributed to the rise in the number of cases of TB. In 1993, 
the World Health Organisation (WHO) declared that the rising incidence of TB was a 
global health emergency (WHO, 1993). 
1.1.1 Global incidence of TB in humans 
The WHO estimates that M. tuberculosis currently infects one third of the world’s 
population, although the number of new TB cases has begun to decline. In 2007, it 
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was estimated that there were 9.3 million incident TB cases and 1.32 million deaths 
caused by the disease. Current data suggest that there were 8.7 million incident 
cases of TB in 2011 (equivalent to 125 cases per 100,000 population) and 1.4 million 
deaths (WHO, 2012c; WHO, 2010). The highest burden of TB is in developing 
countries with 59% of cases in 2011 occurring in Asia and 26% in Africa (WHO, 
2012c). The country with the largest number of new TB cases in 2011 was India, 
which had over 20% of all cases (2 million cases). 
1.1.2 Incidence of TB in the UK 
The number of TB cases in the UK has been gradually increasing since 1987, when 
5,085 cases were reported. By 2011, the number of cases had increased to 8,963 
with a rate of 14.4 cases per 100,000 population. The most recent data for the UK 
show that 433 people who were diagnosed with TB died in 2010 (HPA, 2012). In 
order to reduce the incidence of TB in the UK it is important to understand the reason 
for the increasing number of cases. 
 
Multi-drug resistant (MDR) TB, where bacteria are resistant to two of the three 
antibiotics used to treat the disease, accounted for nearly 4% of global TB cases in 
2011 (WHO, 2012b). There has been a gradual increase in the number of MDR-TB 
cases in the UK, 0.9% of culture confirmed cases in 2000 were MDR, increasing to 
1.6% in 2011 (HPA, 2012). However, the number of MDR cases in the UK is not 
increasing more quickly than the total number of cases suggesting that a rise in MDR 
is not driving the increase in TB. 
 
Section 1.1 
  4 
People who are co-infected with HIV and TB accounted for 13% of global TB cases 
in 2010 (WHO, 2012a). The number of HIV and TB co-infections in England, Wales 
and Northern Ireland peaked in 2004 at 9% and according to the most recent data, 
less than 5% of TB patients also had HIV in 2010. (HPA, 2011b; Crofts et al., 2008). 
The downwards trend in cases of HIV and TB co-infections indicates that the 
prevalence of HIV is not responsible for the increase of TB in the UK. 
 
The number of TB cases amongst the UK-born population has remained stable over 
the past decade, but there has been an increase in the number of cases amongst the 
non-UK born population (Figure 1-1) (HPA, 2012). Nearly three quarters of the cases 
reported in 2011 occurred in people who were not born in the UK and the rate of TB 
among this group (84 cases per 100,000 population) was more than 20 times the rate 
among people born in the UK (4 cases per 100,000 population) (HPA, 2012). The 
highest caseload of TB in the UK is amongst people born in the Indian subcontinent 
(ISC) and Africa (Figure 1-2). Immigration from countries where TB is endemic is 
therefore likely to be the major cause of increased TB cases in the UK (Gilbert et al., 
2009). 
 
There are also hot spots of TB infection, which occur in large urban areas such as 
London and the Midlands, UK where rates of TB are much higher than the national 
average and can reach those seen countries with high TB prevalence such as India 
and Africa (HPA, 2012). 
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Figure 1-1 Tuberculosis case reports by place of birth, UK, 2000 to 2011 
(HPA, 2012) 
 
Figure 1-2 Tuberculosis case reports by place of birth and ethnic group, UK, 2009 
(HPA, 2010) 
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The number of TB patients born in India has been increasing and India was the most 
common country of birth amongst non-UK born TB patients in 2009 and 2010 (Figure 
1-3) (HPA, 2012). According to the 2001 census Indians and people born to Indian 
families were the largest ethnic minority group in the UK, constituting 2% of the total 
population and numbering just over a million people (ONS, 2003). The 2011 census 
shows that Indians are still the largest ethnic minority group, constituting 2.5% of the 
population and numbering 1.4 million people (ONS, 2012) (Figure 1-4). People from 
the Indian ethnic group accounted for a quarter of UK TB cases in 2010, the largest 
proportion of cases amongst a single ethnic group and the rate of TB was the second 
highest in this group (151 cases per 100,000 population) (HPA, 2011b). 
 
 
Figure 1-3 Tuberculosis case reports amongst non-UK born patients by ethnic group, UK,   
2002 to 2010 
(HPA, 2011b) 
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Figure 1-4 Ethnic groups in England and Wales, 2001 and 2011 
(ONS, 2012; ONS, 2003). 1. Comparability issues exist between these ethnic 
groups for the 2001 and 2011 Census. 2. No comparable data exists for these 
ethnic groups in the 2001 Census 
1.2 Transmission of TB 
TB can be contracted when M. tuberculosis is ingested (Rua-Domenech, 2006) or 
when it is introduced through the skin (Kramer et al., 1993). However, M. tuberculosis 
is predominately an airborne pathogen that spreads between hosts by inhalation. 
1.2.1 Respiratory transmission of TB 
Droplets of moisture from the respiratory tract are expectorated when people cough, 
sneeze or talk. Xie and colleagues found that when a person is talking, 60% of the 
droplets that are expelled from the mouth are smaller than 100 µm in diameter, which 
means that they evaporate rapidly (Xie et al., 2009; Xie et al., 2007; Wells, 1934). 
Droplets produced by people with active pulmonary TB contain bacilli and so an 
infectious core is left behind, following evaporation, which is known as a droplet 
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nucleus. Droplet nuclei can travel on air currents and remain airborne for several 
hours. 
 
It is estimated that eight hours of exposure to an infectious person are required for 
TB transmission to occur (Musher, 2003; Riley et al., 1962). Table 1-2 shows the risk 
of TB infection associated with different types of exposure. 
Table 1-2 Risk of infection with TB derived from different types of exposure to an infected 
person (Musher, 2003) 
Nature of contact Risk of infection* 
None known 1 in 100,000 
Casual social contact 1 in 100,000 
School, workplace 1 in 50 to 1 in 3 
Nursing home 1 in 20 
Bar, social club Up to 1 in 10 
Dormitory 1 in 5 
Home 1 in 3 
* values are estimates, reflecting the number of bacilli that are aerosolised by 
the index patient, the proximity to that patient (ventilation, size of space) and the 
duration of the exposure. 
 
The droplet nuclei that are produced when a person with active TB coughs, range in 
size between 1 and 7 µm (Fennelly et al., 2004). If another person inhales the droplet 
nuclei then the fate of the nuclei depends upon its size. The largest droplet nuclei fall 
out of airflow and become trapped in the mucus that coats the upper airways. The 
airway epithelium is lined with cilia, which move the mucus towards the mouth, thus 
removing the trapped particles from the lung. 
 
Droplet nuclei that are smaller than 5 µm in diameter are carried directly to the alveoli 
by diffusion (Musher, 2003). The alveoli have no cilia (Figure 1-5) and so particles 
that are deposited here cannot be removed by mucociliary clearance. 
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Figure 1-5 Structure of the alveoli  
Image taken from http://www.mmi.mcgill.ca/mmimediasampler/ 
1.3 Immune response to TB 
1.3.1 Initial infection 
Free macrophages are present in the alveoli. Their function is to ingest particles and 
destroy bacteria. Ingestion occurs when receptor molecules on the surface of the 
macrophage bind to the surface of a bacterium. M. tuberculosis is a facultative 
intracellular pathogen, which primarily inhabits macrophages. The outcome of the 
deposition of M. tuberculosis in the alveoli depends on the virulence of the bacteria 
and the microbicidal capacity of the alveolar macrophage (Dannenberg, 1991). The 
response of the alveolar macrophage can prevent the host from succumbing to TB. 
However, if the response is excessive the inflammation caused can lead to 
permanent tissue damage (Tomlinson et al., 2012). 
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It has been estimated that 70% of people who are exposed to M. tuberculosis are 
able to destroy the bacteria without specific macrophage activation. This estimate is 
based on the number of close contacts of TB patients who develop disease after 
exposure. There is also anecdotal evidence of natural resistance to M. tuberculosis. 
One such example is the Lübeck disaster, which occurred in 1929 when 251 new-
borns were mistakenly given virulent M. tuberculosis instead of the Bacille 
Calmette-Guérin (BCG) vaccine (discussed in section 1.4). Within a year of 
inoculation, 72 infants had died and 135 had developed active TB, although they later 
recovered. However 44 infants did not develop any clinical signs of infection during a 
12-year follow up period (Rivero-Lezcano, 2012). Cobat and colleagues carried out 
tuberculin skin tests (TST) on a sample of 128 families in Cape Town, where the 
annual rate of TB is 940 cases per 100,000 population and found that over a period 
of 5 years, 40% of the people tested remained TST negative (Cobat et al., 2009). 
 
The macrophages of people who are exposed to TB but do not become infected are 
able to produce toxic reactive nitrogen and oxygen intermediates in response to 
ingestion of M. tuberculosis. The phagosome, containing the ingested bacteria, fuses 
with lysosomes, which introduces digestive enzymes that destroy the bacteria (Hope 
et al., 2004). Proteins from dead bacteria are displayed on the surface of the 
macrophage, in association with major histocompatibility complex (MHC) class II. 
This allows the antigen to be presented to T cell receptors on CD4+ T cells. Lipids 
can be presented to different sets of T cells, including CD8+ T cells by CD1 
molecules (Figure 1-6). This causes stimulation of the T cells and the macrophage 
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which presented the antigen and results in further activation of the immune response 
(Pieters, 2001). 
 
Figure 1-6 Interaction of the phagosomal/endosomal pathways with the adaptive immune 
system 
(a) Antigens that are degraded in the endosomal/lysosomal system can be 
presented by MHC class II molecules. Peptides in complex with MHC class 
II can be recognized by T helper cells, that can either activate the 
presenting cell (this is done by Th1 cells) or stimulate the production of 
antibodies by B cells (this is done by Th2 cells). 
(b) In addition, lipid moieties derived from microbes are presented to various T 
cell subsets (CD4+, CD8+ or γδ T cells) by CD1 molecules. 
(c)  MHC class I molecules present peptides - derived from antigens located in 
the cytosol and processed by the proteasome and TAP (transporter 
associated with antigen processing) - at the cell surface to CD8+ cytotoxic T 
cells. Activation of cytotoxic T cells leads to rapid lysis of the presenting cell 
(Pieters, 2001). 
 
In 30% of individuals, the actions of the alveolar macrophage are not sufficient to kill 
the M. tuberculosis. It has been suggested that the type of macrophage receptor that 
a bacterium binds can determine the response that is generated by the macrophage 
(Le Cabec et al., 2000; Astarie-Dequeker et al., 1999). Another study suggests that 
when reactive nitrogen species, produced by the macrophage, are at a sub-lethal 
concentration they signal the bacteria to enter a quiescent state by up-regulating the 
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expression of a set of 48 genes, which are associated with dormancy (Voskuil et al., 
2003). It has also been shown that when macrophages are unable to destroy 
M. tuberculosis the bacteria prevent the normal maturation of the phagolysosome. 
Some studies have shown that mycobacteria prevent the fusion of the phagosome 
with the lysosome (Vergne et al., 2005; Clemens and Horwitz, 1995; Armstrong and 
Hart, 1971), whereas others have reported that M. tuberculosis is able to escape 
from the phagolysosome (McDonough et al., 1993). Ingested M. tuberculosis remains 
viable and bacterial antigens are not presented on the surface of the infected 
macrophage. Macrophages burst when the number of intracellular bacteria becomes 
too large. The content of the burst macrophage is discharged into the alveoli, 
releasing the bacteria, which are ingested by other alveolar macrophages, or 
monocytes that migrate from the blood stream. These cells are not activated and so 
the bacteria continue to divide and more monocytes are recruited to the area. A 
primary complex forms, which consists of a small lesion at the site of infection and 
enlarged regional lymph nodes. 
 
Dendritic cells are a small population of cells that line the trachea and can also 
phagocytose mycobacteria. Once mycobacteria have been ingested, the dendritic 
cell travels to the draining lymph node and displays mycobacterial antigens on the 
cell surface. Dendritic cells are able to activate T cells and can polarise the T cell 
response towards Th1 or Th2 phenotypes (Hope et al., 2004). Th1 and Th2 
phenotypes are discussed in section 1.3.2. 
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1.3.2 Cell mediated immunity 
A cell mediated immune (CMI) response is generated following the formation of a 
primary complex, which leads to an influx of inflammatory cells such as macrophages 
and T cells. There are subsets of T cells, which can be classified by the presence of 
cell surface molecules. T cells that express the cell surface molecule CD4 are known 
as helper T cells. T helper cells are further classified into T helper 1 (Th1) and T 
helper 2 (Th2) subsets. Th1 and Th2 cells produce cytokines, which are 
cell-signalling molecules that modulate the immune system (Berger, 2000). Th1 cells, 
which have been activated by dendritic cells, recognise the antigen displayed by 
infected macrophages and respond by secreting pro-inflammatory cytokines such as 
interferon-gamma (IFN-γ). IFN-γ activates macrophages, increasing production of 
nitrogen and oxygen metabolites, which are toxic to microorganisms. Macrophage 
activation also increases the rate at which phagosomes and lysosomes fuse. 
Phagosomes contain the ingested bacteria and lysosomes contain digestive 
enzymes so an increase in their rate of fusion increases the capacity of the 
macrophage to kill intracellular bacteria. 
 
If the activated macrophage is still unable to kill the mycobacteria, it becomes 
successively less responsive to activation. The persistently infected macrophage will 
be surrounded by lymphocytes and macrophages, which encase it, forming a 
granuloma or tubercle. The infected macrophages are destroyed by natural killer 
cells and later by cytotoxic T cells, in order to eliminate the intracellular environment 
that favours bacterial growth. The centre of the granuloma undergoes caseous 
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necrosis, which forms a solid structure that is presumed to inhibit the growth of 
extra-cellular bacteria. 
 
Approximately 10% of people who form a primary complex develop primary active 
TB. Primary TB usually occurs in children and immunocompromised adults because 
the CMI response is inadequate. Bacilli can escape from the edge of the caseous 
area and begin multiplying in non-activated macrophages, which are present at the 
edge of the caseous area. Cytotoxic T cells, which express the cell surface molecule 
CD8, destroy the infected macrophages and the caseous area is enlarged. This 
process destroys lung tissue and the bacteria are able to spread by the lymphatic 
system to other sites, where they may cause extra-pulmonary TB. If the lungs sustain 
enough injury, it will result in death (Ottenhoff, 2012; Davies, 1999). 
 
Immunocompetent hosts develop good CMI and the macrophages that surround the 
caseum are highly activated. This means that any bacilli that escape from the 
caseous centre are ingested and destroyed. The lesions do not enlarge and the 
patient is unaware of the infection. These tubercles can calcify and become visible on 
X-rays (Janeway, 1999). 
 
The infection is contained in such individuals by the CMI response but it is not 
eliminated and so people are described as being latently infected. M. tuberculosis is 
able to persist within granulomata for decades without causing any sign of illness in 
the host. Latently infected people are not able to transmit the infection to other 
people but they have a 10% risk of developing active TB over their lifetime 
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(Comstock, 1982), with this risk increasing if accompanied by HIV infection (Corbett 
and De Cock, 1996). 
 
A weakening of the host immune system, which could be caused by malnutrition, 
stress, old age or the administration of therapeutic immunosuppressants, causes the 
caseum of the granulomata to liquefy, although the mechanism by which this occurs 
is unknown. The growth of bacteria was inhibited by the solid caseum but once the 
caseum is liquefied, the bacilli are able to multiply extracellularly. A large quantity of 
bacteria builds up and the granuloma breaks down, releasing the bacteria and 
leading to active post-primary TB. The large numbers of bacilli that are released often 
overwhelm the CMI response. A delayed type hypersensitivity (DTH) reaction 
destroys the lung tissue and discharges the bacteria into the airways where they can 
infect other areas of the lung and spread to other people (Figure 1-7). 
 
1.4 Vaccination 
The only established vaccine available against M. tuberculosis is BCG, which is a live 
attenuated vaccine that was produced by repeated passage of an M. bovis isolate 
using a medium containing bile (Calmette, 1931). After 230 passages it was shown 
that the strain was no longer able to cause disease in animals or humans. 
Administration of the BCG vaccine to humans began in 1921 and since then it has 
been given to over three billion people. It was not possible to store the vaccine strain 
in 1921 so its repeated passage continued so that there are now several different 
vaccine strains (Behr, 2002). 
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Figure 1-7 Result of infection with M. tuberculosis 
Adapted from (Sasindran and Torrelles, 2011) 
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The efficacy of the BCG vaccine has been questioned; several studies have shown 
that the protective immunity varies in different human populations, which may be due 
in part to the use of different vaccine strains. Datta and colleagues reported that BCG 
had no protective immunity in adults in south India (Tuberculosis Research Centre, 
1999), whereas 80% protection has been reported in adults in the UK (Colditz et al., 
1994). The vaccine appears to be more efficacious against TB meningitis in young 
children than it is against pulmonary TB in adults (Fine, 2001; Colditz et al., 1995; 
Colditz et al., 1994; Comstock, 1994; Rodrigues et al., 1993). Routine BCG 
vaccination of UK schoolchildren ended in 2005 as the risks associated with the 
vaccine, including infection of immune-compromised people were deemed to 
outweigh the protective benefits of the vaccine. The vaccine is now only 
recommended in the UK for babies born in areas with high TB rates, health workers, 
recent immigrants from countries where TB is endemic and people who have come 
into close contact with a TB patient. 
1.5 Diagnosis of TB 
The symptoms of pulmonary TB in humans include a persistent cough, weight loss, 
fever and night sweats. People feel generally tired and unwell and suffer a loss of 
appetite. In the later stages of the disease, there may be blood present in the mucus 
or sputum that is coughed up from the airways. 
 
1.5.1 Clinical diagnosis of TB 
A sputum sample and a chest X-ray are taken from a person who shows signs of 
pulmonary TB. Extra-pulmonary TB is diagnosed with computerised tomography (CT) 
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or magnetic resonance imaging (MRI) scans. Blood and urine samples are collected 
for identification of systemic mycobacterial infection and a tissue biopsy may be 
taken from the infected area when extra-pulmonary TB is suspected. 
 
1.5.2 Immunological diagnosis of TB 
People who may be infected with TB but are asymptomatic (e.g. contacts of index 
patients or immigrants from areas where TB is endemic) can be tested for latent TB. 
A person who has been exposed to TB will have memory T cells that are specific for 
TB antigens. Subsequent intra-dermal or subcutaneous injection of protein antigen 
causes a local T cell-mediated inflammatory reaction, which evolves over 
24-72 hours. The reaction results in a palpable, raised and hardened area (known as 
an induration) that indicates a positive TST. If a person has been vaccinated with 
BCG or has been in contact with non-TB mycobacteria then this will also cause a 
reaction when the TST is administered. The sensitivity of TST in 
immunocompromised people is low. The problems associated with TST have led to 
the development of blood tests for TB, which are called IFN-γ release assays 
(IGRAs). 
 
An IGRA measures the amount of IFN-γ that is released by CD4+ T cells. Blood 
samples are mixed with two M. tuberculosis specific protein antigens, which are not 
present in BCG or in non-TB mycobacteria (Brosch and Vincent, 2007). If a person 
has been in contact with M. tuberculosis, their T cells will react to the antigen and 
release IFN-γ. The amount of IFN- γ that is released can be measured using an 
enzyme linked immunosorbent assay (ELISA) (Mazurek et al., 2001). 
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1.5.3 Laboratory diagnosis of TB 
Samples from patients including sputum, blood, urine or tissue biopsies are sent for 
bacteriological identification. Samples from non-sterile sites may contain commensal 
flora so they are decontaminated with 4% sodium hydroxide. Decontamination is 
necessary because M. tuberculosis has a slow growth rate, which means that 
cultures are quickly dominated by contaminants, making it difficult to isolate the 
mycobacteria. Rapidly growing microorganisms have a lower resistance to sodium 
hydroxide than mycobacteria, so a controlled exposure to sodium hydroxide can kill 
the contaminants without destroying all of the mycobacteria. 
 
1.5.3.1 Microscopic observation of acid fast bacilli 
The cell wall of mycobacteria is rich in lipids, which makes them resistant to 
acid-alcohol decolourisation when certain staining techniques are employed; this is 
described as being acid-fast. Two staining techniques are routinely used for 
identification of TB, the Ziehl-Neelsen (ZN) method, which stains mycobacteria pink 
and a fluorescent procedure using auramine, which stains mycobacteria yellow-green 
(Figure 1-8). 
 
Microscopic analysis is inexpensive and provides rapid results, although there is a 
requirement for experienced staff who can distinguish between mycobacteria and 
other acid-fast bacteria. A lack of observable acid-fast bacteria in a stained sample 
does not always mean that a patient is not infected and so in the UK further tests are 
carried out. In countries where there is a high burden of disease, microscopy may be 
the only diagnostic test that is performed. 
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1.5.3.2 Mycobacterial culture 
Culture of patient samples is more sensitive than microscopy for the detection of 
M. tuberculosis (Yeager, Jr. et al., 1967). In the UK, patient samples are inoculated 
into mycobacterial growth indicator tubes (MGITs™) which contain Middlebrook 7H9 
liquid broth and an oxygen-quenched fluorophore. Bacteria deplete oxygen as they 
respire until there is insufficient oxygen to quench the fluorophore, which causes an 
increase in fluorescence. Tubes are placed in a BACTEC™ MGIT™ 960 System (BD 
Biosciences, Oxford, UK), which incubates them at 37°C and monitors for increasing 
fluorescence. Once the fluorescence from a tube reaches 75 units it is declared 
positive. Tubes that show no fluorescence for a minimum of 34 days are declared 
negative. 
 
MGITs™ also contain an antimicrobial mixture called PANTA™ (Polymyxin B, 
Amphotericin B, Nalidixic Acid, Trimethoprim, Azlocillin) which reduces contamination 
from non-mycobacterial organisms and an enrichment, OADC (Oleic acid, Albumin, 
Dextrose and Catalase) which is essential for growth of mycobacteria. 
 
1.5.3.3 Genotyping using DNA amplification 
Bacteria from positive MGIT™ cultures are identified with a species specific 
M. tuberculosis complex DNAstrip® test (Hain Lifescience, Nehren, Germany) 
(Richter et al., 2004). The test can differentiate between M. tuberculosis, 
M. africanum, M. bovis, Mycobacterium caprae, M. microti and M. bovis BCG. 
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Figure 1-8 Examples of different acid fast stains 
A. Auramine stained M. tuberculosis H37Rv (yellow/ green) 
B. Ziehl-Neelsen stained M. tuberculosis H37Rv (pink) 
Images were taken during the current study. 
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DNA is extracted from positive cultures and amplified by PCR using several primers 
each of which are specific to a different species. The amplicons are denatured and 
placed on a DNAstrip® that is coated with complementary probes. The amplicon 
binds to its complementary probe and a conjugation reaction produces a colour that 
appears as a band. The specific banding pattern is used to identify the species 
(Figure 1-9). 
 
1.5.3.4 Antibiotic sensitivity testing 
Liquid culture is used to test the susceptibility of a patient isolate to isoniazid, 
rifampicin, ethambutol and pyrazinamide, which are the four drugs used in routine 
treatment of TB. The test is based on the growth of an M. tuberculosis isolate in a 
MGIT™ containing a drug compared to a MGIT™ that does not contain the drug. 
 
If there is resistance to rifampicin or isoniazid then it is confirmed using a test that is 
similar to the Hain Lifescience genotype test, which can identify the presence of a 
DNA mutation conferring drug-resistance. 
 
1.6 Treatment of TB 
Patients with drug sensitive TB are treated with a combination of the antibiotics 
rifampicin, isoniazid, pyrazinamide and ethambutol for two months, followed by 
rifampicin and isoniazid for a further four months (Brosch and Vincent, 2007; 
Gillespie and Hawkey, 2006). 
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Figure 1-9 Differentiation of M. tuberculosis complex organisms using the Hain Lifescience genotype test 
Image taken from www.hain-lifescience.de 
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Rifampicin inhibits mycobacterial transcription by binding to DNA-dependent RNA 
polymerase and blocking the path of the elongating RNA transcript. Mutation in a 
specific region of a gene, which encodes the β-subunit of RNA polymerase (rpoB), 
prevents rifampicin from binding, leading to rifampicin resistance (Campbell et al., 
2001). More than 96% of rifampicin resistant strains have a mutation in an 81 base 
pair region of rpoB (Telenti et al., 1993). 
 
Isoniazid is believed to block the synthesis of components of the mycobacterial cell 
envelope. Isoniazid is a pro-drug that is activated by a mycobacterial catalase-
peroxidase. Approximately half of the clinical isolates that are resistant to isoniazid 
have mutations in the katG gene, which codes for the primary catalase-peroxidase 
(Somoskovi et al., 2001). 
 
Pyrazinamide is also a pro-drug, which is activated by a mycobacterial enzyme. 
Pyrazinamide is thought to disrupt fatty acid synthesis and resistance can arise when 
the action of the activating enzyme is ablated by mutation. Up regulation of efflux 
pumps that extrude pyrazinamide can also lead to drug resistance (Louw et al., 2009; 
Somoskovi et al., 2001). 
 
Patients who have drug resistant TB can be treated with second line antibiotics, 
which are prescribed on an individual basis, although cases of extensively drug 
resistant TB (XDR-TB) have been described which are resistant to all known 
antibiotics (Velayati et al., 2009). 
Section 1.7 
  25 
1.7 Evidence for M. tuberculosis phenotypic strain diversity 
TB disease results from the interaction of a favourable environment for transmission, 
a susceptible host, and a virulent strain of M. tuberculosis. Virulence can be defined 
as the ability to cause disease, mortality and morbidity, or the capacity of a pathogen 
to overcome host defences (Thomas and Elkinton, 2004). Several strains of 
M. tuberculosis are described as having increased virulence. There are also 
examples of attenuated strains of M. tuberculosis, which have lost their virulence. 
Some of the observations of strains with altered virulence are described below. 
1.7.1 Laboratory strains 
In 1905, a strain of M. tuberculosis was isolated from the sputum of a patient with 
pulmonary TB (Steenken et al., 1934). This isolate was called H37 and it was used 
extensively for laboratory studies of TB. In 1926, Petroff and Steenken found that 
H37 occasionally failed to infect guinea pigs (Petroff and Steenken, 1930). Different 
types of culture media were used to ‘dissociate’ H37 into two distinct variants. One 
was termed H37Rv as it was virulent in guinea pigs and the other was termed H37Ra 
as it was avirulent (Steenken, 1935; Steenken et al., 1934). H37Ra and H37Rv are 
available from the American Type Culture Collection (ATCC) but the original H37 
strain was lost. 
1.7.2 Epidemiological strain variation 
A number of TB outbreaks have provided evidence that some strains of 
M. tuberculosis possess characteristics that make them better able to spread 
between hosts and more proficient at causing disease (Thwaites et al., 2008). The 
strain CDC1551 caused an outbreak of TB near Kentucky, USA in 1995, which was 
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characterised by a high rate of transmission to patient contacts. Patient contacts also 
had a strong response to TST (Valway et al., 1998). Initial investigators described 
CDC1551 as hypervirulent because transmission occurred in a low risk population 
and there was evidence of transmission occurring in an outdoor setting. The authors 
suggested that transmission was due to a characteristic of the strain rather than 
susceptibility of the patients or environmental factors that may have favoured the 
spread of the disease. CDC1551 belongs to the X3 spoligotype clade (spoligotype 
international type 549) (Mathema et al., 2012). 
 
A study by Zhang and colleagues identified five unique isolates from patients with 
pulmonary TB in Los Angeles, USA. They were described as unique because each 
strain was only isolated once during the study period, none of them had caused 
disease in another person prior to their identification and they were not found in any 
other patient in the four-year follow up study. The isolates were all taken from sputum 
samples that contained acid-fast bacilli and could be grown in culture. All five patients 
had spent time at homeless shelters before they were diagnosed with TB. The 
authors concluded that each of these strains had caused disease in only one person, 
despite being present in an environment where transmission of TB was common. 
The people in the homeless shelters who were exposed to these isolates had high 
risk factors for TB development, which implies that the reason that these strains did 
not spread to others was due to the characteristics of the strains (Zhang et al., 1999). 
 
In 2001, the Crown Hills (CH) strain caused an outbreak of TB in a school in 
Leicester, UK. Tuberculin skin testing was performed on 1,128 people who attended 
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the school which identified a further 69 cases of active TB and 254 cases of latent 
infection (Ewer et al., 2003). The rate of transmission was unusually high in this 
outbreak and there was a high rate of active disease (Rajakumar et al., 2004). The 
CH strain is a member of the Central Asian Spoligotype (CAS) clade. 
1.8 Evidence for M. tuberculosis genotypic strain diversity 
Variation between strains of the same bacterial species can have a large impact on 
the disease that they cause in humans. The influence of strain variation is well 
established for a number of pathogens, including Escherichia coli, Haemophylus 
influenzae and Neisseria, Bordetella and Streptococcus species. 
 
Infection with M. tuberculosis can lead to active or latent TB, as discussed in section 
1.3. There are several well-known risk factors that increase the probability of 
developing active TB, including behaviours such as substance abuse (Oeltmann et 
al., 2009; Reichman et al., 1979), underlying medical conditions and socioeconomic 
factors including poor diet and housing (Goh et al., 2001; Terris, 1948). 
 
Several human gene polymorphisms, which increase the risk of contracting TB 
disease have been identified (Bellamy et al., 1998), for example those leading to 
altered serum levels of mannose binding protein (Soborg et al., 2003; Selvaraj et al., 
1999). There is a polymorphism in the Toll-like receptor 2 gene, which was found 
more significantly associated with TB patients than with healthy control subjects 
(Ogus et al., 2004). Polymorphisms in the gene encoding the vitamin D receptor have 
been linked to an increased likelihood of developing active TB (Wilbur et al., 2007; 
Wilkinson et al., 2000). However a meta-analysis carried out in 2005 that looked at 
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vitamin D receptor polymorphisms found that results were inconclusive and studies 
were underpowered (Lewis et al., 2005). More recently, a study compared the 
interleukin-23 (IL-23) receptor gene of 168 TB patients with 150 healthy people in 
Tunisia and found an association between a functional single nucleotide 
polymorphism (SNP) and the severity of pulmonary disease (Ben-Selma and 
Boukadida, 2012). These observations have focussed attention on host factors 
however, it is also important to consider the effect that bacterial variation has on the 
outcome of infection with M. tuberculosis. 
 
In order to investigate the genetic diversity of M. tuberculosis strains and the impact 
that this has on human disease, molecular strain typing techniques are required, 
which can identify genotypic differences between strains. The sampling frameworks 
that are used to discriminate between strains exploit the unique ways in which 
M. tuberculosis undergoes genetic rearrangements (Gagneux and Small, 2007; 
Tanaka et al., 2000). 
 
The advent of molecular strain typing techniques that analyse the genome of 
bacterial isolates has revolutionised outbreak investigations by detecting or refuting 
epidemiological links. Effective control of TB transmission relies on tracing the 
contacts of people with active disease and treatment of latent cases before they 
become active. However because M. tuberculosis can exist in a dormant state, 
strains that belong to the same outbreak can be temporally separated and become 
difficult to link by common case factors such as location and time. 
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1.8.1 Typing methods giving insight into clinical outbreaks 
Clinical isolates of M. tuberculosis are usually typed by analysing chromosomal 
regions that are associated with mobile insertion elements or repetitive DNA 
sequences (Barnes and Cave, 2003). In order to be clinically applicable, the rate at 
which polymorphism in the chosen chromosomal region takes place, must be fast 
enough to distinguish between strains that are not related by epidemiology, but must 
also occur slowly enough to allow related cases to be linked reliably (Mathema et al., 
2006). Three methods have been widely used for typing clinical isolates, they are 
summarised in Table 1-3 and discussed below in detail. 
Table 1-3 Comparison of the three most commonly used M. tuberculosis strain-typing 
techniques in clinical practice (Malik and Godfrey-Faussett, 2005) 
Method Target 
Culture 
required 
Time Output 
Discrimination 
(compared with 
IS6110 RFLP) 
Cost 
IS6110-
RFLP
1
 
IS6110 
insertion 
sequence 
Yes Weeks Analog 
Gold standard: 
limited in isolates 
with <6 copies 
High 
Spoligo-
typing 
43 DR
2
 
cluster; 
presence or 
absence 
No Days Digital Lower Low 
MIRU-
VNTR
3
 
12 MIRU 
used 
No Days Digital Slightly lower Medium 
1
 RFLP=restriction fragment length polymorphism 
2
 DR=direct repeat
 
 
3
MIRU-VNTR= mycobacterial interspersed units containing variable number of 
tandem repeats 
1.8.1.1 IS6110 restriction fragment length polymorphism 
IS6110 is an insertion element that is widely dispersed throughout the 
M. tuberculosis complex. The number of copies of IS6110 in the genome and their 
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location cause variation between M. tuberculosis strains (Tanaka et al., 2000). 
Digestion of DNA from clinical isolates with a restriction enzyme results in different 
sized fragments that are detected by Southern hybridisation. Differences between 
strains are known as restriction fragment length polymorphisms (RFLP). 
 
IS6110 RFLP was the first genomic method used for typing of clinical M. tuberculosis 
isolates and it gives good discrimination between strains. However, the technique is 
labour intensive and requires large amounts of genomic DNA (Gascoyne-Binzi et al., 
2002). Skilled workers are needed to identify patterns and the data is not digitised, 
making comparison of results difficult. Some strains, including many from the ISC, 
have less than six copies of IS6110 and cannot be typed by IS6110 RFLP, (Sola et 
al., 2003). The method also assumes that distribution of IS6110 through the genome 
is random; however, IS6110 is restricted to two-thirds of the genome and there are 
insertion hot spots (Gillespie et al., 2000). IS6110 RFLP analysis of clinical isolates 
has been superseded by PCR-based methods, which are more suitable for high 
through put screening (Fang et al., 1998). 
1.8.1.2 Spoligotyping 
The DR locus of M. tuberculosis complex organisms contains a variable number of 
well-conserved 36 base pair direct repeats, interspersed with non-repetitive unique 
spacer sequences (Figure 1-10A). Uni-directional deletion of spacers and repeats 
causes variation between strains. In M. tuberculosis H37Rv, which has a genome of 
4.4 Mb, the DR locus is 5,186 base pairs in length. PCR amplification of the locus, 
using primers targeting DRs, produces multiple DNA fragments of different sizes 
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(Figure 1-10B). Hybridisation of the fragments to 43 spacer oligonucleotides (37 
spacers from M. tuberculosis H37Rv and 6 from M. bovis BCG) allows detection. 
 
If a strain is positive for a spacer it is represented by the number 1 and if it is 
negative, it is represented by a 0, which produces a 43 digit binary code known as a 
spoligotype. Spoligotypes can be compared to an international database called 
SpolDB4 (Brudey et al., 2006), which can be queried online using SITVIT 
(http://www.pasteur-guadeloupe.fr:8081/SITVITDemo/). The database contained 
39,609 strains from 122 countries when it was accessed in January 2013. 
Bioinformatics and a number of visual rules are used to classify spoligotype patterns 
into 62 clades or lineages, for example, members of the Beijing clade have retained 
spacers 35 to 43 but spacers 1 to 34 are absent (Filliol et al., 2003). Clades are 
generally named after the area where a spoligotype was first identified however 
groups of poorly defined strains that have been isolated from several areas have 
been named using letters (Table 1-4). Spoligotype clades can be sub-divided into 
shared-types (STs) which are also known as spoligotype international types (SITs). 
 
The existence of the SpolDB4 database means that spoligotypes can be used to 
make global comparisons between strains. However, spoligotyping does not 
discriminate between strains as well as IS6110 RFLP and is therefore not as useful 
for outbreak investigation (Nguyen et al., 2004). 
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Figure 1-10 Structure of the direct repeat locus 
A. Structure of the DR locus, DRs are depicted by rectangles and numbers correspond to unique spacer regions. 
B. PCR amplification of the DR region. All DRs in the region can act as targets for the primers so that DNA is a mixture of 
fragments of different sizes. The amplification products shown would be produced from amplification of a region containing only 
five contiguous DRs (Kamerbeek et al., 1997). 
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Spoligotyping was carried out by reverse line blot hybridisation, which was labour 
intensive and relied on skilled workers to visually assign the designation of each 
spacer. The introduction of a partially automated multi-analyte bead based system 
has reduced the amount of time taken to produce a spoligotype and the designation 
of positive or negative spacers is more accurate. 
Table 1-4 Definition of major clades present in the SpolDB4 database (Brudey et al., 2006) 
Clade 
name 
Derivation of clade name 
Geographical regions where the clade is 
commonly isolated 
CAS Central Asian Spoligotype Far east Asia, ISC and Tanzania 
EAI East African Indian Originated in east Africa and India 
U Unknown Isolated in Bangladesh 
Beijing Beijing China with recent global spread  
LAM Latin American Mediterranean Mediterranean basin, and the Caribbean 
S Sicilian Sicily and Sardinia 
T Poorly defined World wide 
Haarlem Haarlem Europe 
X Poorly defined UK, USA and former British colonies 
1.8.1.3 Mycobacterial interspersed repetitive unit (MIRU) typing 
Variable number of tandem repeats (VNTRs) are locations in the genome where a 
short nucleotide sequence is organised as a tandem repeat. Two or more nucleotides 
are repeated and the repetitions are directly adjacent e.g. GATCG|GATCG|GATCG. 
VNTRs can increase and decrease by rare strand slippage of DNA polymerase, 
recombination and looping out of sections of DNA. 
Section 1.8 
   34 
Mycobacterial interspersed repetitive units (MIRU) containing VNTRs (MIRU-VNTR) 
are mini-satellite sequences of 53-111 base pairs in length. They occur throughout 
the genome as single or multiple repeats. MIRU-VNTR profiles are generated using a 
PCR-based method where multiple independent loci are amplified and then 
differentiated by size, which can be used to calculate the number of repeats at each 
locus as shown in Figure 1-11 (Cowan et al., 2002). 
 
MIRU-VNTR can discriminate between strains better than spoligotyping and IS6110 
RFLP for low IS6110 copy number strains, although it does not discriminate as well 
as IS6110 RFLP for high IS6110 copy number strains (Nguyen et al., 2004). 
However, the method is widely used for clinical investigation, as it is robust and easy 
to perform. The process has been partially automated and results can be digitised for 
comparison of data (Evans et al., 2004). 
 
Figure 1-11 Principle of MIRU-VNTR typing 
Two MIRU-VNTR loci, exact tandem repeat A (Etr-A) and exact tandem repeat 
B (Etr-B) are shown in three example strains (I, II and III). Primers that are 
specific for the DNA up and downstream of each loci are used to produce PCR 
amplicon. The number of repeats at each locus can be calculated based on the 
size of the PCR amplicon and used to produce the complete MIRU-VNTR 
profile. 
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1.8.2 Typing methods giving insight into the evolutionary origins 
of M. tuberculosis strains 
In order to identify the evolutionary origin of strains, a typing method must 
differentiate between evolutionary distinct strains. This means that typing methods 
that give insight into the evolutionary origin of strains can be less stringent when 
discriminating between strains than typing methods used for clinical strains, as 
chains of transmission do not need to be identified. 
1.8.2.1 Single nucleotide polymorphisms 
Generation of genetic diversity in M. tuberculosis complex organisms can occur 
through single nucleotide polymorphisms (SNPs). Few spontaneous mutations 
become fixed within the population structure if there is no selective pressure. SNPs 
that are established in a clonal lineage are relatively stable, and are often used to 
group strains into phylogenies (Huard et al., 2006). Sreevatsan and colleagues 
carried out the first major study using SNPs for strain classification. They found that 
SNPs in the katG codon 463 and the gyrA codon 95 were phylogenetically 
informative and used them to assign strains of M. tuberculosis to three principal 
genetic groups (PGGs) as shown in Figure 1-12 (Sreevatsan et al., 1997). PGG1 
organisms are the oldest in evolutionary terms and are described as ancient. Genetic 
diversity is greatest in PGG1 because organisms have evolved over a longer period. 
PGG2 organisms are evolutionary more modern than PGG1 organisms, followed by 
PGG3 organisms, which are the most modern strains and show the least genetic 
diversity. 
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Figure 1-12 SNP based evolutionary scenario for M. tuberculosis complex organisms 
Lineage defining SNPs in katG codon 463 and gyrA codon 95 for principal 
genetic group (PGG) 1, 2 and 3 organisms are shown with the DNA triplet code 
and the corresponding amino acid three-letter code (Sreevatsan et al., 1997). 
1.8.2.2 Large sequence polymorphisms 
Comparison of M. tuberculosis complex sequenced genomes has revealed the loss 
of segments of chromosomal DNA (Brosch et al., 2002). These losses are called 
large sequence polymorphisms (LSPs) and they represent irreversible, unique event 
polymorphisms (Gagneux et al., 2006). 
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When the genome of M. tuberculosis H37Rv was compared to BCG, 14 major 
regions of difference (RD) were discovered (Gordon et al., 1999). The regions of 
DNA, which are absent from the genome of BCG, are denoted as RD1 to RD14. RD1 
is a 9.5 Kb region that deletes seven genes and truncates a further two. The region is 
absent from all BCG strains but present in other strains of M. bovis. The deletion of 
RD1 is believed to be an important event in the loss of virulence associated with the 
attenuation of the vaccine strain (Lewis et al., 2003). The functions of the deleted 
genes are unknown; however, two of the genes encode early secretory antigen-6 
(ESAT-6) and culture filtrate protein-10 (CFP10). Experiments that delete the RD1 
region from M. tuberculosis H37Rv give rise to mutants that have reduced virulence 
(Lewis et al., 2003). 
 
Genomic comparison of M. tuberculosis H37Rv with other members of the 
M. tuberculosis complex revealed a deletion specific to M. tuberculosis strains, 
named M. tuberculosis specific deletion 1 (TbD1). A large set of strains from 
geographically diverse settings have been analysed and the regions of DNA that 
border the TbD1 region, were conserved. This indicates that deletion of the TbD1 
region occurred in a common progenitor. The same study found that a small number 
of strains retained the TbD1 region. These strains clustered together when analysed 
with different typing techniques and it was noted that they had low copy numbers of 
IS6110 (Brosch et al., 2002). Subsequent analysis of PGG typing has indicated that 
strains belonging to PGG1 may have retained or lost TbD1, but none of the strains 
belonging to PGG2 or PGG3 have retained the region. Therefore, presence of the 
TbD1 region is a marker for ancient strains and the absence of tbD1 is a marker for 
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modern strains. There are no repetitive DNA sequences bordering the TbD1 or RD1 
regions so the mechanism of DNA elimination is unknown. It is possible that rare 
strand slippage errors of DNA polymerase are responsible for the deletions. 
 
Subsequent studies have supported the division of M. tuberculosis strains into 
modern and ancient lineages based on the absence or presence of the TbD1 region 
respectively. Hershberg and colleagues produced a phylogenetic tree based on the 
DNA sequences of 89 genes for a collection of 108 M. tuberculosis complex strains 
(Hershberg et al., 2008). The authors found that the primary branches of their 
phylogenetic tree grouped modern and ancient strains which corresponded with the 
presence or absence of TbD1. The authors also showed that the difference between 
modern and ancient strains was greater than previously assumed and was not 
restricted to the TbD1 region. Wirth and colleagues produced a phylogenetic tree 
based on MIRU data for 355 isolates and showed that strains can be divided into two 
major lineages (Wirth et al., 2008). The authors describe lineage one, which includes 
the spoligotype clades T, Haarlem, LAM, S, X, Beijing and CAS all of which are TbD1 
negative strains and lineage two that includes the spoligotype clade EAI and 
M. africanum. All the strains in lineage 2 have retained the TbD1 region. 
1.8.3 Whole genome sequencing 
The first M. tuberculosis whole genome sequence (WGS) was published in 1998 
(Cole et al., 1998). Since then improvements in technology have reduced the cost 
and time required to produce a WGS so that there are currently over 600 
M. tuberculosis genomes available (http://tinyurl.com/b3bowce - accessed 2013). 
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In 2011, Gardy and colleagues used WGS to compare 36 M. tuberculosis clinical 
isolates. They found that two distinct groups were present in an outbreak in which all 
of the strains had the same MIRU-VNTR profile (Gardy et al., 2011). When the 
sequence data was combined with social-network analysis, the authors were able to 
identify the chain of transmission that had occurred in the outbreak, which was not 
revealed by conventional genotyping and contact tracing. 
 
The improvements in WGS technology and studies such as the one carried out by 
Gardy and colleagues show that WGS is a powerful tool that could improve clinical 
outbreak investigations. WGS will undoubtedly lead to greater understanding of the 
evolution of M. tuberculosis and the epidemiology of the disease. Pallen and 
colleagues report that WGS can cost less than £1,000 per strain (Pallen et al., 2010). 
The cost of 24 loci MIRU-VNTR typing is approximately £75 per strain so whilst the 
cost of WGS is constantly falling, it may be some time before it replaces the 
conventional typing methods described in sections 1.8.1 and 1.8.2. 
1.8.4 Evolution of the M. tuberculosis complex 
Several studies have used a combination of typing techniques to construct an 
evolutionary scenario for M. tuberculosis organisms (Gagneux, 2012). Allelic 
variations in bacteria can occur by random mutation, horizontal gene transfer (HGT) 
or recombination events. Microorganisms can acquire genetic diversity by HGT 
between different species. New genes obtained by HGT may confer an advantage to 
the recipient under certain selective pressures. Sequences that have been acquired 
by HGT have defining characteristics such as aberrant GC (guanine-cytosine) 
content, which allow them to be identified (Jang et al., 2008; Becq et al., 2007). 
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There is evidence of HGT and recombination in M. tuberculosis complex organisms, 
but the exchange of genetic material appears to have occurred only in the distant 
past (Dos Vultos et al., 2008; Gutierrez et al., 2005). Streevatsen and colleagues 
noted that the number of SNPs in M. tuberculosis complex organisms is lower than in 
other pathogenic organisms, meaning that there is a high degree of conservation in 
the housekeeping genes of members of the complex (Hirsh et al., 2004; Sreevatsan 
et al., 1997). 
 
The high degree of conservation in housekeeping genes and the lack of HGT 
signifies that members of the M. tuberculosis complex are the clonal progeny of a 
single successful ancestor. This progenitor strain resulted from an evolutionary 
bottleneck at the time of speciation, which occurred between 20,000 and 35,000 
years ago (Ernst et al., 2007; Gutierrez et al., 2005; Supply et al., 2003). Figure 1-13 
shows a scheme for the proposed evolution of the M. tuberculosis complex. The 
scheme is based on the presence or absence of conserved deleted regions and on 
sequence polymorphisms in five selected genes. 
 
1.8.5 Geographical partitioning of M. tuberculosis strains 
In 1961, Bhatia and colleagues compared 281 TB isolates from patients in Madras, 
India with 93 isolates from patients in the UK (Bhatia et al., 1961). The isolates were 
injected into guinea pigs and the progression of the disease was monitored. The 
study found that Indian isolates were less virulent than UK isolates as they caused 
lower mortality in the guinea pig model. This was one of the earliest observations of 
phenotypic differences between strains of M. tuberculosis from different regions. 
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Figure 1-13 Proposed evolutionary pathway of members of the M. tuberculosis complex 
The distances between branches are for illustration and may not be consistent 
with calculated phylogenetic differences. 
 
Blue boxes depict successive loss of DNA in certain lineages,  
blue arrows show ancient strains belonging to PGG1, 
green arrows indicate that strains belong to PGG2 and 
the red arrow indicates that strains belong PGG3, 
according to Sreevatsan’s definitions (Brosch et al., 2002). 
 
Molecular typing methods, which assess variation in mobile genetic elements or 
repetitive DNA sequences (as discussed in sections 1.8.1 and 1.8.2), have identified 
groups of strains that are closely related and can be assembled into strain families 
(Bhanu et al., 2002; van Soolingen et al., 1995). Members of the same family share 
several independent genetic characteristics and are believed to have recently 
diverged from a common ancestor. 
 
There are different classification systems for the identification of phylogeographical 
lineages. The most widely recognised lineages were identified using spoligotyping or 
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LSP analysis (Garzelli et al., 2010). LSP-based analysis carried out by Gagneux and 
colleagues identified six major lineages that were associated with specific human 
populations and geographical areas (Gagneux et al., 2006). Spoligotyping has 
divided strains into a larger number of families, the majority of which are 
geographically partitioned (Brudey et al., 2006). There is good correlation between 
the two classification systems so that spoligotype clades correspond to LSP-based 
lineages proposed by Gagneux and colleagues (Table 1-5). 
 
Table 1-5 Association between major spoligotype clades and LSP lineages, adapted from 
(Gagneux and Small, 2007) 
LSP lineage Spoligotype clade Geographical area 
Indo-oceanic EAI All around the Indian Ocean 
East Asian Beijing 
East and south east Asia, rapid 
spread in eastern Europe 
East African-Indian CAS 
East Africa, north India and 
Pakistan 
Euro-American T, Haarlem, LAM, S, X 
Europe and the Americas, Africa 
and the Middle East 
West African I and  
West African II  
M. africanum Africa 
 
Early studies identified that certain M. tuberculosis strain families were dominant in 
particular geographical regions, for example the Beijing family was found to be the 
principal strain in China, Mongolia, South Korea, and Thailand, but was not prevalent 
in The Netherlands. The global distribution of 11 of the major spoligotype clades is 
shown in Figure 1-14. 
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Figure 1-14 Percentage of main spoligotyping-defined M. tuberculosis complex genotype 
families within the international spoligotype database (SpolDB4) 
(Brudey et al., 2006; van Soolingen et al., 1995). 
 
It is hypothesised that M. tuberculosis emerged in Africa (Gagneux, 2012), before an 
evolutionary bottleneck occurred approximately 35,000 years ago that allowed the 
expansion of a successful clone (Brosch et al., 2002). Gutierrez and colleagues have 
suggested that the successful clone was dispersed globally at the same time as 
ancient humans migrated out of Africa (Gutierrez et al., 2005). Following the global 
dispersal of M. tuberculosis, it is believed that different regions became isolated, with 
little movement of human population between areas. It is thought that co-evolution of 
the pathogen and the host occurred in each geographically isolated area, allowing 
M. tuberculosis to adapt to specific human populations (Chapman and Hill, 2012). 
This co-evolution has led to distinct families of M. tuberculosis strains that are seen to 
be closely associated with different global regions (Baker et al., 2004). 
AFR    = Africa CAM = central America EUR = Europe FEA = far east Asia 
MECA = Middle East & central Asia NAM = North America OCE = Oceania SAM =  South America 
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Gagneux and colleagues have shown that the association between pathogen and 
host is stable by studying a migrant population living in the large multicultural city of 
San Francisco. The results from 875 isolates indicate that when a person relocates to 
a different geographical area, they are more likely to become infected with an 
M. tuberculosis strain that is associated with the region where they were born, 
despite being exposed to other, more prevalent strains. For example, TB patients 
born in the USA who declared themselves to be of Filipino ethnicity were infected 
with the same strains as TB patients who were born in the Philippines. Whilst the 
authors concede that these observations could be caused by social factors such as 
lack of social mixing due to the presence of ethnic enclaves, they go on to state 
further evidence in support of their theory of a stable host pathogen association. For 
example patients born in the USA who were not of Filipino ethnicity rarely became 
infected with M. tuberculosis strains associated with the Philippines, however when 
this did occur the patients were HIV positive or homeless. The authors suggest that 
Filipino M. tuberculosis strains are not adapted to cause disease in 
immunocompetant non-Filipino’s and are only able to do so when the host immune 
system is weakened (Gagneux et al., 2006). The study carried out by Gagneux and 
colleagues was replicated using 798 isolates from Montreal. The conclusions 
reached by the two studies were similar in spite of differences between the human 
population structures in the two cities (Reed et al., 2009). 
1.9 Investigation of virulence 
If strains of TB have adapted to host ethnicity then the genotype of a patient isolate 
could be used to identify at risk populations that are more susceptible to that strain. 
This would enable more efficient contact tracing and help to reduce the spread of TB. 
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M. tuberculosis strains that are able to infect people from different ethnic 
backgrounds may exist which could be an indication of altered virulence. There is no 
definitive measure of virulence, however a number of studies have assessed the 
propensity of different strains to cause disease by using epidemiological data or 
models. The systems, which have been used to compare the virulence of different 
strains of M. tuberculosis, are described below. 
1.9.1 Cohort studies 
Several groups have followed outbreaks of TB to assess links between the strain of 
M. tuberculosis and the symptoms of the patient. Thwaites and colleagues showed a 
correlation between mycobacterial genotype and features of chest X-rays, but were 
not able to adjust their analysis for variation in the duration of illness prior to 
diagnosis. They were able to show some correlation between genotype and 
progression of the disease in the case of TB meningitis and between lineage and 
drug resistance (Thwaites et al., 2008). 
 
Sun and colleagues compared 21 people infected with M. tuberculosis strains from 
the Beijing spoligotype clade with 20 people infected with non-Beijing strains. They 
found that people infected with Beijing strains had a longer duration of cough before 
diagnosis than those infected with non-Beijing strains but were less symptomatic as 
there was a lower frequency of night sweats, fever and pulmonary cavitation (Sun et 
al., 2006). 
 
De Jong and colleagues followed the household contacts of TB patients in The 
Gambia. The percentage of contacts with incident TB during the two-year follow-up 
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varied five-fold between contacts exposed to different strains. Only 1% of contacts in 
households exposed to M. africanum went on to develop active disease, whereas 
nearly 6% developed active disease when exposed to Beijing strains from the 
M. tuberculosis lineage (de Jong et al., 2008). 
 
Some studies have identified genes that act as virulence factors. These studies have 
compared the clinical characteristics of disease caused by strains that are positive or 
negative for the virulence factor. Kong and colleagues found an involvement between 
a mycobacterial gene mutation and extra-thoracic TB, which remained significant 
after controlling for host related risk factors such as ethnicity, sex and HIV infection 
(Kong et al., 2005). 
 
Talarico and colleagues looked at polymorphisms in mycobacterial lipase genes, 
which may be involved in M. tuberculosis survival in macrophages. They found that 
one group of mutations was over-represented among TB patients with no lung 
cavitation compared to patients with lung cavitation (Talarico et al., 2007). 
 
Cohort studies provide evidence that M. tuberculosis strain variation can lead to 
altered disease progression. However, large numbers of patients are required for 
these studies and patients must be followed up over several years (Thwaites et al., 
2008). Treatment of patients will unavoidably change the epidemiology, so the true 
rate of transmission cannot be measured. Measurement of clinical characteristics 
such as fever, lung cavitation and duration of cough before diagnosis can be 
subjective, which makes it difficult to compare data between studies. These issues 
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have led investigators to develop model systems for studying mycobacterial 
infections. 
1.9.2 Model systems for studying mycobacterial infections 
Model systems are useful for the study of M. tuberculosis virulence because host 
genetics and behaviour can be standardised. 
1.9.2.1 Animal models 
Replication of M. tuberculosis within specific organs of experimental animals and the 
length of time than an experimental animal survives once it has been infected are 
both used as measures of virulence (Palanisamy et al., 2008; Theus et al., 2004). 
 
Rabbits, guinea pigs, mice and non-human primates are all susceptible to infection 
with M. tuberculosis when it is artificially induced and have been used to model 
different aspects of TB, including active disease and latency (Dharmadhikari and 
Nardell, 2008). M. tuberculosis is categorised by the Advisory Committee on 
Dangerous Pathogens as a hazard group three organism because it can cause 
severe disease in humans. Special containment facilities are required in order to 
work with a hazard group three organism, so animal models of TB infection are only 
carried out at a limited number of centres. The use of animal-based models to assess 
the virulence of M. tuberculosis strains is discussed in more detail in section 4.1.1.1. 
1.9.2.2 In vitro assays 
In vitro assays that use cells in tissue culture are cheaper and more accessible than 
animal models for assessment of M. tuberculosis virulence. Most assays of 
mycobacterial virulence use phagocytic cells, although some research has been 
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carried out with lung epithelial cells (Danelishvili et al., 2003; Dobos et al., 2000). 
Models of macrophage infection can use either primary cells or a cell line, which has 
been immortalised. Cells can be obtained from experimental animals or from human 
donors. The use of cell-based models to study the virulence of M. tuberculosis strains 
is discussed in more detail in section 4.1.1.2. 
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2 AIMS AND HYPOTHESIS 
2.1 Assessment of M. tuberculosis genotypes and patient 
ethnicity in the Midlands, UK 
2.1.1 Hypothesis 
Strains of TB that are prevalent in the ISC will also be prevalent in the Midlands. 
2.1.2 Aim 
To determine whether there is a correlation between the ethnicity of TB patients in 
the Midlands and the genotype of the TB strains with which they are infected. 
 
2.2 Assessment of virulence of the most prevalent TB strains 
in the Midlands, UK using in vitro models 
2.2.1 Hypothesis 
Prevalent TB strains from the Midlands will be more virulent in a cellular model of 
infection than strains that are not prevalent. 
 
2.2.2 Aim 
To assess the impact of M. tuberculosis strain genotypic variation on virulence in 
cellular models of infection.  
Section 3.1 
   50 
3 ASSESSMENT OF M. TUBERCULOSIS GENOTYPES 
AND PATIENT ETHNICITY IN THE MIDLANDS, UK 
3.1 Introduction 
Within the UK, the West Midlands region has the second largest proportion of people 
with Indian ethnicity (ONS, 2003). The region has a total population of 9.5 million and 
contains 24% of the UK’s south Asian population (ONS, 2003). Approximately 1.5% 
of the people in the West Midlands were born in India and in some regions such as 
Wolverhampton, the percentage is over 5%; the national average is 0.9%. According 
to the 2001 census over 50% of the population served by the Heart of Birmingham 
Primary Care Trust (PCT), which provides services for approximately 300,000 people 
in the centre of Birmingham, had ISC ethnicity (Figure 3-1). The 2011 census data 
has not yet been analysed according to PCT, however regional data shows that the 
proportion of people with ISC ethnicity has increased (Figure 3-2). The West 
Midlands also has the second highest proportion of TB cases in the UK, with 11% of 
the case load in 2009 and the second highest rate of TB at 18.7 cases per 100,000 
(95% CI 17.6-19.9) (Figure 3-3). 
 
A recent study suggested that 20% of immigrants entering the UK are latently 
infected with TB and the majority of these infections are missed by current screening 
practices (Pareek et al., 2011). Data from the HPA shows that only 21% of TB cases 
amongst immigrants are diagnosed within two years of arriving in the country (HPA, 
2010). The increase in the number of UK TB cases amongst people born in India 
coupled with the delay in presentation of active disease and the failure to detect all 
latent infections means that strains of TB that are being imported from India are likely 
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to account for a significant amount of disease in the UK in the coming years. There is 
also evidence that immigrants are more likely to contract TB from bacteria that are 
endemic in their home country, rather than from bacteria that are endemic in the 
country to which they have emigrated (Gagneux et al., 2006). It has been suggested 
that immigrants become infected with M. tuberculosis strains that are endemic in their 
home country because they are genetically more susceptible to these strains, the 
pathogen having co-evolved with the host. However, a lack of social mixing amongst 
immigrants, who will therefore not be frequently exposed to strains that are endemic 
in the indigenous population, could also explain the association. 
 
The West Midlands has a large population of people who were born in India or have 
ISC ethnicity and it has a high rate of TB. The rate of TB in the UK has been linked 
with the number of immigrants from countries where TB is endemic (Gilbert et al., 
2009). It is therefore hypothesised that the most prevalent TB strains in the Midlands 
will also be those that are commonly found in the ISC. In order to test this hypothesis 
it is necessary to identify the ethnicity of the TB patients in the Midlands and to 
identify the prevalent lineages of TB. 
3.1.1 Identification of patient ethnic origin 
Studies that are concerned with the pattern of change in the conveyance of TB from 
one person to another have analysed population groups. Population groups are 
usually based on declarations made by the patient about their ethnic origin or country 
of birth. Country of birth information is useful for classifying the origin of an immigrant, 
but is less useful for identifying people who were born in the UK but whose parents or 
grandparents were immigrants. Patient declared ethnicity data is collected using a 
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limited number of ethnic group classifications, which masks the complexity found 
within a group (Mateos, 2007). Ethnicity can be interpreted in different ways for 
example Asian ethnicity can mean continental Asia or ISC (Aspinall, 2003). The 
analysis of name origins is one method of identifying a person’s ethnicity and can 
overcome some of the problems associated with the ethnic group classifications that 
are used to collect health care data. 
 
In the current study, Origins software (Origins; Experian, Nottingham, UK) was used 
to predict the ethnicity of TB patients in the Midlands. Origins software partitions 
people by cultural, ethnic or religious origin based on their name. Origins was 
developed to identify UK consumers who were born abroad or to recent immigrants, 
so that they could be sent targeted advertising (Webber, 2007). The software was 
first used in healthcare to identify how migration of people from Poland to the UK 
affected the use of an National Health Service (NHS) hospital emergency department 
(Leaman et al., 2006). It has also been used to identify the global origins of TB in the 
Midlands, UK (Evans et al., 2010). 
 
Origins software uses a database of names with records from 12 countries making it 
more reliable than other databases, such as Nam Pehchan and SANGRA, which are 
based on UK data (Webber, 2007; Nanchahal et al., 2001; Cummins et al., 1999). 
The Origins database contains 1,600,000 family names and 600,000 given names. 
Expert knowledge and data mining algorithms were used to place each name into 
one of 200 origin types based on cultural, ethnic and linguistic (CEL) factors. 
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Figure 3-1 Proportion of ethnic groups in selected West Midlands primary care trusts, and 
aggregated data for London, the West Midlands and England 
(ONS, 2003) 
 
Figure 3-2 Proportion of ethnic groups in selected local authorities in the West Midlands, and 
aggregated data for London, the West Midlands and England 
(ONS, 2012; ONS, 2003) 
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Figure 3-3 Rate of TB and the number of TB cases by region, England, 2011 
(HPA, 2012) 
 
The origin type can correspond to a particular country or more than one origin type 
can come from the same country, as is the case for India where there are several 
different religions. In some cases, countries can share the same origin type, for 
example Germany and Austria, which have similar naming practices because of the 
use of the same language. 
 
To infer the origin of a name the origin type of both the given and the family name are 
identified, which in most cases will be the same. Occasionally the given and family 
name will have different origin types and so a set of rules, based on confidence 
scores, is used to determine which name is the most faithful indicator of the origin of 
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that person. The 200 origin types can then be grouped depending on how the data 
will be analysed. The groups could be based on broad geographical regions, religion 
or language. For example the surname, ‘Mascarenhas’ would identify a person as 
having Goan ancestry. This would mean that the geographical region that they come 
from is south Asia. Their language and culture is likely to be Portuguese and their 
religion is likely to be Catholic (Webber, 2007). 
 
The use of a person’s name to infer their origin is useful in cases where ethnicity or 
country of birth has not been recorded or where data protection regulations mean 
that the information can only be used for the original purpose for which it was 
recorded. In the current study, the use of origins software meant that data could be 
analysed immediately rather than waiting for the ethnic origin of a patient to be 
collated by the enhanced tuberculosis surveillance network (ETSN). It also allows 
more detailed analysis to be carried out as it can be used to give an indication of the 
region of a country that a name originates from, a parameter that is not recorded by 
the ETSN. 
3.1.2 Molecular typing of M. tuberculosis isolates in the Midlands 
The HPA Midlands Regional Centre for Mycobacteriology (MRCM) at Birmingham 
Heartlands Hospital receives approximately 1,300 specimens and isolates per year 
from 35 laboratories in the East and West Midlands of the UK. The MRCM 
undertakes mycobacterial culture, identification, drug susceptibility testing and DNA 
fingerprinting for these samples (Evans et al., 2007). 
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Most databases that are publicly available for the identification of TB strain lineages 
are based on spoligotyping or LSP typing. However, the MRCM uses MIRU-VNTR to 
type all clinical isolates, as it is gives better discrimination of strains. Allix-Beguec and 
colleagues developed a database called MIRU-VNTRplus, which combines data from 
several typing methods and allows correlations between methods to be identified 
(Allix-Beguec et al., 2008b). Spoligotyping has been widely used for typing TB strains 
across the globe and the spolDB4 database, which can be accessed online via 
SITVIT, was the largest publicly available database of TB typing data (Brudey et al., 
2006). MIRU-VNTRplus was therefore used to match MIRU-VNTR profiles to their 
most likely spoligotype. TB isolates from the Midlands, UK could then be compared 
with the spolDB4 database, without having to carry out the spoligotyping procedure, 
in turn allowing global strain lineages to be identified. 
 
MIRU-VNTRplus contains 186 reference isolates for which the MIRU-VNTR profile, 
spoligotype, SNP and LSP profile has been recorded, some of these data are shown 
in Table 3-1 and Table 3-2. The reference isolates are representative of the main TB 
lineages as assessed by spoligotyping and LSP analysis. Other members of the MTB 
complex and a number of ATCC type strains are also included in the database 
(M. tuberculosis H37Rv; ATCC 27294, M. bovis; ATCC 19210 and M. africanum; 
ATCC 25420). To identify the spoligotype lineage that a test isolate belongs to a 
categorical distance is calculated by scoring the number of markers where there is a 
difference divided by the total number of markers used, best matching then identifies 
the reference genotypes with the closest distance to the test isolate. A categorical 
distance of 0.17 was proposed by the designers of MIRU-VNTRplus as a cut off, 
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which corresponds to a difference in 4 loci when using 24 loci MIRU-VNTR typing or 
a difference of 7 spacers when using spoligotyping (Allix-Beguec et al., 2008b). 
Table 3-1 Spoligotype data for 186 reference strains present in the MIRU-VNTRplus database 
(Allix-Beguec et al., 2008b) 
SITVIT 
spoligotype 
clade 
No. of 
different 
SITs 
Percentage of 
isolates (No.) 
Most prevalent 
SIT (No. of 
isolates) 
No. of other SITs 
(No. of isolates) 
No. of 
isolates 
with no 
SIT 
AFRI 6 17 (31) 326 (7) 5 (11) (13) 
Beijing 1 5 (10) 1 (10) 0 (0) (0) 
BOV 7 6 (11) 482 (3) 6 (6) (2) 
CANETTI 1 1 (2) 592 (2) 0 (0) (0) 
CAP 4 6 (11) 647 (7) 3 (3) (1) 
CAS 4 5 (10) 1,092 (5) 3 (4) (1) 
EAI 8 6 (12) 11 (2) 7 (8) (2) 
H37Rv 1 1 (1) 451 (1) 0 (0) (0) 
Haarlem 8 11 (20) 50 (5) 7 (14) (1) 
LAM 9 13 (25) 61 (8) 8 (15) (2) 
MICROTI 2 3 (6) 642 (4) 1 (2) (0) 
PIN 0 1 (2) N/A (0) 0 (0) (2) 
S 4 6 (12) 34 (9) 3 (3) (0) 
T 6 16 (30) 53 (10) 5 (11) (9) 
X 1 2 (3) 119 (2) 0 (0) (1) 
Total 62 100 (186)  (75)  (77) (34) 
 
Table 3-2 VNTR data for 186 reference strains present in the MIRU-VNTRplus database (Allix-
Beguec et al., 2008b) 
SITVIT 
spoligotype 
clade 
No. of isolates 
(%) 
Most 
prevalent 
VNTR 
profile 
No. of 
isolates 
No. of 
other 
VNTR 
profiles 
No. of 
isolates 
Total 
no. of 
VNTR 
profiles 
AFRI 31 (17) 42432 15 11 16 12 
Beijing 10 (5) 42435 9 1 1 2 
BOV 11 (6) 45543 2 9 9 10 
CANETTI 2 (1) N/A 0 2 2 2 
CAP 11 (6) N/A 0 11 11 11 
CAS 10 (5) 42235 8 *1 2 2 
EAI 12 (6) 46464 2 10 10 11 
H37Rv 1 (1) 33443 1 0 0 1 
Haarlem 20 (11) 32333 11 7 9 8 
LAM 25 (13) 22232 5 7 20 8 
MICROTI 6 (3) 93571 2 4 4 5 
PIN 2 (1) 93463 2 0 0 1 
S 12 (6) 32443 4 3 8 4 
T 30 (16) 32333 9 8 21 9 
X 3 (2) 32333 2 1 1 2 
Total 186 (100)     88 
* the other CAS VNTR profile is 42234, N/A indicates not applicable 
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3.2 Aims and hypothesis 
3.2.1 Hypothesis 
CAS and EAI strains will be the most prevalent spoligotypes clades in the Midlands 
and will be isolated from TB patients with ISC ethnicity. 
3.2.2 Aims 
 Use Origins software to select 100 M. tuberculosis isolates predicted to be 
from patients of ISA ethnicity and genotype the isolates to identify the most 
prevalent spoligotype clades 
 Compare patient declared ethnicity for 100 strains with predictions made by 
Origins software to assess the accuracy of the predictions 
 Compare MIRU-VNTR profiles from 100 selected isolates to the 
MIRU-VNTRplus database in order to test the accuracy of spoligotype 
predictions made by the MIRU-VNTRplus database 
 To use Origins software to predict the most prevalent ethnic groups amongst 
TB patients in the Midlands from 2007 to 2008 
 To use the MIRU-VNTRplus database to predict the spoligotype of Midlands 
isolates from 2007 to 2008 in order to identify the most prevalent spoligotypes 
in the Midlands and to make global comparisons 
3.3 Materials and methods 
3.3.1 Study population 
The study took place in the Midlands region of the UK. The study population included 
all M. tuberculosis isolates submitted to the MRCM between 1st January 2007 and 
31st December 2008 (n = 2,185). The MRCM undertook mycobacterial culture, 
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identification, drug susceptibility testing and DNA fingerprinting for these isolates 
(Evans et al., 2007). Ethical approval was obtained according to local guidelines. 
 
Origins software version 1 (Professor Richard Webber, King’s College London, UK) 
identified that 1,186 of 2,185 (54%) isolates came from patients who originated in the 
ISC. A sample of 100 isolates was selected from amongst these patients (Table 3-3). 
These isolates represented the range of MIRU-VNTR profiles, weighted so that the 
most common strains were represented proportionally. Once all commonly isolated 
strains had been included in the sample in the correct proportion, strains that had 
only been isolated once but had been typed in 2008 were randomly selected until the 
set included 100 isolates. 
 
Control organisms M. bovis NCTC 10772, M. tuberculosis H37Rv NCTC 7416 and 
M. tuberculosis H37Ra NCTC 7417 were obtained from the National Collection of 
Type Cultures, Colindale, London, UK. M. bovis BCG Danish Vaccine strain 1331 
was obtained from the Statens Serum Institute, Copenhagen. 
 
3.3.2 Bacterial growth conditions 
TB isolates were incubated in liquid culture in a BACTEC™ MGIT™ 960 System (BD 
Biosciences, Oxford, UK) at 37°C until a positive growth index was detected by 
fluorescence. Positive cultures were identified with the HAIN GenoType species-
specific M. tuberculosis complex DNAstrip test (Hain Lifescience, Nehren, Germany) 
(Richter et al., 2004). 
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Table 3-3 MIRU-VNTR profiles in the Midlands from patients with ISC* ethnicity, 2007-2008 
VNTR 
profile 
MIRU profile 
No. 
typed 
% 
No. 
selected 
 
VNTR 
profile 
MIRU profile 
No. 
typed 
% 
No. 
selected 
42235 2542517333 120 4.6 5  61464 2432722334 6 0.2 1 
42235 2642515333 50 1.9 2  61466 2432622334 6 0.2 1 
42234 2642517323 45 1.7 2  -2235 2642517333 5 0.2 1 
42235 2642517333 40 1.5 2  -2235 2542517332 5 0.2 1 
42234 2742511334 38 1.5 2  21433 2232515323 5 0.2 1 
32333 2432515314 37 1.4 2  32433 2312515322 5 0.2 1 
-2235 2542517333 33 1.3 2  42234 2742511323 5 0.2 1 
42235 2642516333 31 1.2 2  42235 2542515333 5 0.2 1 
32433 2512511322 27 1.0 2  42235 2542517334 5 0.2 1 
61464 2432622334 26 1.0 2  42235 2632515333 5 0.2 1 
32333 2532515323 21 0.8 1  76466 2422622322 5 0.2 1 
21433 2412615221 16 0.6 1  -5265 2632622313 4 0.2 1 
42235 2642513333 14 0.5 1  -2235 2542516333 4 0.2 1 
32433 2312515324 13 0.5 1  -2235 2442517333 4 0.2 1 
42435 2332517333 13 0.5 1  21433 2312615221 4 0.2 1 
42235 2442517333 12 0.5 1  22333 2532315323 4 0.2 1 
42235 2542516333 12 0.5 1  22433 2322615321 4 0.2 1 
42435 2332515333 11 0.4 1  22433 2442615221 4 0.2 1 
42235 2532517333 10 0.4 1  31533 2222513323 4 0.2 1 
42235 2742517333 10 0.4 1  32432 2322615321 4 0.2 1 
-2544 2742414322 9 0.3 1  42232 2542517333 4 0.2 1 
32433 2512511323 9 0.3 1  42234 2342517323 4 0.2 1 
42235 2541517333 9 0.3 1  42234 2642517324 4 0.2 1 
61466 2432622333 9 0.3 1  42235 1542517333 4 0.2 1 
32333 2532315323 8 0.3 1  42235 2432517333 4 0.2 1 
42235 2342517333 8 0.3 1  42235 2442517323 4 0.2 1 
42235 2532517323 8 0.3 1  42235 2452517333 4 0.2 1 
42235 2542518333 8 0.3 1  42235 2542517331 4 0.2 1 
31433 2232515323 7 0.3 1  42235 2642515332 4 0.2 1 
32235 2642517333 7 0.3 1  42235 2642517331 4 0.2 1 
32333 2531315323 7 0.3 1  32334 2632516323 3 0.1 1 
42235 2642517332 7 0.3 1  32433 2332615321 3 0.1 1 
42235 2642517334 7 0.3 1  42234 2842511334 3 0.1 1 
42235 2642518333 7 0.3 1  42235 2642516332 3 0.1 1 
42435 2232517343 7 0.3 1  42236 2542517333 3 0.1 1 
32235 2542517333 6 0.2 1  61456 2432622334 3 0.1 1 
32433 2332514327 6 0.2 1  614-4 2432722334 3 0.1 1 
32433 2432515324 6 0.2 1  -4455 2432622132 2 0.1 1 
42234 2542517333 6 0.2 1  -2445 2332522133 2 0.1 1 
42234 2742511324 6 0.2 1  22233 2662117333 2 0.1 1 
42235 2542517323 6 0.2 1  31233 2222514323 2 0.1 1 
42235 2632517333 6 0.2 1  42234 2632517331 2 0.1 1 
42443 2332616324 6 0.2 1   Total 908 35 98 
* prediction of patient ethnicity was made using Origins software Version 1 
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3.3.3 Bacterial DNA extraction 
Bacteria were sonicated for 15 minutes in a bath sonicator then heated to 100°C for 
30 minutes. The resulting lysate was centrifuged at 10,000 × g to remove cellular 
debris before removal of the supernatant from the category 3 containment facility and 
storage at -20°C. Lysate was used as template for PCR reactions. 
3.3.4 General PCR amplification primers and conditions 
Target gene loci, their primer names and sequences are listed in Table 3-4. All 
oligonucleotides were obtained from MWG, Germany. PCR reaction mixtures 
contained 0.5 μM of forward and reverse primer, 200 μM dNTP mix, 3 mM MgCl2, 
5 μl reaction buffer, 1 μl template DNA, 1 U Amplitaq Gold polymerase (Applied 
Biosystems, Warrington, UK), and sterile water to 50 μl. Amplification was performed 
in a Multi-Block System Thermal Cycler (ThermoHybaid, Ashford, UK). An initial 
denaturation of 10 minutes at 95°C was followed by 35 cycles of denaturation at 
95°C for 30 seconds, annealing between 54 and 70°C (Table 3-4) for 1 minute, and 
extension at 72°C for 1 minute, followed by a final extension step of 5 minutes at 
72°C. 
 
PCR products and 50 base pair step ladder (Promega, London, UK) were separated 
by agarose gel (1% wt/vol) electrophoresis at 150 V and visualised with ethidium 
bromide. All PCR reactions included a positive control (M. tuberculosis H37Rv, 
M.  bovis or M.  bovis BCG) for amplification of the target locus as well as a negative 
control, containing water but no template DNA. 
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Table 3-4 Published primer sequences 
Locus Sequence (5’ to 3’) Tm (°C) Source 
RD1 
internal 
GTC AGC CAA GTC AGG CTA CC 
CAA CGT TGT GGT TGT TGA GG 
55.0 (Rao et al., 2005) 
RD1 
flanking 
GAA ACA GTC CCC AGC AGG T 
TTC AAC GGG TTA CTG CGA AT 
54.0 (Rao et al., 2005) 
katG GAC GAG GTC GGC GAA GGG ACA TTT TGA 
GGG CCG CTG GTC CCC AAG CAG AC 
70.0 (Huard et al., 2006) 
gyrA GGA GGT GCG CGA CGG GCT CAA G 
ACC CGG CCG TCG TAG TTA GGG ATG AAA TC 
69.6 (Huard et al., 2006) 
TbD1 
internal 
CGT TCA ACC CCA AAC AGG TA 
AAT CGA ACT CGT GGA ACA CC 
57.3 (Brosch et al., 2002) 
TbD1 
flanking 
CTA CCT CAT CTT CCG GTC CA 
CAT AGA TCC CGG ACA TGG TG 
59.4 (Brosch et al., 2002) 
DR GGT TTT GGG TCT GAC GAC 
CCG AGA GGG GAC GGA AAC 
58.0 (Kamerbeek et al., 1997) 
3.3.5 DNA fingerprinting 
Isolates were analysed by MIRU-VNTR typing using 15 loci as previously described 
(ETR-A, -B, -C, -D, -E and MIRU-02, -10, -16, -20, -23, -24, -26, -27, -39, -40) (Evans 
et al., 2007) using non-denaturing high performance liquid chromatography with a 
WAVE microbial analysis system (Transgenomic, Elancourt, France) (Evans et al., 
2004). 
3.3.6 Spoligotyping 
Spoligotyping was performed using the Luminex Multianalyte Profiling System 
(Cowan et al., 2004). 
3.3.6.1 Amplification of the DR locus 
The primer sequences for the DR locus are listed in Table 3-4. Primer DRa is 
biotinylated at the 5’ terminus to allow subsequent detection using a streptavidin 
conjugate. The primers hybridise to the 36 base pair DR between each spacer and 
simultaneously amplify all of the present spacers (Cowan et al., 2004). 
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3.3.6.2 Bead coupling 
The sequences of the 43-oligonucleotide probes are listed in Table 3-5. Probes were 
synthesised with a 5’-terminal amino group with a 6-carbon spacer to allow covalent 
attachment to carboxyl group (COOH) linked beads. 
 
A mixture of 200 pmol probe, 2.5 X 106 beads (Biorad, Bath, UK), and 25 μg 
1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC) (Thermo Fisher 
Scientific, UK) was prepared in 25 μl of 100 mM 2-(N-morpholino)ethanesulfonic acid 
(MES), pH 4.5 (Sigma, UK). The reaction mixture was incubated at room temperature 
in the dark for 30 minutes. The addition of EDC and subsequent incubation were 
repeated once. After coupling the beads were washed with 0.5 ml of 0.02% 
Tween 20 followed by 0.5 ml of 0.1% sodium dodecyl sulfate. Coupled beads were 
suspended in 50 μl of Tris-EDTA, pH 8 and quantified using a haemocytometer. 
There was an average recovery of 45,000 beads/µl. Coupled beads were stored at 
4°C in the dark. A mixture of all 43 bead-sets was prepared by combining equal 
volumes of each. 
3.3.6.3 Hybridisation of coupled beads to PCR amplicons 
Bead mix was diluted by addition of 1.5 X hybridization buffer (1.5 M 
tetramethylammonium chloride (Sigma, UK), 75 mM Tris, pH 8.0, 6 mM EDTA, 
0.15% Sarkosyl) to a final concentration of approximately 150 beads of each set/ μl. 
PCR amplicon (5 μl), diluted bead mix (33 μl) and TE (12 μl) were combined in a 
Thermowell 96-well plate (VWR International) and incubated for 10 min at 94°C, 
followed by incubation for 30 min at 52°C, in a GeneAmp 9700 PCR System 
(Perkin-Elmer, UK). The plate was centrifuged at 2,250 × g for 3 minutes and beads 
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were resuspended in 75 μl detection buffer (R-phycoerythrin-conjugated streptavidin 
(Invitrogen, Paisley, UK) diluted to 4 μg/ml with 1X hybridization buffer). Samples 
were then incubated at 52°C for 5 minutes. 
3.3.6.4 Analysis 
Samples were analysed using a Bioplex 100, version 1.7; with a minimum of 100 
events per bead set. Final spoligotypes were generated with a Microsoft Excel 
spreadsheet designed by the Centre for Disease Control (CDC). Spoligotype profiles 
were submitted to the SpolDB4 database for clade assignation 
3.3.7 RD1 and TbD1 analysis 
To test for the presence of LSPs in the genome of M. tuberculosis isolates, two sets 
of primers were used, one set complementary to sequence flanking the target region 
and one set complementary to the internal sequence of the target region. If a region 
is deleted amplicon is produced with the flanking primers but not the internal primers 
and vice versa (Gutierrez et al., 2006). 
3.3.8 Principal Genetic Grouping 
PGG was determined by PCR-RFLP of katG and gyrA amplicon with restriction 
enzymes BstNI and AleI (New England Biolabs, UK) according to the manufactures 
instructions. BstNI digestion of katG PCR amplicon from group 1 isolates produced 
four DNA fragments (12, 61, 104 and 174 base pairs), while that from groups 2 and 3 
produced three DNA fragments (12, 61 and 278 base pairs). AleI digestion of gyrA 
PCR amplicon produced two DNA fragments (161 and 193 base pairs) from group 1 
and 2 isolates, while that from group 3 strains remained uncut (354 base pairs). 
Digest products were separated by 2 hours agarose (2%) gel electrophoresis. 
Section 3.3 
   65 
Table 3-5 Oligonucleotides used for Spoligotyping (Kamerbeek et al., 1997) 
Name Sequence (5’ to 3’) Tm (°C) 
SPF01 MMT ATA GAG GGT CGC CGG TTC TGG ATC A 66.3 
SPF02 MMT CCT CAT AAT TGG GCG ACA GCT TTT G 63.0 
SPF03 MMT CCG TGC TTC CAG TGA TCG CCT TCT A 66.3 
SPF04 MMT ACG TCA TAC GCC GAC CAA TCA TCA G 64.6 
SPF05 MMT TTT TCT GAC CAC TTG TGC GGG ATT A 61.3 
SPF06 MMT CGT CGT CAT TTC CGG CTT CAA TTT C 63.0 
SPF07 MMT GAG GAG AGC GAG TAC TCG GGG CTG C 71.2 
SPF08 MMT CGT GAA ACC GCC CCC AGC CTC GCC G 74.5 
SPF09 MMT ACT CGG AAT CCC ATG TGC TGA CAG C 66.3 
SPF10 MMT TCG ACA CCC GCT CTA GTT GAC TTC C 66.3 
SPF11 MMT GTG AGC AAC GGC GGC GGC AAC CTG G 72.8 
SPF12 MMT ATA TCT GCT GCC CGC CCG GGG AGA T 69.5 
SPF13 MMT GAC CAT CAT TGC CAT TCC CTC TCC C 66.3 
SPF14 MMT GGT GTG ATG CGG ATG GTC GGC TCG G 71.2 
SPF15 MMT CTT GAA TAA CGC GCA GTG AAT TTC G 61.3 
SPF16 MMT CGA GTT CCC GTC AGC GTC GTA AAT C 66.3 
SPF17 MMT GCG CCG GCC CGC GCG GAT GAC TCC G 77.7 
SPF18 MMT CAT GGA CCC GGG CGA GCT GCA GAT G 71.2 
SPF19 MMT TAA CTG GCT TGG CGC TGA TCC TGG T 66.3 
SPF20 MMT TTG ACC TCG CCA GGA GAG AAG ATC A 64.6 
SPF21 MMT TCG ATG TCG ATG TCC CAA TCG TCG A 64.6 
SPF22 MMT ACC GCA GAC GGC ACG ATT GAG ACA A 66.3 
SPF23 MMT AGC ATC GCT GAT GCG GTC CAG CTC G 69.5 
SPF24 MMT CCG CCT GCT GGG TGA GAC GTG CTC G 72.8 
SPF25 MMT GAT CAG CGA CCA CCG CAC CCT GTC A 69.5 
SPF26 MMT CTT CAG CAC CAC CAT CAT CCG GCG C 69.5 
SPF27 MMT GGA TTC GTG ATC TCT TCC CGC GGA T 66.3 
SPF28 MMT TGC CCC GGC GTT TAG CGA TCA CAA C 67.9 
SPF29 MMT AAA TAC AGG CTC CAC GAC ACG ACC A 64.6 
SPF30 MMT GGT TGC CCC GCG CCC TTT TCC AGC C 72.8 
SPF31 MMT TCA GAC AGG TTC GCG TCG ATC AAG T 64.6 
SPF32 MMT GAC CAA ATA GGT ATC GGC GTG TTC A 63.0 
SPF33 MMT GAC ATG ACG GCG GTG CCG CAC TTG A 69.5 
SPF34 MMT AAG TCA CCT CGC CCA CAC CGT CGA A 67.9 
SPF35 MMT TCC GTA CGC TCG AAA CGC TTC CAA C 66.3 
SPF36 MMT CGA AAT CCA GCA CCA CAT CCG CAG C 67.9 
SPF37 MMT CGC GAA CTC GTC CAC AGT CCC CCT T 69.5 
SPF38 MMT CGT GGA TGG CGG ATG CGT TGT GCG C 71.2 
SPF39 MMT GAC GAT GGC CAG TAA ATC GGC GTG G 67.9 
SPF40 MMT CGC CAT CTG TGC CTC ATA CAG GTC C 67.9 
SPF41 MMT GGA GCT TTC CGG CTT CTA TCA GGT A 64.6 
SPF42 MMT ATG GTG GGA CAT GGA CGA GCG CGA C 69.5 
SPF43 MMT CGC AGA ATC GCA CCG GGT GCG GGA G 72.8 
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3.3.9 Identification of patient ethnic origin 
The given and family names of 2,185 patients were entered into Origins software 
Version 6 (Origins; Experian, Nottingham, UK) to obtain a CEL group for each, which 
was then assigned a continent on the basis of the United Nations Standard Country 
and Area Coded Classification Scheme as previously described (Evans et al., 2010). 
3.3.10 Strain lineage assignment 
MIRU-VNTR data for each isolate was compared to the MIRU-VNTRplus database 
(Allix-Beguec et al., 2008b). A categorical co-efficient which generates a match 
distance was used to identify strains from the database which are related to the 
MIRU-VNTR profile for each Midlands isolate. A match value of 0 indicates an 
absolute match and a value of 1 indicates that there was no match at any of the 15 
MIRU-VNTR. A cut off value of 0.17 indicates differences at no more than four loci 
and a cut off value of 0.3 indicates differences at no more than seven loci. 
3.3.11 Identification of patient location 
Postcodes were matched to known PCTs in the Midlands. PCTs are healthcare 
organisations based on population and geographical boundaries, which are 
responsible for 80% of the NHS budget. There are 17 PCTs in the West Midlands 
and 9 in the East Midlands. Postcode data was missing for 291 isolates which were 
excluded from the study and a further 211 isolates were excluded as the patient did 
not reside in the Midlands region. A summary of the strains that were selected is 
shown in Figure 3-4. 
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Figure 3-4 Strains selected for analysis of phylogeographic lineages of M. tuberculosis present 
in the Midlands 
* patients not residing in the Midlands or for whom postcode data was not 
available were excluded from further study 
3.3.12 Geographical distribution of spoligotype clades 
Geographical distribution of spoligotype clade and TB patient ethnicity was analysed 
as a whole and within the Midlands region, which is made up of 11 counties and 
within the West Midlands county, which consists of nine Primary Care Trusts (PCT). 
3.4 Results 
3.4.1 Phylogeographic lineages of M. tuberculosis amongst 100 
patients of ISC ethnicity in the Midlands, UK 
3.4.1.1 Spoligotype clade assignation 
A selection of 100 M. tuberculosis isolates from the most prevalent MIRU-VNTR 
profiles identified in patients who had ISC ethnicity were analysed by spoligotyping. 
Spoligotype interrogation was successful for 96 of 100 isolates and resulted in 60 
different spoligotype patterns. Spoligotype patterns were not obtained in four cases 
as DNA amplification was unsuccessful. Comparison of the 60 spoligotype patterns 
to SITVIT showed that 40 of the patterns were SITs and 20 were unique patterns that 
are described as orphan profiles, (one pattern was not compared to SITVIT). Nearly 
80% (75 of 96) of the isolates belonged to a SIT. 
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Of the 40 SITs that were found the largest group was SIT 26 (CAS1_DELHI), which 
contained 18 isolates. SIT 11 (EAI3_IND) contained five isolates and SIT 21 
(CAS1_KILI) contained four isolates. SIT 53 (T1), SIT 2696 (CAS1_Delhi) and SIT 1 
(BEIJING) each had three isolates. SIT 2993 (CAS2), SIT 288 (CAS2), SIT 485 
(CAS1_DELHI), SIT 25 (CAS1_DELHI), SIT 490 (X1) and SIT 50 (H3) each 
contained two isolates. The 28 other SITs contained one isolate each. When the SITs 
and orphan profiles were grouped into clades, the largest clade was CAS, which 
contained 57 isolates. EAI was the second largest clade and contained 10 isolates. 
Clades T and H contained eight and seven isolates respectively. The rest of the 
clades contained three isolates or fewer (Table 3-6). 
Table 3-6 Number of M. tuberculosis isolates belonging to different spoligotype clades 
Clade No. of isolates Sub-clade 
No. of 
isolates 
No. of 
different SITs 
No. of 
orphan 
patterns 
CAS 57 
CAS1-Delhi 45 15 10 
CAS1-Kili 5 1 1 
CAS2 6 2 2 
CAS 1 1 0 
EAI 10 
EAI 3 1 2 
EAI3-IND 5 1 0 
EAI6-BGD1 2 2 0 
T 8 
T1 7 5 0 
T5 1 1 0 
H 7 
H2 1 1 0 
H3 3 1 1 
H4 3 2 1 
Beijing 3 Beijing 3 1 0 
U 3 U 3 1 2 
LAM 2 LAM11-ZWE 2 1 1 
X 2 X1 2 1 0 
AFRI 1 AFRI 1 1 0 
MANU 1 MANU2 1 1 0 
S 1 S 1 1 0 
Unclassified 1 Unclassified 1 0 1 
Total 96  96 40 21 
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3.4.1.2 Principal Genetic Grouping 
Figure 3-5 shows example PCR-RFLP patterns from PGG1, PGG2 and PGG3 
strains. These strains were determined to belong to each group by sequencing of 
PCR amplicon for the katG and gyrA regions. AleI digestion of amplicon from the 
gyrA loci of PGG1 and PGG2 strains produced two DNA fragments (161 and 193 
base pairs) (Figure 3-5, lanes two and three), while amplicon from PGG3 strains 
remained uncut (354 base pairs) (Figure 3-5, lane 4). BstNI digestion of amplicon 
from the katG loci of PGG1 strains produced four DNA fragments (12, 61, 104 and 
174 base pairs), three of these fragments were visible on a 2% agarose gel (Figure 
3-5, lane six); the 12 base pair fragment was too small to be resolved. BstNI 
digestion of amplicon from the katG loci of PGG2 and PGG3 strains produced three 
DNA fragments (12, 61 and 278 base pairs), two of which were visible on a 2% 
agarose gel (Figure 3-5, lanes seven and eight) again the 12 base pair fragment was 
not resolved. PGG typing identified that 72 of 96 (75%) isolates belonged to PGG1, 
18 of 96 (19%) belonged to PGG2 and 6 of 96 (6%) belonged to PGG3. 
 
3.4.1.3 RD1 and TBD1 analysis 
The RD1 region was present in all 96 selected isolates (100%). The TbD1 region was 
retained (TbD1+) in 11 of 96 (12%) isolates and the region was deleted (TbD1-) in 84 
of 96 (88%) isolates. DNA from one isolate failed to amplify when PCR was carried 
out using primers that were complementary to the internal sequence of the TbD1 
region or with primers that were complementary to the sequence that flanks the TbD1 
region. DNA from this isolate was re-extracted but PCR was still unsuccessful and so 
the presence or absence of the region in this isolate could not be determined. 
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Figure 3-5 Ethidium bromide staining of PCR products for katG and gyrA loci 
Loci were amplified from total genomic DNA of PGG 1, 2 and 3 organisms and 
digested with AleI (gyrA amplicon), and BstNI (katG amplicon), separated on a 
2% agarose gel by electrophoresis, then stained with ethidium bromide, bp 
stands for base pairs 
 
Lane 1; 50 base pair ladder 
Lane 2; digested gyrA amplicon from PGG1 organism 
Lane 3; digested gyrA amplicon from PGG2 organism 
Lane 4; digested gyrA amplicon from PGG3 organism 
Lane 5; negative control containing no PCR amplicon 
Lane 6; digested katG amplicon from PGG1 organism 
Lane 7; digested katG amplicon from PGG2 organism 
Lane 8; digested katG amplicon from PGG3 organism 
Lane 9; negative control containing no PCR amplicon 
Lane10; 50 base pair ladder 
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3.4.1.4 Summary of genotyping data 
Of the 96 isolates selected for analysis there were 11 PGG1 strains that had retained 
the TbD1 region (TbD1+) and were ancient in terms of evolution. Ten of the TbD1+ 
isolates belonged to the EAI spoligotype and one isolate belonged to the AFRI clade 
(Table 3-7). There were 60 PGG1 isolates in which the TbD1 region was deleted 
(TbD1-), meaning they were modern compared to the PGG1 isolates that have 
retained the TbD1 region. Of these 60 isolates, 56 belonged to the CAS spoligotype 
clade, three isolates belonged to the Beijing clade and one was not analysed. There 
were 18 PGG2 TbD1- isolates, which were more modern than the PGG1 isolates. 
There were six PGG3 TbD1- isolates, which were the most modern strains. PGG2 
and PGG3 isolates belonged to various modern spoligotype clades. 
Table 3-7 Distribution of ancient, and modern strains of M. tuberculosis amongst the 
spoligotype clades 
 Time  
 
 
 
Spoligotype 
TbD1+ 
PGG1 
TbD1- 
PGG1 
TbD1- 
PGG2 
TbD1- 
PGG3 
Total 
strains 
CAS 0 56 0 0 56 
EAI 11 0 0 0 11 
T 0 0 3 5 8 
Haarlem 0 0 7 0 7 
Beijing 0 3 0 0 3 
U 0 0 3 0 3 
LAM 0 0 2 0 2 
X 0 0 2 0 2 
AFRI 1 0 0 0 1 
S 0 0 0 1 1 
MANU 0 0 1 0 1 
Not defined 0 1 0 0 1 
Total strains 12 64 18 6 96 
3.4.1.5 Identification of patient country of birth 
Information about country of birth was available for 69 of the 96 patients from whom 
TB isolates were selected for further analysis. Eighteen of the 69 patients (26%) were 
born in India, which was the most common country of birth, followed by Pakistan, 
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where 11 of the patients (16%) were born. There were 10 patients (15%) born in 
Somalia and 10 patients born in the UK respectively. Country of birth was recorded 
as unknown for 9 of the 69 patients (13%). There were two patients (3%) born in 
Kenya and there was one patient (2%) born in each of the following countries; 
Afghanistan, Bangladesh, Congo, Iraq, Malaysia, Saudi Arabia, Sri Lanka, Sudan 
and Zimbabwe. 
 
When countries were grouped by continent, it was found that more than half of the 
patients were born in Asia (35 of 69), a fifth were born in Africa (15 of 69) and less 
than a sixth of patients were born in Europe (10 of 69), of the patients that data was 
available for. 
3.4.1.6 Verification of population groups assigned by Origins software 
Self-declared population group data for 69 patients identified as originating from the 
ISC was assessed to determine the accuracy of ethnicity predictions made by Origins 
software Version 1. Nearly three quarters (74%) of the predictions made by Origins 
Version 1 were concordant with patient self-declared ethnicity. The predications 
made for 9% of the patients (6 of 69) could not be confirmed because the ethnicity of 
the patient was not recorded. If these patients are removed from the analysis, the 
concordance is increased to 83% (52 of 63). In the 17% of cases (11 of 69) where 
the ethnicity of a patient was incorrectly predicted by Origins Version 1, the patient 
was always assigned to the Black African CEL group. 
 
Of the 69 patients for whom self-declared ethnic origin data was available, over 40% 
(29 of 69) had Indian ethnicity. More than 20% of the patients (15 of 69) had 
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Pakistani ethnicity and 17% (12 of 69) had Black African ethnicity. Mixed ethnicity 
was recorded for one patient (<2%) and ethnic origin was recorded as not known for 
five patients (7%). There were five patients listed as having other Asian ethnicity and 
two patients (3%) with Bangladeshi ethnicity. When patient ethnicity was grouped by 
continent, nearly 74% (51 of 69) of the patients had Asian ethnicity, 17% (12 of 69) 
had African ethnicity and the ethnicity of the remaining patients was not recorded. 
 
Origins software Version 6 (Experian, Nottingham, UK) was released after 
spoligotyping had been carried out on the 96 selected strains. The ethnicity of the 
patients was reanalysed using the updated version of Origins. Origins software 
Version 6 predicted that 2 of the 96 patients had African ethnicity, 2 had east Asian 
ethnicity, 16 had Middle Eastern ethnicity, 72 had south Asian ethnicity, 3 had south 
European ethnicity and there was 1 patient for whom no match was found. 
 
The predictions made by Origins software Version 6 about the ethnicity of 69 patients 
were concordant with patient self-declared ethnicity in 74% of cases (51 of 69). The 
predictions made for 9% of the patients (6 of 69) could not be confirmed, as patient 
declared ethnicity was not recorded. If these patients are removed from the analysis, 
the concordance is increased to 85% (51 of 60). In 17% of cases (11 of 69), the 
ethnicity of a patient predicted by Origins software Version 6 was discordant with 
patient declared ethnicity (Table 3-8). 
3.4.1.7 Evaluation of spoligotype clade assignation using MIRU-VNTRplus 
MIRU-VNTR profiles using 15 loci were recorded between 2007 and 2008 for 2,185 
Midlands M. tuberculosis isolates. However, an international database of 
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MIRU-VNTR profiles was not available at the time of analysis to allow identification of 
phylogeographical lineages in the Midlands. In order to study phylogeographical 
lineages the MIRU-VNTRplus database was used to assign spoligotype clades 
based on MIRU-VNTR data, which could then be compared to SITVIT. In order to 
evaluate the accuracy of spoligotype assignations made using MIRU-VNTRplus, the 
spoligotype clade assignments made by SITVIT for the 96 isolates for which 
experimental spoligotype profiles have been generated were compared to 
spoligotype assignations made by MIRU-VNTRplus. A categorical co-efficient which 
generates a matching distance was used to identify strains from the MIRU-VNTRplus 
database which are related to the MIRU-VNTR profiles obtained for the Midlands 
strains. 
Table 3-8 Comparison of patient declared ethnicity with predictions made by Origins software 
Version 6 for 69 patients for whom ethnicity data was available 
  
Patient declared ethnicity (%) 
African Asian European Unknown 
Ethnicity predicted 
by Origins 
African 1 (8) 0 (0) 0 (0) 1 (17) 
Asian 8 (67) 50 (98) 0 (0) 5 (83) 
European 2 (17) 1 (2) 0 (0) 0 (0) 
Unknown 1 (8) 0 (0) 0 (0) 0 (0) 
 
The spoligotype clades assigned by SITVIT and MIRU-VNTRplus were concordant 
for 75 of 95 isolates (79%). One isolate was not compared to SITVIT and so the 
spoligotype pattern was not assigned to a clade. There was 91% (52 of 57) 
concordance between the assignations made for the CAS spoligotype clade. 
However, MIRU-VNTRplus incorrectly assigned four CAS isolates to the Beijing clade 
(matching distance for each isolate = 0.133) and one to the T clade (matching 
distance = 0.200). 
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There was 90% concordance between the assignations made by SITVIT and 
MIRU-VNTRplus for the EAI clade (9 of 10). However, one EAI isolate was incorrectly 
assigned to the Beijing clade by MIRU-VNTRplus (matching distance = 0.286). There 
was 13% concordance between assignations made by SITVIT and MIRU-VNTRplus 
for clade T (1 of 8). MIRU-VNTRplus predicted that three isolates belonged to clade 
T, however only one of these predictions was correct, the other two isolates actually 
belonged to the CAS and AFRI clades. Six T clade isolates were assigned to the 
LAM clade by MIRU-VNTRplus and one to the Haarlem clade (Table 3-9). The 
positive predictive power of MIRU-VNTRplus for spoligotype clades that are prevalent 
in the ISC, such as CAS and EAI was high. The predictive power of MIRU-VNTRplus 
for modern spoligotype clades such as T, Haarlem and LAM was much lower. 
3.4.2 Phylogeographic lineages of M. tuberculosis present in the 
Midlands, UK 
3.4.2.1 Identification of patient ethnic origin 
Of the 2,185 TB patients from whom M. tuberculosis isolates were assessed by the 
MRCM between 2007 and 2008, Origins was able to assign a CEL group in 2,143 
cases (98%). A CEL group could not be assigned for 42 patients (2%) as either the 
first or the second name was not recognised by the Origins database (40 cases) or 
only the first initial had been recorded (two cases). When CEL groups were arranged 
by continent, Asia was the most common continent of origin amongst TB patients 
(1,186 of 2,185; 54%) and Europe was the second most common continent of origin 
(709 of 2,185; 32%). Patients who originated from Africa (212 of 2,185; 10%), the 
Americas (28 of 2,185; 1%), and Oceania (eight of 2,185; <1%) accounted for 12% of 
the TB cases. 
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Table 3-9 Comparison of the spoligotype assignments made by the SITVIT and MIRU-VNTRplus databases 
Clade 
SITVIT 
assignment* 
MIRU-
VNTRplus 
prediction 
MIRU-
VNTRplus 
average 
match 
distance (all 
matches) 
No. of correct 
MIRU-VNTRplus 
predictions** 
MIRU-
VNTRplus 
average 
match 
distance 
(correct 
matches) 
SITVIT assignment of 
MIRU-VNTRplus under 
predictions 
SITVIT assignment of 
MIRU-VNTRplus over 
predictions 
CAS 57 52 0.15 52 0.15 4 Beijing, 1 T - 
EAI 10 9 0.17 9 0.17 1 Beijing - 
T 8 3 0.18 1 0.13 6 LAM, 1 Haarlem 1 CAS, 1 AFRI 
Haarlem 7 11 0.07 7 0.05 - 2 X, 1 T 1 orphan 
Beijing 3 8 0.14 3 0.09 - 1 EAI, 4 CAS 
Orphan 3 0 - 0 - 1 Haarlem, 2 LAM - 
LAM 2 11 0.15 2 0.17 - 6 T, 2 orphan, 1 MANU 
X 2 0 - 0 - 2 Haarlem - 
AFRI 1 0 - 0 - 1 T - 
MANU 1 0 - 0 - 1 LAM - 
S 1 1 0.13 1 0.13 - - 
Total 95 95 - 75 -   
* SITVIT assignments were made by experts at the Institute Pasteur 
** correct assignments are where MIRU-VNTRplus predictions correlate with SITVIT assignments 
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The majority of TB patients were assigned to the Asian continental group. When this 
group was examined in more detail it was found that 79% of patients within the Asian 
continental CEL group could be further classified as belonging to the south Asian 
group (933 of 1,186), meaning that 43% of all of TB patients could be assigned to the 
south Asian group (933 of 2,185). There were three other groups within the Asian 
CEL group; Middle Eastern, which contained 18% of the patients (212 of 1,186), east 
Asian which contained 3% of the patients (38 of 1,186) and diasporic which 
contained less than 1% of the patients (3 of 1,186). 
3.4.2.2 Spoligotype assignation using MIRU-VNTRplus 
MIRU-VNTR profiles for 1,683 Midlands TB isolates obtained between 2007 and 
2008 were compared to the MIRU-VNTRplus database. The numbers of matches 
made at different specificities are shown in Table 3-10. 
 
An exact match to a database isolate was made for 6% of the Midlands isolates (97 
of 1,683). When 0.17 was selected as the matching distance cut off, which 
corresponds to differences at no more than four MIRU-VNTR loci, a match was found 
for 61% of the Midlands isolates (1,025 of 1,683; average matching distance 0.10). 
Of the 1,025 isolates for which a match was found, 54% (911 of 1,683; average 
matching distance 0.10) were assigned to a single spoligotype clade but a 
spoligotype could not be assigned for 7% (114 of 1,683: average matching distance 
0.13) of the isolates as they had a mixed assignation. Mixed assignations occurred 
because a test isolate matched to two or more database isolates with the same 
matching distance but the database strains belonged to different spoligotype clades, 
meaning that the test isolate was equally likely to belong to either spoligotype clade. 
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When the matching distance cut off was relaxed to 0.3, which corresponds to 
differences at no more than seven MIRU-VNTR loci a spoligotype was identified for 
97% of the isolates (1,628 of 1,683; average matching distance 0.15). Of the 1,628 
matches that were identified, 85% (1,437 of 1,683; average matching distance 0.14) 
were assigned to a single spoligotype clade and a mixed assignation was made for 
11% of the isolates (191 of 1,683; average matching distance 0.16). 
 
Using the least stringent matching criteria to permit a match to be found for all of the 
Midlands isolates, 88% of the isolates (1,483 of 1,683; average matching distance 
0.15) were assigned to a single spoligotype clade. However, 12% of the isolates (200 
of 1,683, average matching distance 0.17) could not be assigned to a single 
spoligotype clade as they had a mixed assignation. The 200 isolates with a mixed 
spoligotype assignation were excluded from further analysis, leaving 1,483 isolates. 
Matching distances ranged from 0 (exact match) to a maximum of 0.4, the average 
matching distance was 0.15. The average matching data for all strains, which were 
assigned to a single spoligotype clade with no ambiguity by matching to the 
MIRU-VNTRplus database, are shown in Table 3-11. 
 
The most prevalent spoligotype clade in the Midlands was the CAS clade, which 
contained 39% of the isolates that were assigned to a single spoligotype clade (574 
of 1,483: average matching distance 0.15). LAM, EAI and Haarlem contained 16%, 
15% and 14% of the isolates respectively (LAM; 239 of 1,483, average matching 
distance 0.16.,EAI; 225 of 1,483, average matching distance 0.19, Haarlem; 209 of 
1,483, average matching distance 0.10). The AFRI clade showed the lowest average 
Section 3.4 
   79 
matching distance of 0.05 and the Caprae clade showed the highest average 
matching distance of 0.24. 
 
Table 3-10 Number of Midlands isolates from 2007 to 2008 for which a spoligotype clade was 
identified using the MIRU-VNTRplus database at different levels of specificity 
Matching 
distance 
cut off 
Definition 
Same 1
st
 and 2
nd
 match  Different 1
st
 and 2
nd
 match 
Total (%) Different 
matching 
distance 
Same 
matching 
distance 
 Different 
matching 
distance 
Same 
matching 
distance 
0 
Exact 
match 
5 92 
 
0 0 97 (6) 
0.17 
4 locus 
difference 
325 415 
 
74 114 928 (55) 
0.3 
7 locus 
difference 
154 304 
 
69 77 604 (36) 
>0.3 
More than 7 
locus 
difference 
5 36 
 
4 9 54 (3) 
Total  489 847  147 200* 1,683 (100) 
* these isolates were equally likely to belong to two different spoligotype clades 
 
Table 3-11 Comparison of Midlands isolates from 2007 to 2008 that were accurately matched to 
the MIRU-VNTRplus database 
Spoligotype 
clade 
No. of isolates 
(%) 
Average 
matching 
distance 
Number of isolates with a 
MIRU-VNTRplus matching distance of 
<0.17 (%) 0.18-0.3 (%) >0.3 (%) 
CAS 574 (39) 0.15 374 (65) 193 (34) 7 (1) 
LAM 239 (16) 0.16 111 (46) 118 (49) 10 (4) 
EAI 225 (15) 0.19 97 (43) 105 (47) 23 (10) 
Haarlem 209 (14) 0.10 167 (80) 39 (19) 3 (1) 
Beijing 102 (7) 0.11 85 (83) 16 (16) 1 (1) 
T 65 (4) 0.17 30 (46) 33 (51) 2 (3) 
S 24 (2) 0.15 17 (71) 7 (29) 0 (0) 
X 23 (2) 0.12 19 (83) 4 (17) 0 (0) 
AFRI 10 (1) 0.05 10 (100) 0 (0) 0 (0) 
Bovis 8 (1) 0.21 1 (13) 7 (88) 0 (0) 
Caprae 4 (0) 0.24 0 (0) 4 (100) 0 (0) 
Total 1,483* (100) 0.15 911 (61) 526 (35) 46 (3) 
* 1,683 isolates from patients between 2007 and 2008 for which postcode data 
indicated residence within the Midlands, minus 200 isolates that could not be 
accurately assigned to a spoligotype clade by MIRU-VNTRplus 
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Mixed spoligotype assignations occurred for 12% of the isolates (200 of 1,683) 
(Table 3-12). Haarlem clade was the most likely to be present in a mixed assignation, 
82% (164 of 200) of the isolates which had a mixed assignation could have belonged 
to Haarlem or another clade, 43% (86 of 200) were assigned to either Haarlem or X 
clade and 31% (62 of 200) could have belonged to Haarlem or LAM. Of the isolates 
with a mixed assignation 47% (94 of 200) belonged to X or another clade and 39% 
(77 of 200) belonged to LAM or another clade. 
Table 3-12 Sub-analysis of 200 isolates which were unmatched by comparison to the 
VNTR-MIRUplus database 
 Haarlem X LAM T CAS Caprae AFRI Beijing Bovis S EAI Seal Total 
Haarlem - 86 62 7 8 0 0 0 0 1 0 0 164 
X 86 - 8 0 0 0 0 0 0 0 0 0 94 
LAM 62 8 - 4 0 0 0 2 0 1 0 0 77 
T 7 0 4 - 3 4 2 2 0 0 0 0 22 
CAS 8 0 0 3 - 0 0 3 0 0 0 0 14 
Caprae 0 0 0 4 0 - 3 0 2 0 0 0 9 
AFRI 0 0 0 2 0 3 - 0 0 0 1 1 7 
Beijing 0 0 2 2 3 0 0 - 0 0 0 0 7 
Bovis 0 0 0 0 0 2 0 0 - 0 0 0 2 
S 1 0 1 0 0 0 0 0 0 - 0 0 2 
EAI 0 0 0 0 0 0 1 0 0 0 - 0 1 
Seal 0 0 0 0 0 0 1 0 0 0 0 - 1 
Total 164 94 77 22 14 9 7 7 2 2 1 1  
 
The MIRU-VNTRplus database contains the species assignation for each isolate. 
The species of each TB isolate in the Midlands is identified by the MRCM using a 
species specific M. tuberculosis complex DNAstrip®. Species assignations made by 
the MRCM were compared to the assignations made by MIRU-VNTRplus in order to 
check the accuracy of the matches at a species level. Nearly all of the species 
assignations made by MIRU-VNTRplus were the same as the assignations made by 
the MRCM (1,667 of 1,683; 99%) (Table 3-13). Less than 1% (16 of 1,683) of the 
species assignations did not match when the two methods were compared. 
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MIRU-VNTRplus assigned 12 isolates as M. africanum however, the MRCM 
identified 16 M. africanum isolates present in the sample. MIRU-VNTRplus correctly 
identified seven M. africanum isolates; but it assigned five M. africanum isolates as 
M. caprae, two M. africanum isolates as M. bovis and two M. africanum isolates as 
M. tuberculosis. MIRU-VNTRplus assigned nine isolates as M. bovis but the MRCM 
identified six M. bovis isolates present in the sample. MIRU-VNTRplus correctly 
identified six M. bovis isolates; however, it assigned two M. africanum isolates as 
M. bovis and one M. tuberculosis isolate as M. bovis. MIRU-VNTRplus assigned six 
isolates as M. caprae but the MRCM did not identify any M. caprae isolates. 
MIRU-VNTRplus assigned five M. africanum isolates and one M. tuberculosis isolate 
as M. caprae. MIRU-VNTRplus assigned 1,656 isolates as M. tuberculosis whereas 
the MRCM identified 1,661 M. tuberculosis isolates. MIRU-VNTRplus correctly 
assigned 1,654 M. tuberculosis isolates; but two of the isolates that it assigned as 
M. tuberculosis were M. africanum. MIRU-VNTRplus incorrectly assigned five 
M. tuberculosis isolates as M. africanum, one M. tuberculosis isolate as M. bovis and 
one M. tuberculosis isolate as M. caprae. 
Table 3-13 Number of isolates that were assigned to different M. tuberculosis complex species 
by the MRCM and the MIRU-VNTRplus database 
Species 
identified by 
DNAstrip
®
 test 
Species identified by MIRU-VNTRplus 
Total 
M. africanum M. bovis M. caprae M. tuberculosis 
M. africanum 7 2 5 2 16 
M. bovis 0 6 0 0 6 
M. caprae 0 0 0 0 0 
M. tuberculosis 5 1 1 1,654 1,661 
Total 12 9 6 1,656 1,683 
 
3.4.2.3 Prominent CEL groups in the Midlands 
There were a high proportion of M. tuberculosis strains from the CAS spoligotype 
clade in the Midlands. To determine whether the high proportion of CAS stains was 
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due to a high proportion of people from the ISC living in the Midlands, the population 
structure of the Midlands was assessed. The Origins database was used to assign 
patients to CEL groups, which were then grouped by geographical regions. 
 
A CEL group was identified for 99% of the patients (1,659 of 1,683) who were 
diagnosed with TB between 2007 and 2008 (Table 3-14). When CEL groups were 
arranged by continent, Asia was the most common continent of origin amongst TB 
patients (945 of 1683, 56%) and Europe was the second most common continent of 
origin (538 of 1683, 32%). Patients who originated from Africa (151 of 1,683, 9%), the 
Americas (20 of 1,683, 1%), and Oceania (five of 1,683, <1%) were responsible for 
10% of the TB cases. 
 
When continental assignations were broken down into regions, nearly half of all 
patients were assigned to the south Asian region (783 of 1,683, 47%), with India 
being the most prevalent CEL group (397 of 1,683, 24%) from the Asian region. A 
quarter of all patients were assigned to the northern European region (432 of 1683, 
26%), with England being the most prevalent CEL group (317 of 1683, 19%) from the 
region. There were 82 different CEL groups in the Midlands TB patient population. 
Europe was the most diverse region with 28 different CEL groups, followed by Asia, 
which had 25 different CEL groups. A quarter of the Midlands TB patients (417 of 
1,659) that were assigned to a CEL group using origins had a UK CEL group, 
whereas three quarters of the patients (1,242 of 1,659) did not have a UK CEL group. 
Nearly two thirds of the people who did not have a UK CEL group (783 of 1,242, 
63%) had a south Asian CEL group. 
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Table 3-14 Major Cultural, Ethnic, and Linguistic (CEL) groups present in typed M. tuberculosis 
isolates in the Midlands between 2007 and 2008 
Continental 
origin of 
patient 
Region 
Most prevalent 
CEL group 
n (%) 
No. of 
other 
CEL 
groups 
n (%) 
Total 
isolates 
(%) 
Asia 
South India 397 (24) 14 386 (23) 783  (47) 
West West Asia 84 (5) 3 55 (3) 139 (8) 
East 
Chinese 
Cantonese 
6 (0) 3 9 (1) 15 (1) 
South east Philippines 6 (0) 1 2 (0) 8 (0) 
       945 (56) 
Europe 
North England 318 (19) 10 114 (7) 432 (26) 
West Germany 26 (2) 5 21 (1) 47 (3) 
South Italy 17 (1) 6 27 (2) 44 (3) 
East Poland 10 (1) 3 5 (0) 15 (1) 
       538 (32) 
Africa 
East Somalia 47 (3) 8 24 (1) 71 (4) 
South Black S. Africa 21 (1) 3 8 (0) 29 (2) 
North Morocco 16 (1) 0 0 (0) 16 (1) 
West Nigeria 11 (1) 2 14 (1) 25 (1) 
Africa Africa 5 (0) 1 1  (0) 6 (0) 
Middle Congo 3 (0) 1 1 (0) 4 (0) 
       151 (9) 
Americas 
Caribbean Black Caribbean 5 (0) 1 1 (0) 6 (0) 
South Brazil 5 (0) 0 0  (0) 5 (0) 
North USA Black 4 (0) 2 5 (0) 9 (1) 
       20 (1) 
Oceania Oceania Australia 4 (0) 1 1 (0) 5 (0) 
Not assigned   24 (1) 0 0 (0) 24 (1) 
Total        1,683 (100) 
3.4.2.4 Global distribution of M. tuberculosis lineages in CEL groups 
resident in the Midlands, UK 
Two-thirds of the TB patients belonged to an Asian CEL group (895 of 1,483, 60%) 
so the most prevalent spoligotype clades amongst these patients strongly influenced 
the prevalence of clades within the Midlands. CAS was the most prevalent 
spoligotype clade in the Midlands (574 of 1,483, 39%) and it was the most prevalent 
spoligotype clade amongst TB patients from an Asian CEL group (Table 3-15). More 
than half of the TB strains from people belonging to an Asian CEL group belonged to 
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the CAS clade (463 of 895, 52%) (Figure 3-6). The second most prevalent CEL 
group was the European group (414 of 1,483, 28%). CAS was the third most 
prevalent clade (78 of 414, 19%) amongst patients from the European CEL group. 
 
LAM was the second most prevalent spoligotype clade within the Midlands (239 of 
1,483, 16%). LAM was the third most prevalent spoligotype clade amongst TB 
patients from an Asian CEL group (88 of 895, 10%) and the second most prevalent 
clade amongst TB patients from a European CEL group (88 of 414, 21%). The third 
most prevalent spoligotype clade in the Midlands was EAI (225 of 1,483, 15%). EAI 
was the second most prevalent spoligotype clade amongst TB patients from an Asian 
CEL group (157 of 895, 18%) and the fourth most prevalent clade amongst TB 
patients from a European CEL group (40 of 414, 10%). The fourth most prevalent 
spoligotype clade in the Midlands was Haarlem (209 of 1,483, 14%). Haarlem was 
the fifth most prevalent spoligotype clade amongst TB patients belonging to an Asian 
CEL group (66 of 895, 7%) but it was the most prevalent clade amongst TB patients 
belonging to a European CEL group (127 of 414, 31%). 
Table 3-15 Distribution of M. tuberculosis isolates in the Midlands according to predicted 
spoligotype clade and continent of patient origin based on CEL group 
 Spoligotype clade predicted by MIRU-VNTRplus (% of total by region)  
Region 
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Total 
Asia 1 (0) 71 (8) 2 (0) 4 (0) 463 (52) 157 (18) 66 (7) 88 (10) 6 (1) 32 (4) 5 (1) 895 
Europe 3 (1) 21 (5) 6 (1) 0 (0) 78 (19) 40 (10) 127 (31) 88 (21) 12 (3) 24 (6) 15 (4) 414 
Africa 5 (4) 6 (4) 0 (0) 0 (0) 26 (19) 23 (17) 11 (8) 50 (37) 4 (3) 8 (6) 2 (2) 135 
Others* 2 (5) 4 (10) 0 (0) 0 (0) 7 (18) 5 (13) 5 (13) 13 (33) 2 (5) 1 (3) 1 (3) 39 
Total 10 102 8 4 574 225 209 239 24 65 23 1,483 
* this group included Americas, Oceania and not identified 
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Figure 3-6 Global distribution of CEL groups and the eight major M. tuberculosis spoligotype clades 
Each circle is located in the continental region where the CEL group originated. The size of the circle is proportional to the 
number of patients from each region. Map adapted from http://commons.wikimedia.org/wiki/File:BlankMap-World-2009.PNG. 
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3.4.2.5 The composition of M. tuberculosis lineages distributed across the 
Midlands, UK 
The Midlands region of the UK consists of 11 counties, which are divided into the 
East Midlands (Derbyshire, Leicestershire, Lincolnshire, Northamptonshire and 
Nottinghamshire) and the West Midlands (Herefordshire, Shropshire, Staffordshire, 
Warwickshire, West Midlands county and Worcestershire). Nearly two thirds of the 
TB isolates from 2007 and 2008 came from patients who lived in the West Midlands 
(920 of 1,483, 62%), one third came from patients who lived in the East Midlands 
(563 of 1,483, 38%) (Figure 3-7). More than half of all these TB isolates came from 
patients who lived in the county of West Midlands (771 of 1,483, 52%) which is in the 
West Midlands region. Leicestershire had the second highest number of typed 
isolates (205 of 1,483, 17%) and Nottinghamshire had the third highest number of 
isolates (125 of 1,483, 8%). There were five counties that had less than 50 isolates 
(Herefordshire, Shropshire, Warwickshire, Lincolnshire and Worcestershire) and 
three counties with between 51 and 100 isolates (Staffordshire, Northamptonshire 
and Derbyshire). The lowest number of isolates came from the county of 
Herefordshire (5 of 1,483, <1%). 
 
CAS was the most prevalent spoligotype in six counties (6 of 11, 55%), the highest 
proportion of CAS was in Staffordshire where it accounted for 32 of 67 (48%) isolates 
(Figure 3-7). The county of West Midlands had the highest number of CAS isolates 
with 340 of 771 (44%); followed by Leicestershire where CAS accounted for 98 of 
250 isolates (39%). 
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Figure 3-7 Distribution of the eight major M. tuberculosis spoligotype clades in the Midlands, UK 
Each circle is located in the region that the TB patient resided in; the size of the circle is proportional to the number of 
patients from each region. Map adapted from 
http://en.wikipedia.org/wiki/File:Map_of_the_administrative_geography_of_the_ United_ Kingdom.png. 
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3.4.2.6 Distribution of CEL groups across eleven counties in the East and 
West Midlands 
Nearly two thirds of the TB patients in the Midlands had a CEL code that belonged to 
the Asian continental group (895 of 1,483, 60%), which made Asia the most 
prevalent continental group (Figure 3-8). The Asian continental CEL group was the 
most prevalent group in five of 11 counties (45%). Leicestershire had the highest 
proportion with 182 of 250 patients (73%) originating from Asia. The Asian CEL 
group was also the most prevalent CEL group in the county of West Midlands (518 of 
771, 67%), Warwickshire (17 of 30, 57%), Derbyshire (46 of 84, 55%) and 
Staffordshire (32 of 67, 48%). For comparison, the CEL structure of the total 
population of each county in the Midlands, UK is shown in Table 3-16. 
 
The European continental CEL group was the second most prevalent group in the 
Midlands (414 of 1,483, 28%), and was the most prevalent group in 4 of 11 counties 
(36%). Worcestershire had the highest proportion with 25 of 35 patients (71%) 
originating from Europe. The European CEL group was also the most prevalent CEL 
group in Lincolnshire (24 of 35, 69%), Shropshire (8 of 12, 67%) and Herefordshire (3 
of 5, 60%). In Nottinghamshire and Northamptonshire the proportions of patients 
from an Asian CEL group (Nottingham; 53 of 125, 42%, Northamptonshire; 27 of 69, 
39%) was the same as those with a European CEL. The county with the highest 
proportion of patients from the African continental CEL group was Northamptonshire 
(12 of 69, 17%) and the county with the highest number of patients from this CEL 
group was the West Midlands county (83 of 771 11%). Patients from other 
continental CEL groups accounted for less than 3% of all patients (39 of 1,483). 
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Figure 3-8 Distribution of five continental CEL groups amongst TB patients across the Midlands, UK 
Each circle is located in the region that the TB patient resided in; the size of the circle is proportional to the number of 
patients from each region. Map adapted from 
http://en.wikipedia.org/wiki/File:Map_of_the_administrative_geography_of_the_ United_ Kingdom.png. 
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3.4.2.7 Distribution of M. tuberculosis lineages across Primary Care Trusts 
in the West Midlands county 
There are nine Primary Care Trusts (PCT) in the West Midlands county. Nearly a 
third of the TB isolates from the West Midlands county came from the Heart of 
Birmingham PCT (240 of 771, 31%). Six PCTs had less than 100 isolates typed 
(Coventry Teaching, Wolverhampton City, Walsall Teaching, South Birmingham, 
Dudley and Solihull) and two PCTs had between 100 and 110 isolates (Birmingham 
East and North and Sandwell). The most prevalent spoligotype clade within the West 
Midlands county is the CAS clade (340 of 771, 44%). The CAS clade was also the 
most prevalent clade in every PCT within the West Midlands county (Figure 3-9). 
3.4.2.8 Distribution of CEL groups across Primary Care Trusts in the West 
Midlands county 
More than two thirds of the TB patients in the West Midlands county had a CEL code 
that belonged to the Asian continental group (518 of 771, 67%), which made Asia the 
most prevalent continental group. The Asian continental CEL group was the most 
prevalent group in all nine PCTs within the county (Figure 3-10). The Heart of 
Birmingham PCT had the highest proportion and the highest number of TB patients 
with an Asian continental CEL (175 of 240, 73%). Dudley PCT had the lowest 
proportion of TB patients with an Asian continental CEL (15 of 30, 50%) and Solihull 
PCT had the lowest number of TB patients with an Asian continental CEL (7 of 12, 
58%). For comparison, the CEL structure of the total population of each PCT in the 
West Midlands county is shown in Table 3-17. 
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Figure 3-9 Distribution of the eight major M. tuberculosis spoligotype clades in the West Midlands county 
Each circle is located in the region that the TB patient resided in; the size of the circle is proportional to the number of 
patients from each region. Map adapted from http://en.wikipedia.org/wiki/File:West_Midlands_County.png. 
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A fifth of the TB patients in the West Midlands county had a CEL code that belonged 
to the European continental group (158 of 771, 20%), which made Europe the 
second most prevalent continental group. The European continental CEL group was 
the second most prevalent group in all of the nine PCTs within the West Midlands 
county. Dudley PCT had the highest proportion of TB patients with a European 
continental CEL (13 of 40, 33%). The Heart of Birmingham PCT had the lowest 
proportion of TB patients with a European continental CEL (34 of 240, 14%), 
although it had the highest number of TB patients with a European continental CEL. 
 
South Birmingham PCT had the highest proportion of TB patients with an African 
continental CEL group (9 of 53, 17%).The highest number of patients with an African 
continental CEL group were from the Heart of Birmingham Teaching PCT (29 of 240 
12%). Patients from other continental CEL groups accounted for less than 2% of 
patients in the West Midlands county (12 of 771, <2%). 
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Figure 3-10 Distribution of the five continental CEL groups amongst TB patients in the West Midlands county 
Each circle is located in the PCT that the TB patient resided in. The size of the circle is proportional to the number of 
patients from each region. Map adapted from http://en.wikipedia.org/wiki/File:West_Midlands_County.png. 
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Table 3-16 Distribution of the five continental CEL groups amongst TB patients in the Midlands, UK and amongst the total population 
County 
Percentage of TB patients belonging to different ethnic 
groups 
Percentage of total population belonging to different 
ethnic groups* 
Africa Americas Asia Europe Oceania Not Found Africa Americas Asia Europe Oceania Mixed 
Derbyshire 2.4 1.2 54.8 36.9 1.2 3.6 0.1 0.4 2.3 96.0 0.0 1.1 
Leicestershire 5.6 2.0 72.8 17.6 0.4 1.6 0.5 0.6 11.5 85.5 0.0 1.8 
Lincolnshire 8.6 0.0 20.0 68.6 0.0 2.9 0.1 0.1 0.4 98.7 0.0 0.8 
Northamptonshire 17.4 1.4 39.1 39.1 0.0 2.9 0.4 0.8 2.0 95.1 0.0 1.7 
Nottinghamshire 12.0 0.0 42.4 42.4 0.0 3.2 0.3 1.1 2.5 94.1 0.0 1.9 
Shropshire 0.0 0.0 25.0 66.7 0.0 8.3 0.1 0.2 1.2 97.3 0.0 1.1 
Staffordshire 9.0 1.5 47.8 41.8 0.0 0.0 0.1 0.2 1.7 97.0 0.0 1.0 
Warwickshire 0.0 0.0 56.7 43.3 0.0 0.0 0.1 0.3 2.8 95.6 0.0 1.2 
West Midlands 10.8 0.5 67.2 20.5 0.3 0.8 0.7 3.0 13.4 80.0 0.0 2.9 
Worcestershire 0.0 2.9 25.7 71.4 0.0 0.0 0.1 0.2 1.1 97.5 0.0 1.1 
Herefordshire 0.0 0.0 20.0 60.0 0.0 20.0 0.1 0.0 0.2 99.1 0.0 0.6 
* Data obtained from the 2001 census (ONS, 2003) 
Table 3-17 Distribution of the five continental CEL groups amongst TB patients in the West Midlands and amongst the total population 
PCT 
Percentage of TB patients belonging to different ethnic 
groups 
Percentage of total population belonging to different ethnic 
groups 
Africa Americas Asia Europe Oceania 
Not 
Found 
Africa Americas Asia Europe Oceania Mixed 
Birmingham 
East and North 
11.8 0.0 66.7 21.6 0.0 0.0 0.7 3.1 15.4 77.8 0.0 3.0 
Coventry 
Teaching 
15.6 0.0 53.1 26.0 1.0 4.2 0.7 1.1 11.3 84.0 0.0 3.0 
Dudley 3.3 3.3 50.0 43.3 0.0 0.0 0.2 0.8 4.0 93.7 0.0 1.4 
HOB Teaching** 12.1 0.4 72.9 14.2 0.4 0.0 2.6 10.7 51.7 29.1 0.0 5.9 
Sandwell 5.7 0.9 71.7 21.7 0.0 0.0 0.5 3.3 14.0 79.7 0.0 2.5 
Solihull 16.7 0.0 58.3 25.0 0.0 0.0 0.2 0.8 2.5 94.6 0.0 1.9 
South 
Birmingham 
17.0 0.0 60.4 22.6 0.0 0.0 0.8 2.4 8.4 84.4 0.0 3.9 
Walsall 
Teaching 
9.4 0.0 70.3 18.8 0.0 1.6 0.3 1.1 10.4 86.4 0.0 1.8 
Wolverhampton 
City 
4.4 1.5 72.1 20.6 0.0 1.5 0.7 3.9 14.3 77.8 0.0 3.3 
* Data obtained from the 2001 census (ONS, 2003), ** HOB = Heart of Birmingham 
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3.5 Discussion 
The current study examined the spoligotype clade distribution of 1,483 
M. tuberculosis strains isolated between 2007 and 2008 from patients in the Midlands 
region of the UK. This showed that CAS was the predominant spoligotype clade 
(39%), followed by LAM (16%) and EAI (15%). The CAS spoligotype clade is 
widespread in east Africa, northern India and Pakistan, the LAM clade is common in 
Europe and America and EAI is prevalent in east Africa and India (Gagneux and 
Small, 2007). The M. tuberculosis strain population was highly diverse with 11 clades 
identified. 
 
The ethnicity of TB patients was predicted using a novel software programme 
(Origins) which assigned CEL groups based on a patient’s name (Webber, 2007). 
More than half of the TB patients in the Midlands were predicted to have Asian 
ethnicity and one third were predicted to have European ethnicity. The prevalence of 
spoligotype clades from Asia and Europe corresponded with prevalence of patient 
ethnic groups, which is consistent with observations of an association between 
M. tuberculosis lineages and the geographical origin of TB patients (Reed et al., 
2009; Gagneux et al., 2006). 
 
In the current study, the population groups identified by Origins software were 
compared with self-declared population groups for a subset of patients that were 
predicted to have ISC ethnicity. There was a high degree of concordance (83%) 
between the two methods. This enabled population groups to be assigned to the rest 
of the patients in this study. Origins software is useful because self-declared 
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population data is not always available. A study in London, UK, which assessed 
M. tuberculosis genotyping and patient ethnicity, found that self-declared patient 
ethnicity data was missing in 40% of cases (Brown et al., 2010). 
 
The MRCM receives M. tuberculosis strains from referring laboratories across the 
Midlands region of the UK and analyses them by MIRU-VNTR typing. The use of the 
MIRU-VNTRplus database to assign spoligotype clade based on MIRU-VNTR data 
was evaluated (Allix-Beguec et al., 2008b). Isolates that represented the most 
prevalent MIRU-VNTR profiles amongst patients who were predicted to have ISC 
ethnicity were selected and 98 isolates were spoligotyped. The spoligotype clades 
that were obtained from direct comparison of data to SITVIT were compared with 
inferred spoligotype clades from MIRU-VNTRplus. There was a high level of 
concordance (79%) between the two databases for all spoligotype clades. SITVIT 
and MIRU-VNTRplus were concordant for 91% of CAS strains spoligotyped in this 
study. This enabled spoligotype clades based on MIRU-VNTR data and comparison 
to MIRU-VNTRplus to be assigned to all M. tuberculosis isolates from the Midlands 
between 2007 and 2008 with a high degree of confidence. 
 
The matching distance of all strains and spoligotype clades assigned by 
MIRU-VNTRplus were evaluated. Overall, there was a high degree of matching with 
1,025 of 1,683 (61%) strains matched at less than 0.17 and 1,628 of 1,683 (97%) 
strains matched at less than 0.30. However, there were only 10 CAS strains present 
in the MIRU-VNTRplus database (Allix-Beguec et al., 2008b) whereas SITVIT 
contained 1,098 CAS strains (Brudey et al., 2006). This disparity of CAS isolates in 
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the MIRU-VNTRplus database could have resulted in incorrect assignment of 
spoligotype clades for some strains. Comparison to databases such as 
MIRU-VNTRplus and SITVIT is likely to introduce inaccuracies as there is no uniform 
international TB surveillance and so data that is submitted to global databases is 
heavily biased towards strains from countries where there are adequate resources to 
carry out surveillance. 
 
When the spoligotype clades that were present in a subset of strains from patients 
with southern Asian ethnicity were analysed the most prevalent clade was CAS 
(59%) and the second most prevalent clade was EAI (10%). The CAS and EAI 
spoligotype clades are both prevalent in the ISC (Table 3-18). CAS and EAI clades 
differ in their evolutionary history, EAI an ancient clade of M. tuberculosis and CAS is 
a TbD1- modern clade (Brosch et al., 2002). These two clades have different 
geographical distributions within the ISC, CAS is predominant in the north and EAI is 
predominant in the south. This north, south geographical partitioning is seen most 
clearly in India (Table 3-18). The predominance of modern CAS strains amongst 
people of ISC ethnicity in the Midlands suggests that the majority of TB patients in 
the Midlands originated from regions in the north of the ISC. Origins software is 
constantly updated and a more in-depth understanding of the CEL group structure in 
the ISC is being constructed. 
 
Typing of a subset of M. tuberculosis isolates from the Midlands using PGG and 
TbD1 showed good correlation with spoligotyping and MIRU-VNTR typing. This 
provides evidence to suggest that the clades of TB that are present in the Midlands 
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have not diverged from clades that are present in the SpolDB4 database, which 
indicates that local evolution of clades has not occurred in the Midlands (Lazzarini et 
al., 2007). 
Table 3-18 Summary the most prevalent spoligotype clades present in different regions of India 
reported in published studies 
Reference 
No. of 
isolates 
Region 
Clade 1 Clade 2 Clade 3 
most prevalent                      least prevalent 
(Kulkarni et al., 2005) 216 Central India CAS (30%) EAI (17%) - 
(Gutierrez et al., 2006) 12 Central India EAI (52%) CAS (24%) - 
(Singh et al., 2007) 85 Central India CAS (41%) EAI (18%) - 
(Chatterjee et al., 2010) 646 Central India MANU (26%) CAS (10%) EAI (5%) 
(Thomas et al., 2011) 101 Central India CAS (40%) EAI (38%) MANU (8%) 
(Bhanu et al., 2002) 83 North India CAS (68%) - - 
(Singh et al., 2004) 105 North India CAS (33%) EAI (9%) - 
(Gutierrez et al., 2006) 54 North India CAS (32%) EAI (32%) Beijing (15%) 
(Singh et al., 2007) 296 North India CAS (45%) EAI (24%) - 
(Mathuria et al., 2008) 83 North India CAS (36%) EAI (19%) - 
(Sharma et al., 2008) 97 North India CAS (49%) EAI (15%) - 
(Stavrum et al., 2009) 65 North India CAS (55%) EAI (22%) - 
(Varma-Basil et al., 2011) 101 North India CAS (42%) EAI (26%) - 
(Gutierrez et al., 2006) 25 South India EAI (80%) - - 
(Narayanan et al., 2008) 1215 South India EAI (84%) - - 
(Singh et al., 2007) 159 South India EAI (66%) CAS (5%) - 
(Narayanan et al., 2010) 23 South India EAI (45%) CAS (9%) - 
(Gutierrez et al., 2006) 91 India EAI (45%) CAS (26%) Beijing (10%) 
(Singh et al., 2007) 540 India EAI (35%) CAS (32%) - 
 
Gilbert and colleagues showed that between 1996 and 2005, the incidence of TB fell 
in 18 of the 21 European Organisation for Economic Co-operation and Development 
(OECD) member countries (Gilbert et al., 2009). However during the same period the 
incidence of TB in the UK increased by 31% (10.8 per 100,000 population in 1996 to 
14.2 per 100,000 in 2005). The incidence of TB also increased in Norway (4.3 per 
100,000 in 1996 to 6.3 per 100,000 in 2005; a 29% increase) and Sweden (5.6 per 
100,000 in 1996 to 6.3 per 100,000 in 2005; a 13% increase). Gilbert estimated that 
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the increases in TB rate were equivalent to 75 extra cases in Norway and Sweden 
annually, and more than 2,200 in the UK in 2005. In all three countries, people born 
abroad accounted for 5% of the total population and approximately 75% of the TB 
cases. However, the number of foreign-nationals from countries with high incidence 
of TB was much greater for the UK than for Norway and Sweden. In the UK 10% of 
foreign-born nationals came from countries with a TB rate of more than 500 cases 
per 100,000 population, whereas none of the foreign-born nationals in Sweden and 
Norway came from countries with a TB rate of more than 250 cases per 100,000 
population. The pattern of migration in the UK is likely to account for the increase in 
TB cases, although the authors concede that the provision of health services may 
also affect the trends in TB notification in Europe (Gilbert et al., 2009). 
 
The current study showed that 39% of TB cases in the Midlands between 2007 and 
2008 belonged to the CAS clade and 15% belonged to the EAI clade. Brown and 
colleagues spoligotyped 2,233 M. tuberculosis strains isolated in London, UK 
between 2005 and 2006. The authors showed that CAS and EAI were the most 
prevalent M. tuberculosis clades and patients originating from the ISC were the 
largest patient population group (Brown et al., 2010). There were 552 CAS strains 
(24%) and nearly 40% of them came from patients who had Asian ethnicity, the 
ethnicity of 40% of patients infected with CAS strains was unknown. There were 357 
EAI strains (16%) and 40% came from patients with Asian ethnicity, the ethnicity of 
35% of patients infected with EAI strains was unknown (Brown et al., 2010). Within 
the UK, the highest number of TB cases is in London. However, TB rates in London 
have been constant since 2006 (HPA, 2011a). The Midlands has the second highest 
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number of TB cases in the UK however, the proportion of CAS strains in the 
Midlands is much higher than in London. The importation of CAS strains to the 
Midlands may be driving the increase in TB. Comparison of the proportion of CAS 
and EAI strains in London and the Midlands during the same period would give a 
better understanding of how immigration is contributing to the M. tuberculosis 
population structure in different parts of the UK. 
 
Strains from the CAS and EAI clades are not commonly isolated in other European 
countries. Oelemann  and colleagues assessed 154 M. tuberculosis strains that were 
isolated from Hamburg, Germany in 2003 and found that Haarlem was the most 
prevalent clade (37%), only 8% of strains belonged to the CAS clade and 6% to the 
EAI clade (Oelemann et al., 2007). Allix-Beguec and colleagues assessed the 
population structure of 807 M. tuberculosis strains isolated in Brussels, Belgium 
between 2002 and 2005. The authors reported that nearly half of the TB patients 
(47%) had African ethnicity. The prevalent spoligotype clades were LAM (19.7%), 
followed by Haarlem (17%), CAS and EAI clades each accounted for 5% of the total 
(Allix-Beguec et al., 2008a). Viedma and colleagues did not find any M. tuberculosis 
strains from the CAS or EAI clades in a study of 233 strains isolated from Madrid, 
Spain between 2001 to 2002 (Garcia de Viedma et al., 2005a). However, Alonso and 
colleagues analysed 48 M. tuberculosis strains isolated from Madrid and Barcelona, 
Spain between 2003 and 2006. These strains were specifically selected from patients 
with Asian ethnicity, 12 isolates belonged to the CAS clade, and 13 isolates belonged 
to the EAI clade. CAS and EAI strains were not isolated from any patients with non-
Asian ethnicity (Alonso et al., 2008). CAS was reported to comprise 9% of a sample 
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of 53 drug resistant M. tuberculosis strains isolated in Greece between 2007 to 2008 
(Rovina et al., 2011). Ojo and colleagues analysed 171 M. tuberculosis strains 
isolated from Cork, Ireland between 2004 and 2006 and found that the most 
prevalent clade was X (29%). There were five EAI strains (3%) and four CAS strains 
(2%). Only four of the patients who were infected with CAS or EAI strains were 
nationals of Ireland, the other patients were born in India, Bangladesh, Pakistan or 
Zimbabwe (Ojo et al., 2010). 
 
The current study used the five Exact Tandem Repeats (ETR) originally described by 
Frothingham and Meeker (Frothingham and Meeker-O'Connell, 1998) and twelve 
classical MIRU loci originally described by Supply and colleagues (Supply et al., 
2001) to assign spoligotype clades. These 15 loci can be used to assign spoligotype 
clades using MIRU-VNTRplus as shown by the close matching distances identified in 
this study (Allix-Beguec et al., 2008b). However, accurate estimation of transmission 
rates cannot be obtained by using 15 MIRU-VNTR loci alone (Christianson et al., 
2010; Garcia de Viedma et al., 2006; Supply et al., 2006). Routine analysis of the 
current internationally recommended set of 24 MIRU-VNTR loci is now carried out for 
all M. tuberculosis strains (Christianson et al., 2010; Garcia de Viedma et al., 2006; 
Supply et al., 2006). 
 
The UK as a whole has low rates of TB; however, rates in migrant populations are far 
higher (HPA, 2012). The identification of clades present in the ISC and the UK 
combined with continued migration indicates that clades such as CAS are likely to 
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account for a significant proportion of disease in the UK in the future (Gilbert et al., 
2009). 
 
Previous studies indicated that the global origin of a patient is an important 
determinant in the associated M. tuberculosis genotype of TB (Gagneux et al., 2006). 
Whether this is due to bacterial adaptation to specific host populations or sociological 
and epidemiological factors is not clear. The mechanism and causes for the 
distribution of CAS in individuals resident in the Midlands and who have originated 
from the ISC warrant further investigation to examine the interaction between host 
and strain properties. 
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4 ASSESSMENT OF VIRULENCE OF THE MOST 
PREVALENT TB STRAINS IN THE MIDLANDS, UK 
USING IN VITRO MODELS 
4.1 Introduction 
4.1.1 Model systems for studying mycobacterial infections 
Model systems are useful for the study of M. tuberculosis virulence because host 
genetics and behaviour can be standardised. For example, the CDC1551 strain 
caused an outbreak of TB in the USA; the strain was described as hypervirulent 
because of its high rate of transmission to patient contacts, which occurred in a low 
risk population. There was also evidence of transmission occurring outdoors where 
risk of infection should have been low (Valway et al., 1998). Initial investigators 
concluded that transmission was due to a characteristic of the strain rather than 
susceptibility of the patients or environmental factors that may have favoured the 
spread of the disease. 
 
The finding that CDC1551 grew more rapidly in mice than the laboratory strain 
M. tuberculosis Erdman demonstrated the increased virulence of the strain in a more 
effective way than inferences made about transmission between human hosts 
(Valway et al., 1998). However, a study carried out by Manca and colleagues found 
that the rate of growth for CDC1551 was similar to H37Rv in the lungs of 
aerosol-infected mice and in human monocytes (Manca et al., 1999). Manca found 
that rather than CDC1551 having a higher growth rate in mice, the Erdman strain had 
a lower growth rate. Although CDC1551 did not exhibit increased growth in vitro or in 
vivo, the increased virulence that was suggested by the epidemiology of the outbreak 
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was demonstrated by the induction of a more rapid and vigorous immune response in 
a murine model of infection and a human monocytic model of infection. The study 
carried out by Manca highlights the importance of control strain selection for 
comparison with clinical isolates. 
4.1.1.1 Animal models 
There are no natural animal reservoirs for M. tuberculosis; however, a number of 
species are susceptible to infection when it is artificially induced. Robert Koch used 
the guinea pig in 1882 to demonstrate that M. tuberculosis is responsible for causing 
TB (Koch, 1882). In 1961 Bhatia and colleagues showed that clinical isolates from 
south Indian TB patients had a reduced ability to produce gross TB in a guinea pig 
model when compared to British isolates (Gagneux and Small, 2007; Smith and 
Wiegeshaus, 1989; Bhatia et al., 1961). 
 
Guinea pigs are highly susceptible to infection with M. tuberculosis and infections can 
be established through the inhalation of relatively few bacteria. The course of disease 
in the guinea pig has many aspects in common with human disease, especially 
primary pulmonary disease. When guinea pigs develop TB, they form granulomata 
that can caseate and lead to necrosis (Dharmadhikari and Nardell, 2008). There are 
however fewer immunological tools available for the study of guinea pig models 
compared to other animal models and their larger size compared to mice is 
associated with higher rearing costs and requirement for more laboratory space. 
 
Rabbits have also been used to study TB although they have a natural resistance to 
infection. When pulmonary infection is established, cavities may form but they often 
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regress and heal. Because of this, rabbits are often used to study latency, although 
spontaneous reactivation of disease will only occur if the immune system of the 
animal is suppressed (Dharmadhikari and Nardell, 2008). 
 
Mice are frequently used for the study of TB because they have cheaper rearing 
costs than rabbits and guinea pigs. There is a wide range of immunological tools 
available for studying murine models and the development of selective gene 
knockout mice has enhanced the understanding of TB immunology. However, the 
course of disease in mice is different to humans. Mice form granulomata but these do 
not caseate and mice tend to enter a chronic phase of disease instead of latency, 
which can occur in humans (Dharmadhikari and Nardell, 2008). 
 
The use of guinea pigs, rabbits and mice has been fundamental in studying many 
elements of TB including transmission of the disease and the immune response to it. 
Each animal model has advantages and disadvantages, some of which are 
summarised in Table 4-1. However, susceptibility to TB and the course of the 
disease in animal models differs from TB infection in humans. The immune response 
and the extent of organ involvement also vary considerably between species 
(Dharmadhikari and Nardell, 2008). 
 
Modelling TB in non-human primates, such as the cynomolgus macaque replicates 
TB in humans more faithfully than using small animal models (Kaushal et al., 2012). 
However, non-human primates are not used frequently for TB research because of 
ethical considerations, high costs and their ability to transmit the disease to humans. 
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Humans can develop primary, latent, or reactivation TB, as described in section 1.3. 
Different animal models are therefore more applicable to different states of the 
disease. Animal models can provide information about the host response to TB and 
have also been used to show differences between strains of M. tuberculosis. The 
cost of keeping animals at containment level three is high and requires specialist 
facilities. Variation in host genetics also makes it difficult to compare subtle 
differences between strains of M. tuberculosis. This has led to the development of 
cell-based assays, which are cheaper than using animals and can reduce the 
influence of host genetics. 
Table 4-1 Comparison of features of mouse, rabbit and guinea pig models of pulmonary TB 
with features of the disease in humans* 
  Experimental animal model 
Feature Human host Mouse Rabbit Guinea pig 
Susceptibility to M. tuberculosis ++ + + +++ 
Extrapulmonary dissemination ++ ++ ++ ++ 
Hematogeous seeding of apical lobes ++ ? ? ++ 
Typical mononuclear cell granulomas ++ ++ ++ ++ 
Caseation necrosis ++ − ++ ++ 
Liquifaction/cavitation ++ − ++ − 
Delayed-type hypersensitivity +/+ +/− ++ ++ 
Protection by BCG vaccine ++/− + ++ ++ 
Biosafety level 3 space requirements N/A + ++++ ++ 
Maintenance costs N/A + ++++ ++ 
Immunological reagents ++++ ++++ ++ + 
*adapted from (McMurray, 2001) 
+ indicates the occurrence of this feature, multiple + symbols indicate the 
feature is more prevalent 
– indicates that absence of a feature 
+/- indicates that there are differences between individuals of the species 
? indicates that there is insufficient data 
N/A indicates not applicable 
4.1.1.2 Cell based assays 
Droplet nuclei that are deposited in the alveoli are phagocytosed by alveolar 
macrophages. M. tuberculosis is able to survive and replicate within macrophages, 
which ordinarily kill internalised microorganisms. For these reasons, most assays of 
M. tuberculosis virulence use phagocytic cells, although some research has been 
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carried out with lung epithelial cells (Danelishvili et al., 2003; Dobos et al., 2000). 
Models of macrophage infection use either primary cells or a cell line that has been 
immortalised. 
4.1.1.2.1 Alveolar macrophages 
Primary tissue macrophages are the most relevant cell type for modelling human 
infection with M. tuberculosis. Human alveolar macrophages are acquired by 
bronchoalveolar lavage, which is an invasive procedure that is usually only 
performed for diagnostic purposes. It is therefore difficult to obtain human alveolar 
macrophages from healthy donors. 
 
Monocytes originate from a common precursor in the bone marrow and then travel 
via the blood to extravascular tissues. Monocytes can be recruited to sites of 
inflammation and injury. Monocytes can also differentiate into tissue macrophages in 
response to growth factors. Macrophages from different tissues have different 
phenotypes, suggesting that the unique conditions present in a particular tissue 
influence the development of the tissue macrophages (Rutherford et al., 1993). 
Alveolar macrophages are believed to exist in a primed or activated state, because of 
their constant exposure to inhaled antigen in the lung (Rutherford et al., 1993; 
Andreesen et al., 1990). 
 
Several groups have shown that human alveolar macrophages are a heterogeneous 
population in which distinct subsets of cells can be distinguished (St-Laurent et al., 
2009; Campbell et al., 1986). Due to the difficulty of obtaining alveolar macrophages 
from humans and the inherent heterogeneity of the cell population, the comparison of 
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virulence characteristics of M. tuberculosis strains in alveolar macrophages is 
technically challenging. Monocytes obtained from peripheral blood can be 
differentiated into macrophages in vitro. Most assays using primary human cells for 
the assessment of M. tuberculosis are performed with monocytes or 
monocyte-derived macrophages (MDMs) because of the ease with which blood can 
be collected. Several groups have compared MDMs to alveolar macrophages to 
determine differences and similarities between the cell types. 
 
Li and colleagues used microarrays to assess the gene expression profiles of 
alveolar macrophages and MDMs from four healthy human volunteers. MDMs were 
generated by exposure to macrophage colony stimulating factor (M-CSF). The 
microarrays showed large differences between alveolar macrophages and MDMs, 
16% of genes on the array were differentially expressed (Li et al., 2007). Taylor and 
colleagues showed that alveolar macrophages and MDMs phagocytosed E. coli and 
fluorescently labelled polystyrene beads at the same rate. MDMs were generated by 
exposure to granulocyte-macrophage colony stimulating factor (GM-CSF) (Taylor et 
al., 2010). Juarez and colleagues showed that mRNA levels of Toll-like receptors 2, 4 
and 9 (which are receptors that recognise pathogen-associated molecular patterns) 
in human MDMs resembled the levels seen in alveolar macrophages obtained from 
the same person. MDMs were generated by plastic adherence; addition of cytokines 
was not listed in the methods (Juarez et al., 2010). 
 
It is difficult to compare alveolar macrophages to MDMs because alveolar 
macrophages are a heterogeneous cell population and the phenotype of MDMs can 
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be altered by the methods used to purify and differentiate monocytes. Activation of 
MDMs with different cytokines can alter the gene expression profile and phenotype of 
the cells, which makes it harder to compare studies such as those carried out by Li, 
Taylor and Juarez (Taylor et al., 2010; Juarez et al., 2010; Li et al., 2007). 
4.1.1.2.2 Monocyte-derived macrophages 
The heterogeneity that is observed in human alveolar macrophage populations is due 
to the ability of macrophages to respond to activation signals. Macrophage activation 
occurs along a spectrum in vivo, with classical activation at one end of the scale and 
alternative activation at the opposite extreme. Macrophages are able to respond to 
activation in a reversible manner and are not permanently committed to develop into 
a particular lineage. Macrophage polarization can be simulated in vitro with MDMs 
and is also a reversible phenomenon (Ambarus et al., 2012; Stout et al., 2009). 
 
GM-CSF and M-CSF can promote macrophage generation from human monocytes 
and aid macrophage survival. The use of GM-CSF to produce MDMs results in cells 
that are polarised towards a classically activated M1 phenotype and the use of 
M-CSF results in an alternatively activated M2 phenotype. The terms M1 and M2 are 
used because they mirror the nomenclature used to describe T helper cells, which 
can be polarised in a similar manner. M1 and M2 macrophages have different 
morphologies and express different cell surface markers (Figure 4-1). 
 
M1 macrophages are able to produce reactive nitrogen intermediates and they 
secrete the pro-inﬂammatory cytokines IL-1, IL-12 and IL-23 (Sica and Mantovani, 
2012). M1 macrophages show enhanced phagocytosis and facilitate resistance 
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against intracellular pathogens, including suppression of macrophage-tropic HIV-1 
replication (Matsuda et al., 1995). M2 macrophage is a broad term used for several 
forms of activated macrophage that produce the anti-inflammatory cytokine IL-10 and 
have high levels of mannose and scavenger receptors. M2 macrophages have been 
shown to promote tissue repair and remodelling and have immunoregulatory 
functions, including involvement in anti-parasitic and allergic reactions. M2 
macrophages are not able to suppress the replication of macrophage-tropic HIV-1 
(Lacey et al., 2012; Martinez et al., 2006; Mantovani et al., 2005). 
 
M1 macrophage morphology has been reported to resemble that of normal human 
alveolar macrophages and the expression of cell surface markers is similar. The 
phenotype of M2 macrophages is more closely related to peritoneal macrophages. 
Peritoneal macrophages come from a sterile anaerobic environment and are thought 
to be present in a quiescent, non-activated state (Komuro et al., 2001). 
 
Raju and colleagues found that people with active TB could be divided into two 
groups based on the gene expression profile of their alveolar macrophages. One 
group had alveolar macrophages that showed an M1 gene expression profile and the 
other group had alveolar macrophages that showed an M2 expression profile. Raju 
also showed that alveolar macrophages isolated from one TB patient at the onset of 
antibiotic treatment showed an M2 gene expression profile, but as treatment 
progressed, the alveolar macrophages isolated from this patient showed an M1 gene 
expression profile. In addition, Raju found that alveolar macrophages from some 
individuals who were not infected with TB had gene expression profiles that were 
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indicative of an M2 profile (Raju et al., 2008). People who have M2 polarised alveolar 
macrophages may be more susceptible to infection with M. tuberculosis than people 
who have alveolar macrophages that have an M1 phenotype. 
 
Figure 4-1 Features of M1 and M2 polarised macrophages 
M1 macrophages exhibit classical ‘fried egg morphology’, whilst M2 
macrophages have a stretched spindle like morphology. M2s refers to several 
diverse forms of M2 activation. Chemokines are shown in red, cytokines in 
orange, phenotype in dark blue, cell function in black and cell surface receptors 
in grey. Adapted from (Sica and Mantovani, 2012; Biswas and Mantovani, 2010; 
Verreck et al., 2006). 
CCL = Cysteine-Cysteine motif chemokine ligand 
CD = cluster of differentiation 
CXCL = Cysteine-any-Cysteine motif chemokine ligand 
FR = folate receptor 
GR = galactose receptor 
IFN-γR = interferon-gamma receptor 
IL = interleukin 
IL-1decoyR = interleukin-1 decoy receptor 
Lyve-1 = lymphatic vessel endothelial receptor 1 
MHCII = major histocompatibility complex class II 
MR = mannose receptor 
SR = scavenger receptor 
ST2 = suppressor of tumorigenicity 2 receptor 
TLR = Toll-like receptor 
TNF = tumor necrosis factor 
RNI = reactive nitrogen intermediate 
ROI = reactive oxygen intermediate 
 
A study by Chacón-Salinas and colleagues using murine bone-marrow derived 
macrophages showed that virulent strains of M. tuberculosis caused M2 macrophage 
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polarisation, whereas avirulent strains caused M1 macrophage polarisation (Chacon-
Salinas et al., 2005). Redente and colleagues showed that upon initial infection of 
mice with M. tuberculosis strain Erdman, macrophages from bronchoalveolar lavage 
became M1 polarised but as inflammation progressed macrophages switched to an 
M2 phenotype. However macrophages that were part of a granuloma in the lung did 
not switch to an M2 phenotype, suggesting that free alveolar macrophages and 
macrophages associated with granulomata are exposed to different cytokines 
(Redente et al., 2010). 
 
Almeida and colleagues showed that cells isolated by bronchoalveolar lavage from 
people who were infected with TB, had gene expression patterns that were 
consistent with an M2 macrophage phenotype, whereas people with other infectious 
lung diseases and healthy people had gene expression profiles consistent with an 
M1 macrophage phenotype. They also found that the M2 phenotype switched to an 
M1 phenotype with continuing antibiotic treatment for TB (Ho and Lape e Silva, 2010; 
Almeida et al., 2009). 
 
The capacity of M. tuberculosis to alter the polarisation of macrophages may be an 
indication of virulence; strains that are more virulent may have an increased capacity 
to alter the activation state of macrophages. 
 
Numerous studies have assessed the virulence of clinical isolates and laboratory 
strains of M. tuberculosis in MDMs. Studies have looked at the growth of bacteria 
within macrophages, the viability of infected macrophages and the levels of cytokines 
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produced by infected macrophages. The methods used in some of these studies and 
the results are summarised in Table 4-2, Table 4-3 and Table 4-4. 
 
Despite the observation that M. tuberculosis is able to alter macrophage polarisation 
there is little evidence of whether polarised macrophages are able to control the 
growth of M. tuberculosis, especially clinical isolates. The virulence of M. tuberculosis 
strains in M1 and M2 macrophages has also not been assessed, although Portevin 
and colleagues assessed the cytokine response of M1 and M2 MDMs to 
M. tuberculosis clinical isolates from each of the six lineages defined by Gagneux 
and colleagues (Gagneux et al., 2006). The study by Portevin and colleagues 
concluded that modern M. tuberculosis strains induced a lower IL-6 response in M1 
macrophages than ancient strains 24 hours after infection but not after 72 hours. This 
indicated that there was a delay in the immune response to modern strains (Portevin 
et al., 2011). Infection of M2 macrophages with the same isolates resulted in lower 
IL-6 production than in M1 macrophages. 
 
Verreck and colleagues showed that uptake and growth of a luciferase-transfected 
M. bovis BCG reporter strain was higher in M2 human MDMs than in M1 MDMs, 
using a range of 2 to 20 bacilli per cell. There was no difference in the viability of M1 
and M2 cells after six days of infection with the reporter strain and the phenotype of 
the cells was not altered by the infection. The authors also showed that M1 cells 
could efficiently present antigen and activate T cells but M2 cells could not (Verreck 
et al., 2004). Denis showed that growth of H37Rv was greater in M2 human MDMs 
compared to M1 MDMs when an infection ratio of 10 bacilli per cell was used (Denis, 
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1991). Kahnert looked at gene expression profiles of murine bone marrow-derived 
macrophages that had been polarised to an M1 or an M2 phenotype and then 
infected with M. tuberculosis strain Erdman. There was reduced expression of genes 
associated with production of nitric oxide and iron sequestration in M2 macrophages 
suggesting that M2 macrophages would support the intracellular growth of 
M. tuberculosis rather than inhibit it (Kahnert et al., 2006). 
 
To address the question of whether clinical strains show a difference in virulence in 
polarised macrophages, human MDMs will be treated with M-CSF or GM-CSF and 
then infected with different strains of M. tuberculosis. As most studies of 
M. tuberculosis strain virulence in human cells have been carried out in monocytes or 
immortalised human cell lines, the virulence of the M. tuberculosis strains selected for 
the current study will first be assessed in one these models. 
 
4.1.1.2.3 Immortalised human cell lines 
In order to compare the virulence of M. tuberculosis strains in monocytes or MDMs, 
the same blood donor must be used which means only a limited number of strains 
can be compared, as cell number cannot be expanded in culture. The results are 
also indicative of the individual that the cells were obtained from, necessitating repeat 
experiments using different donors to ensure that results are due to M. tuberculosis 
strain variation and not natural variation of the donor cells. 
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Table 4-2 Summary of treatment of mycobacteria used in published infection models using MDMs 
Reference 
No. of 
bacteria per 
cell 
Method of 
inoculum 
preparation 
Were 
bacteria 
frozen 
before use? 
Bacterial strains included in the study 
No. of hours 
before extra 
cellular 
bacteria 
were 
washed out 
No. of 
clinical 
isolates 
tested 
H37Ra M.bovis BCG H37Rv 
(McDonough et 
al., 1993) 
10 liquid  0     6 
(Paul et al., 
1996) 
1 liquid  0     6 
(Zhang et al., 
1998) 
0.0125 liquid  4     24 
(Silver et al., 
1998) 
1 liquid  0     1 
(Zhang et al., 
1999) 
0.01 liquid  17     24 
(Li et al., 2002) 1 liquid  8     1 
(Wong et al., 
2007) 
- solid  125     18 
(Chen et al., 
2006) 
2 to 10 liquid  0     4 
(Denis, 1991) 10 liquid  0     6 
(Portevin et al., 
2011) 
1 liquid  26     - 
 indicates yes 
 indicates no 
- indicates that the data was not included in the publication 
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Table 4-3 Summary of treatment of MDMs used in published mycobacterial infection models 
Reference 
No. of 
cells/ 
ml 
Method used to isolate 
monocytes 
 
Parameters tested 
Plastic 
adherence 
Positive 
bead 
selection 
M1 or M2 
polarised 
 
Intracellular 
growth rate 
Growth 
rate in 
broth 
Macrophage 
apoptosis 
Macrophage 
necrosis 
Cytokine 
production 
(McDonough et 
al., 1993) 
-    
 
     
(Paul et al., 
1996) 
2 x 10
5
    
 
     
(Zhang et al., 
1998) 
4 x 10
5
    
 
     
(Silver et al., 
1998) 
1 x 10
6
    
 
     
(Zhang et al., 
1999) 
5 x 10
5
    
 
     
(Li et al., 2002) 1 x 10
6
    
 
     
(Wong et al., 
2007) 
5 x 10
5
    
 
     
(Chen et al., 
2006) 
5 x 10
5
    
 
     
(Denis, 1991) 1 x 10
6
    
 
     
(Portevin et al., 
2011) 
1 x 10
5
    
 
     
 indicates yes 
 indicates no 
- indicates that the data was not included in the publication 
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Table 4-4 Summary of results from published mycobacterial infection models using MDMs 
1
 A higher number of bacteria was used obtain measurable cytokine concentrations. 
2
 Modern and ancient as defined by LSP-based analysis (Gagneux et al., 2006). 
- indicates that data was not included in the publication 
CFU stands for colony forming unit. 
Reference 
Growth in MDM 
 Growth in 
broth 
 
MDM apoptosis 
 
MDM necrosis 
 
Cytokine production 
Method used to 
assess growth (No. 
days post infection) 
Lowest rate 
↓ 
Highest rate 
 Lowest rate 
↓ 
Highest rate 
 Lowest rate 
↓ 
Highest rate 
 Lowest rate 
↓ 
Highest rate 
 
Pro-
inflammatory 
Anti-
inflammatory 
(McDonough 
et al., 1993) 
Electron microscopy 
(7) 
Only H37Rv grew 
 
- 
 
- 
 
Only with H37Rv 
 
- - 
(Paul et al., 
1996) 
CFU / microscopy (6) No difference 
 
- 
 
- 
 
- 
 
- - 
(Zhang et 
al., 1998) 
CFU (10) 
H37Ra, 
H37Rv, 
Clinical isolates 
 
No difference 
 
- 
 
No difference 
 
No difference for 
TNF-α or IL-12
1
 
No difference 
for  
IL-10
1
 
(Silver et al., 
1998) 
CFU (7) 
H37Ra, 
BCG, 
H37Rv 
 
- 
 
- 
 BCG, 
H37Ra, 
H37Rv 
 High intracellular 
growth caused 
high TNF-α 
No difference 
(Zhang et 
al., 1999) 
CFU (14) 
Unique, 
Small cluster, 
Large cluster 
 
No difference 
 
- 
 
No difference 
 
No difference for 
TNF-α or IL-12
1
 
No difference 
for  
IL-10
1
 
(Li et al., 
2002) 
CFU (7) 
EAI, 
H37Rv, Beijing 
 
- 
 
- 
 
- 
 
- - 
(Wong et al., 
2007) 
CFU (10) 
Only H37Rv and 3 
clinical isolates 
grew 
 
- 
 
- 
 
- 
 High intracellular 
growth caused 
low TNF-α 
- 
(Chen et al., 
2006) 
- - 
 
- 
 H37Rv, 
H37Ra 
 H37Ra, 
H37Rv 
 
- - 
(Denis, 
1991) 
CFU (8) 
Lower growth in 
M1 cells 
 
- 
 
- 
 
- 
 
- - 
(Portevin et 
al., 2011) 
- - 
 
- 
 
- 
 
- 
 Modern strains 
caused lowest  
IL-6
2
 
- 
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The use of immortalised human cell lines that have phagocytic properties 
circumvents many of the problems associated with primary cells. Cell lines are 
advantageous because there is no donor variation and large numbers of cells can be 
grown. Macrophages from non-human species have been shown to differ from 
human macrophages. For example, murine macrophages produce large quantities of 
nitric oxide; the production of nitric oxide in human macrophages is much lower, 
although it can be stimulated by several conditions including infection with 
M. tuberculosis (MacMicking et al., 1997). The use of cell lines that are human in 
origin avoids many of the problems associated with primary cells or animal cells 
(Silver et al., 1998). 
 
There are several human cell lines, which are commercially available, such as the 
monocytic cell lines Mono Mac 6 (Ziegler-Heitbrock et al., 1988) and HL-60 (Collins 
et al., 1978; Collins et al., 1977), and the promonocytic cell lines THP-1 and U-937. 
The Mono Mac 6 cell line was established from the peripheral blood of a patient with 
monoblastic leukemia in 1988 (Ziegler-Heitbrock et al., 1988). This cell line has been 
used to assess the antimicrobial activities of various compounds. The human 
leukemic cell line HL-60 was established from the peripheral blood leukocytes of an 
adult female with acute promyelocytic leukemia in 1977 (Collins et al., 1977). HL-60 
cells have been used in a number of studies that look at the effect of vitamin D and 
the production of nitric oxide when M. tuberculosis infection is induced. The THP-1 
and U-937 cell lines are commonly used to study the virulence of M. tuberculosis 
strains and will be discussed below. 
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The human macrophage-like cell line U-937 was derived from the pleural infusion of 
a 37 year old Caucasian male with diffuse histiocytic leukemia in 1976 (Sundstrom 
and Nilsson, 1976). U-937 cells can be converted from a non-adherent and weakly 
phagocytic phenotype to an adherent, actively phagocytic state with phorbol esters 
and other agents (Arcila et al., 2007). The U-937 cell line has been used extensively 
as a model system for studying the interaction between macrophages and several 
intracellular pathogens (Wei et al., 2000). Once U-937 cells have been activated, 
they can produce lysozyme, beta-2-microglobulin and tumor necrosis factor alpha 
(TNF-α). Beta-2-microglobulin is part of the MHC class I assembly, which displays 
protein antigens to T cells, and TNF-α is an inflammatory cytokine that is produced 
by activated macrophages. 
 
THP-1 is a pro-monocytic leukaemia cell line that was isolated in 1980 from the blood 
of a 1-year-old male who had acute monocytic leukemia (Tsuchiya et al., 1980). 
THP-1 cells can be differentiated into a mature macrophage-like state with the 
addition of phorbol esters such as phorbol 12-myristate 13-acetate (PMA). 
Differentiation causes THP-1 cells to express several macrophage cell surface 
receptors such as FcγRI (CD64), FcγRII (CD32), complement receptor 3 A (CD11b) 
and the LPS receptor (CD14). CD64 and CD32 are both immunoglobulin G (IgG) 
receptors, CD11b mediates leukocyte adhesion and phagocytosis of 
complement-coated particles and CD14 is a co-receptor for pathogen-associated 
molecular patterns such as bacterial lipopolysaccharide (LPS) (Stokes and Doxsee, 
1999). THP-1 cells have the same capacity as MDM to bind M. tuberculosis 
laboratory strain Erdman in the presence and absence of serum and are able to bind 
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IgG and complement coated particles. However, THP-1 cells differ from MDM in their 
expression of lectin-like receptors, which are capable of binding glycans (Stokes and 
Doxsee, 1999). Daigneault and colleagues carried out a comprehensive comparison 
of monocytes, MDMs and THP-1 cells. Daigneault concluded that when THP-1 cells 
were stimulated with PMA, then rested in the absence of PMA for 5 days, the 
phenotype of the resulting cells was similar to that of MDMs. Daigneault generated 
MDMs using a plastic adherence protocol and noted that the activation state of 
MDMs and differentiated THP-1 cells was different (Daigneault et al., 2010). 
 
A review by Auwerx concluded that differentiated THP-1 cells behave more like 
native MDMs than HL-60 or U-937 cells (Auwerx, 1991). Like all models, THP-1 cells 
do not mimic MDM completely. However, the advantages of being able to grow large 
numbers of cells with no donor variability and the similarities they share with MDMs 
make THP-1 cells a good model to use for assessing bacterial variation. 
Macrophages are an extremely diverse population of cells and so any model is 
subject to limitations that must be accounted for when assessing results. 
4.1.2 Studies using THP-1 cellular models of M. tuberculosis 
infection 
THP-1 cells have been used in numerous studies that have assessed the virulence of 
clinical isolates and laboratory strains. Studies have looked at the growth of bacteria 
within macrophages, the viability of infected macrophages and the levels of cytokines 
produced by infected macrophages. The methods used in some of these studies are 
summarised in Table 4-5 and Table 4-6 and the results are summarised in Table 4-7. 
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Viability of infected macrophages has been studied because macrophage cell death 
is an important response to infection with M. tuberculosis (Duprez et al., 2009). 
Apoptosis is an energy dependant form of cell death that causes the controlled 
breakdown of the cell without induction of an inflammatory response (Figure 4-2), 
thus eliminating the intracellular environment that supports the growth of 
M. tuberculosis (Lammas et al., 1997). Apoptotic bodies are engulfed by other 
macrophages. The mycobacteria are sequestered within the apoptotic body and so 
may be unable to initiate the block on normal phagosome maturation resulting in the 
destruction of the pathogen (Fratazzi et al., 1997). Apoptosis can also facilitate 
antigen presentation to T cells (Winau et al., 2006; Schaible et al., 2003). There are 
several reports showing that virulent strains of M. tuberculosis prevent macrophage 
apoptosis, thus promoting their own survival (Riendeau and Kornfeld, 2003; Sly et al., 
2003; Spira et al., 2003; Keane et al., 2000; Placido et al., 1997), whereas avirulent 
M. tuberculosis strains induce apoptosis. Higher induction of apoptosis by avirulent 
strains is not linked to increased intracellular growth as virulent strains were shown to 
have higher growth rates than avirulent strains (Keane et al., 2000). 
 
Virulent strains of M. tuberculosis are reported to cause cellular necrosis (Keane et 
al., 2000). Necrosis is an energy independent form of cell death that causes 
disruption of the plasma membrane, releasing lysosomal enzymes and causing 
tissue damage (Figure 4-2). Infected macrophages that die by necrosis release 
bacteria, which can then infect other cells. Rapid growth of virulent strains of 
M. tuberculosis coincides with induction of cellular necrosis (Duprez et al., 2009; Park 
et al., 2006). 
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Figure 4-2 Features of apoptotic and necrotic cell death 
Necrosis 
A. The cell swells and small blebs begin to form. 
B. Blebs become larger but do not contain organelles. The cell becomes leaky. 
C. Cellular and nuclear lysis occur and organelles no longer function. The 
contents of the cell are released into the surrounding tissue causing 
inflammation. 
 
Apoptosis 
I. The cell shrinks and the chromatin condenses. 
II. DNA becomes fragmented and membrane-bound apoptotic bodies that 
contain functional organelles, cytosol and DNA bud away from the cell. 
III. The cell breaks into several apoptotic bodies, which are phagocytosed by 
other cells without triggering inflammation. 
Adapted from (Wang et al., 2013) and (van Cruchten and van den Broeck, 
2002) 
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Riendeau and colleagues used a THP-1 model to test the virulent laboratory strain 
H37Rv and the avirulent strain H37Ra as well as a virulent M. bovis strain and BCG 
which is avirulent (Riendeau and Kornfeld, 2003). They found that the avirulent 
strains caused a high level of apoptosis, whereas the virulent strains did not. 
 
In 2003, Sharma and colleagues examined the intracellular growth rate of H37Rv, 
H37Ra and a strain designated as type 1 by IS6110 RFLP, in THP-1 cells. Type 1 
strains accounted for 24% of TB cases in Manitoba, Canada, and were prevalent 
among infected individuals of aboriginal decent. No difference in growth rate was 
found between the strains after 72 hours. Induction of IFN-γ, IL-1β, and TNF-α 
production was highest when THP-1 cells were infected with H37Rv. Levels of IL-10 
were highest when THP-1 cells were infected with the type 1 strain (Sharma et al., 
2003). 
 
In 2004, Theus and colleagues carried out a study that used THP-1 cells to 
investigate H37Rv, TB282; which is a member of the Beijing clade and TB284, an 
isolate that was deemed to have a low rate of transmission based on epidemiological 
analysis. They found that the intracellular growth rates of H37Rv and TB282 were 
similar and significantly higher than TB284, despite all the strains having similar 
growth rates in 7H9 broth (Theus et al., 2004). 
 
In 2005, Theus and colleagues tested 32 clinical isolates, including TB282 and 
TB284. TB284 and six other isolates were unique strains, deemed to have low rates 
of transmission. The other strains, termed cluster strains, had been identified from six 
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different epidemiologically linked clusters of disease. All strains were phagocytosed 
at a similar rate. After three days of infection, the intracellular growth rates began to 
differ between strains, and after seven days, the growth of the unique strains was 
significantly less than for the cluster strains. The THP-1 cells remained viable over 
the seven-day infection period regardless of the infecting isolate. Isolates that 
belonged to the same cluster of disease had similar intracellular growth rates. There 
was no difference in the amount of IL-10 produced as a result of infection with unique 
or cluster strains, regardless of the number of intracellular organisms. Induction of 
IL-10 production by infection with unique strains was delayed by four days compared 
to infection with cluster strains. High intracellular growth rate correlated with rapid 
induction of IL-10. Unique strains induced higher levels of TNF-α than cluster strains, 
showing a strong association between the ability to grow rapidly and the ability to 
suppress TNF-α secretion (Theus et al., 2005). 
 
In 2007, Rajavelu and colleagues compared H37Rv, H37Ra and two clinical strains 
that were prevalent in south India. The clinical strains were able to infect more THP-1 
cells with a lower number of bacilli, whereas the laboratory strains infected fewer 
cells but there were more bacilli per cell. H37Ra caused more apoptosis and there 
was a decrease in intracellular bacterial viability after seven days compared to the 
other strains (Rajavelu and Das, 2007). 
 
Castro-Garza and colleagues looked at four clinical isolates that lacked the 
phospholipase C locus and used a THP-1 cell model to compare them to H37Rv. 
After 24 hours, 10% of the THP-1 cells that were infected with H37Rv had been 
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destroyed and after 72 hours, 50% had been destroyed. The clinical strains had a 
reduced cytotoxic effect; between 0% and 20% of infected THP-1 cells were 
destroyed after 72 hours. 
 
In 2007, Theus and colleagues tested 15 genotypically distinct Beijing family strains. 
The rate of phagocytosis and the growth rate in 7H9 broth were similar for all strains, 
but the growth rate in THP-1 cells differed significantly between strains. Production of 
TNF-α by infected macrophages was inversely related to growth rate; macrophages 
infected with the three strains that had the slowest intracellular growth rates secreted 
more TNF-α than macrophages infected with the 12 strains that had fastest 
intracellular growth rates (Theus et al., 2007a). 
 
In 2008, Sohn and colleagues compared cytokine release and macrophage death 
induced by infection with H37Rv and a Korean isolate termed K-strain, as well as the 
intracellular growth rates of the strains. K-strain is a member of the Beijing clade and 
was most commonly isolated from schoolchildren with pulmonary TB in Korea. Both 
strains had similar intracellular growth rates but K-strain induced less TNF-α, IL-6 
and IL-12-p40 production from THP-1 cells compared to H37Rv. There was more cell 
death when cells were infected with K-strain and H37Rv compared to uninfected 
THP-1 cells, but K-strain induced the most cell death. K-strain induced less apoptosis 
and more necrosis in THP-1 cells than H37Rv (Sohn et al., 2009). 
 
In 2009, Tanveer and colleagues compared H37Rv, BCG and 18 clinical isolates. 
Eight clinical isolates were from the CAS1 clade and eight were from the Beijing 
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clade, which were identified as the most prevalent clades in Pakistan. The clinical 
isolates had lower growth rates in broth and produced lower cytokine responses from 
THP-1 cells than H37Rv. There was a positive correlation between strain growth and 
induction of TNF-α and IFN-γ secretion for all strains. 
 
These studies indicate that production of cytokines by infected THP-1 cells can vary 
according to mycobacterial strain both in the time it takes for production to be 
induced and in the level to which they are produced. The level of apoptosis versus 
necrosis induced in THP-1 cells by infection can also vary according to the 
mycobacterial strain. Some strains of M. tuberculosis suppress inflammatory 
responses causing early progression to active disease. Other strains induce a strong 
inflammatory response, possibly producing latent infection (Talarico et al., 2007). 
 
It is difficult to compare data on different strains and their effects in THP-1 cells. 
There is wide variation in the number of bacteria that THP-1 cells have been infected 
with, ranging from one bacterium to ten cells, to fifty bacteria per cell. Studies have 
used bacteria that are in exponential growth phase or bacteria that have been frozen 
(Table 4-5). THP-1 cells have been differentiated overnight and rested for 3 days 
before use, or used directly after differentiation. Some studies add bacteria to the 
cells for a few hours before washing extra cellular bacteria away, and other studies 
do not wash away extracellular bacteria (Table 4-6). Studies have used laboratory 
strains and compared them to a limited number of clinical isolates. These clinical 
isolates have been typed by IS6110 or spoligotyping, which are not used clinically to 
distinguish between strains, as they are not discriminatory enough. 
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Table 4-5 Summary of treatment of mycobacteria used in published infection models using THP-1 cells 
Reference 
No. of 
bacteria per 
cell 
Method of 
inoculum 
preparation 
Were 
bacteria 
frozen 
before use? 
Bacterial strains included in the study 
No. of hours 
before extra 
cellular 
bacteria 
were 
washed out 
No. of 
clinical 
isolates 
tested 
H37Ra M. bovis BCG H37Rv 
(Riendeau and 
Kornfeld, 2003) 
10 liquid  0     4 
(Sharma et al., 
2008) 
2 solid  1     N/A 
(Theus et al., 
2005) 
50 liquid  32     3 
(Rajavelu and 
Das, 2007) 
10 liquid  2     3 
(Castro-Garza 
et al., 2007) 
0.1 liquid  4     N/A 
(Theus et al., 
2007b) 
50 liquid  15     3 
(Sohn et al., 
2009) 
3 liquid  1     3 
(Tanveer et al., 
2009) 
5 liquid  16     N/A 
 indicates yes 
 indicates no 
N/A indicates that no wash step was included in the protocol 
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Table 4-6 Summary of treatment of THP-1 cells used in published mycobacterial infection models 
Reference 
No. of 
THP-1 
cells/ 
ml 
Method used to differentiate cells 
 
Parameters tested 
Concentration 
of PMA 
Concentration 
of IFN-γ 
Length of 
treatment 
 
Intracellular 
growth rate 
Growth 
rate in 
broth 
THP-1 
cell 
apoptosis 
THP-1 
cell 
necrosis 
Cytokine 
production 
(Riendeau and 
Kornfeld, 2003) 
5 x 10
5
 5 nM 0 18 hours 
 
     
(Sharma et al., 
2008) 
2 x 10
6
 N/A N/A N/A 
 
     
(Theus et al., 
2005) 
- 100 nM 100 U/ml 3 days 
 
     
(Rajavelu and 
Das, 2007) 
1 x 10
5
 20 nM 0 18 hours 
 
     
(Castro-Garza 
et al., 2007) 
5 x 10
5
 10 nM 0 - 
 
     
(Theus et al., 
2007b) 
- 100 nM 100 U/ml 3 days 
 
     
(Sohn et al., 
2009) 
- 40 nM 0 18 hours 
 
     
(Tanveer et al., 
2009) 
- 32 nM 0 - 
 
     
 indicates yes 
 indicates no 
N/A indicates that treatment was not performed; the cells were not differentiated and remained as monocytes 
- indicates that the data not included in the publication.  
    129 
Table 4-7 Summary of results from published mycobacterial infection models using THP-1 cells 
- indicates that the data was not included in the publication 
Reference 
Growth in THP-1 cells 
 Growth in 
broth 
 THP-1 cell 
apoptosis 
 THP-1 cell 
necrosis 
 
Cytokine production 
Test 
method 
(days post 
infection) 
Lowest rate 
↓ 
Highest rate 
 
Lowest rate 
↓ 
Highest rate 
 
Lowest rate 
↓ 
Highest rate 
 
Lowest rate 
↓ 
Highest rate 
 
Pro-inflammatory Anti-inflammatory 
(Riendeau and 
Kornfeld, 2003) 
- - 
 
- 
 M. bovis, 
H37Rv, 
BCG, 
H37Ra, 
 
- 
 
- - 
(Sharma et al., 
2008) 
CFU counts 
(3) 
No difference 
 
- 
 
- 
 
- 
 H37Rv induced 
higher INF-γ, TNF-α 
secretion 
Type I clinical isolate 
induced higher IL-10 
secretion 
(Theus et al., 
2005) 
CFU counts 
(7) 
Unique isolates, 
clustered isolates 
 
- 
 
- 
 
- 
 High intracellular 
growth correlated 
with suppression of 
TNF-α 
High intracellular 
growth correlated 
with rapid IL-10 
secretion 
(Rajavelu and 
Das, 2007) 
CFU counts 
(7) 
H37Ra, 
S7, 
S10, 
H37Rv 
 
- 
 S7, 
H37Rv, 
S10, 
H37Ra 
 
- 
 
- - 
(Castro-Garza et 
al., 2007) 
- - 
 
- 
 
- 
 Clinical 
isolates, 
H37Rv 
 
- - 
(Theus et al., 
2007b) 
CFU counts 
(7) 
Growth rate 
varied amongst 
15 Beijing 
isolates 
 No difference  -  -  
High intracellular 
growth correlated 
with suppression of 
TNF-α 
- 
(Sohn et al., 
2009) 
- - 
 
No difference 
 
H37Rv, 
Clinical isolate 
 Clinical 
isolate, 
H73Rv 
 
- - 
(Tanveer et al., 
2009) 
- - 
 
Clinical 
isolates, H37Rv 
 
- 
 
- 
 High growth in broth 
correlated with 
induction of TNF-α 
- 
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The effect of mycobacterial virulence on host cell apoptosis has also been studied. 
Host cell apoptosis in response to infection with an intracellular virus is a 
well-established phenomenon (Roulston et al., 1999). Some viral pathogens are able 
to prevent host cell apoptosis, thus securing a favourable environment in which to 
replicate. The first report of apoptosis occurring in response to infection with 
M. tuberculosis was published in 1997 by Keane and colleagues. Keane used a 
multiplicity of infection (MOI) of between 5 and 10 bacilli per cell to infect human 
alveolar macrophages and showed that H37Ra caused more apoptosis than H37Rv 
(Keane et al., 1997). A later study showed that other virulent M. tuberculosis and 
M. bovis isolates could evade alveolar macrophage apoptosis, allowing them to grow 
intracellularly, whereas avirulent strains such as BCG caused host cell apoptosis that 
was accompanied by a decrease in bacterial viability (Keane et al., 2000). 
 
There is now a large body of evidence, which shows that death of host cells by 
apoptosis is bactericidal (Lee et al., 2009). Virulent mycobacteria that prevent host 
cells from undergoing apoptosis are able to proliferate intracellularly. Once the 
number of intracellular bacteria becomes high enough the bacteria are able to induce 
necrotic cell death, the bacteria are released and may infect other macrophages 
aiding the dissemination and transmission of the mycobacteria. 
 
Sohn and colleagues showed that an M. tuberculosis isolate belonging to the Beijing 
spoligotype clade caused less apoptosis than H37Rv and caused more necrosis, 
despite the strains having a similar intracellular growth rate. This suggests that 
virulent clinical isolates are able to prevent apoptosis, thus preventing bacterial killing 
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and are able to promote necrosis, which would release the bacteria from the 
phagocyte and allow infection of other cells. A study by Theus suggests that 
virulence correlates with higher intracellular growth rates (Theus et al., 2005). 
Therefore, measurement of intracellular growth rate and THP-1 cell necrosis will be 
used as parameters for assessment of bacterial virulence in the current study. 
4.2 Development of a THP-1 cell model to compare the 
virulence of M. tuberculosis strains 
The aim of this section was to develop a tissue culture assay to assess the virulence 
of clinical M. tuberculosis isolates. In order to test the model, the laboratory strain 
M. tuberculosis H37Rv was used as an example of a virulent strain and M. bovis 
BCG Danish vaccine was used as an example of an avirulent strain. Growth of 
bacteria within cells and death of infected cells was measured to determine virulence. 
The BACTEC™ MGIT™ 960 System was used to measure mycobacterial growth. 
The BACTEC™ MGIT™ 960 System is an indirect method of measuring the number 
of bacteria that are present in a sample based of the amount of time that is taken for 
the oxygen in a tube to be depleted by bacterial respiration, which is known as the 
time to positivity (TTP). The BACTEC™ MGIT™ 960 System was calibrated to allow 
comparisons between strains to be made. 
4.2.1 Preparation of a standard bacterial inoculum 
4.2.1.1 Background 
MGITs™ contain 7 ml of modified Middlebrook 7H9 broth and 100 µl of tris 4,7-
diphenyl-1, 10-phenanthroline ruthenium chloride pentahydrate which is an oxygen-
quenched fluorophore. Bacteria that are inoculated into a MGIT™ deplete the oxygen 
as they respire until there is insufficient oxygen to quench the fluorophore, which 
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results in an increase in fluorescence. Tubes entered into the BACTEC™ MGIT™ 
960 System are incubated at 37°C and monitored for increasing fluorescence. Once 
the fluorescence reaches 75 units, the tube is declared positive and described as 
having a positive growth index. The length of time taken for a MGIT™ to reach a 
positive growth index is called the TTP. Tubes that show no fluorescence for a 
minimum of 34 days are declared negative. MGITs™ also contain an antimicrobial 
mixture called PANTA™ which reduces contamination from non-mycobacterial 
organisms and OADC which is essential for growth of mycobacteria. 
 
Passage number, storage conditions and phase of growth can all affect the growth 
rate of bacteria. Nascimento and Leite showed that three successive rounds of 
freezing and thawing impaired the growth of BCG Moreau strain in liquid culture 
(Nascimento and Leite, 2005). The inoculum was standardised by optical density to 
ensure that comparisons were accurate. Nascimento and Leite also showed that 
BCG passaged three times from actively growing cultures had impaired growth in 
liquid culture compared to BCG that had only been passaged twice. Andreu and 
Gibert found changes in the lipid composition of the cell wall of H37Rv after 20 
passages (Andreu and Gibert, 2008). Molina-Torres and colleagues reported that 
serial subculture of four M. tuberculosis isolates, including H37Rv resulted in 
decreased virulence in a THP-1 cell model (Molina-Torres et al., 2010). Cardona and 
colleagues identified a clinical isolate that lost virulence after repeated passage when 
compared to frozen stock of the strain, which had not been passaged, using an 
immunocompromised murine model of infection (Cardona et al., 2006). Aranaz and 
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colleagues found that the spoligotype of a clinical isolate changed after eight serial 
passages (Aranaz et al., 2004). 
 
The BACTEC™ MGIT™ 960 System has been used in the current study to equate 
TTP to the number of bacteria that were present in a culture. It was therefore 
important that all strains tested in the current study were treated in the same way so 
that differences in virulence could be detected, and could not be attributed to 
differences in passage number, storage condition or growth phase. 
4.2.1.2 Hypothesis 
Bacteria that have been stored at -20°C will take longer to achieve a positive growth 
index in a MGIT™ than bacteria that have been growing in culture. 
4.2.1.3 Aims 
 To compare the TTP of MGITs™ that had been inoculated from a culture in 
exponential growth phase to the TTP of MGITs™ inoculated from a culture 
which had just been removed from storage at -20°C 
 To compare the TTP of MGITs™ that had been inoculated from a culture in 
exponential growth phase to the TTP of MGITs™ inoculated from a culture in 
stationary growth phase 
 To prepare a stock of each mycobacterial strain for use in subsequent 
experiments 
4.2.1.4 Materials and methods 
The MRCM prepares frozen stocks of all strains that are received; briefly, a MGIT™ 
(BD Biosciences, Oxford, UK) is inoculated with 1 ml bacteria from either a patient 
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sample or a culture from the NCTC, Colindale, London, UK. M. bovis BCG Danish 
vaccine strain 1331 was obtained from the Statens Serum Institute, Copenhagen. 
MGITs™ are placed in a BACTEC™ MGIT™ 960 System (BD Biosciences, Oxford, 
UK) at 37°C until a positive growth index is detected by fluorescence. Positive 
cultures are confirmed by microscopy, the culture is genotyped and a 1 ml aliquot is 
placed in a cryovial and stored at -20°C. 
 
During the current study, frozen mycobacterial stocks prepared by the MRCM were 
defrosted and 100 µl was used to inoculate a fresh MGIT™, the time taken for each 
MGIT™ to achieve a positive growth index was recorded. In some cases 100 µl of 
culture was removed from a MGIT™ with a positive growth index and was used to 
inoculate a fresh MGIT™, the TTP for the fresh MGIT™ was recorded. Growth rate 
was assessed by recording the relative fluorescent units produced by a MGIT™ 
culture, which was plotted against time, and then linear regression was used to 
calculate a doubling time. Relative fluorescent units were assessed by the 
BACTEC™ at hourly intervals; however, the data is not stored and has to be 
manually recorded. 
 
In order to prepare a stock of mycobacteria for use in the current study a MGIT™ 
was inoculated from the frozen stock prepared by the MRCM and once this MGIT™ 
reached a positive growth index, 45 aliquots of 150 µl were prepared and stored 
at -20°C. All positive cultures were confirmed as pure mycobacterial cultures by 
microscopy. Where applicable, data sets were compared in Microsoft Excel using 
Student’s two-sample t test. 
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4.2.1.5 Results 
As shown in Figure 4-3 cultures which were inoculated from frozen stock took twice 
as long to reach a positive growth index as cultures which were inoculated from 
actively dividing cultures. The mean number of hours for cultures of BCG which were 
inoculated with 100 µl of bacteria from frozen stock to reach a positive growth index 
was 116 (± 10 hours, n=5). The mean number of hours for cultures which were 
inoculated with 100 µl of bacteria from an actively growing culture to reach a positive 
growth index was 58 hours (± 5 hours n=5) (p= 0.002). 
 
Cultures of H37Rv which were inoculated with 100 µl bacteria from frozen stock 
reached a positive growth index in a mean of 194 hours (± 11 hours, n=5). Cultures 
which were inoculated with 100 µl of bacteria from an actively growing culture 
reached a positive growth index in a mean of 86 hours (± 17 hours n=5) (p= 0.0008). 
 
The variation in TTP for different cultures seen in Figure 4-3 could be caused by a 
difference in the number of bacteria in the inoculum; therefore, linear regression was 
used to calculate a bacterial doubling time based on the number of fluorescent units 
produced per hour. MGIT™ cultures inoculated from actively dividing cultures had a 
mean doubling time of 22 hours (± 1.3 hours, n=4). The mean doubling time of 
MGIT™ cultures inoculated with bacteria from cultures which had reached stationary 
phase was 2 hours longer than MGITs™ inoculated from actively dividing cultures 
(24 hours ± 1.1 hours, n=5). The mean doubling time for MGIT™ cultures inoculated 
with H37Rv directly from frozen stock was 12 hours longer than MGITs™ inoculated 
from actively dividing cultures (34 hours ± 1.1 hours, n=5) (p=0.03). 
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Figure 4-3 Mean TTP cultures of H37Rv and BCG, inoculated from frozen stocks or cultures in 
exponential growth phase 
Error bars depict SEM, (n=5) 
 
Results from experiments that calculated bacterial doubling time indicate that the 
growth phase of the bacterial inoculum affects the growth of the subsequent culture. 
In order to confirm the effect of inoculum growth phase on TTP in a MGIT™, bacteria 
from stationary or actively growing cultures were enumerated (for method see section 
4.2.2) and used to inoculate MGITs™. The mean TTP for MGITs™ inoculated with 
5 × 105 H37Rv from an exponential phase culture (113 hours ± 5 hours, n=5) was 52 
hours shorter than the mean TTP for MGITs™ inoculated with 5 × 105 H37Rv from a 
stationary phase culture (165 hours ± 8 hours, n=5) (p= 0.02) (Figure 4-4). 
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Figure 4-4 Mean TTP for MGITs™ inoculated from H37Rv cultures in exponential or stationary 
phase growth 
Error bars depict SEM, (n=5) 
4.2.1.6 Discussion 
Results from the current study indicate that the TTP of a MGIT™ culture can vary 
significantly depending on the conditions used to store the bacterial inoculum. To 
reduce variability between future experiments a standard bacterial inoculum was 
prepared for each strain that was tested in the tissue culture model. 
 
A standard inoculum was prepared by growing a bacterial culture until it achieved a 
positive growth index in a MGIT™. The positive culture was stored at -20°C in single 
use aliquots to avoid repeated cycles of freezing and thawing, as there are reports of 
a reduction in the number of colony forming units (CFU) after bacteria have been 
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frozen (O'Sullivan et al., 2007a). Each aliquot will be used to inoculate a MGIT™. 
Once the MGIT™ had reached a positive growth index 100 µl of the culture was used 
to inoculate a second MGIT™, as the current study has shown that MGITs™ 
inoculated with bacteria which have been frozen have a longer TTP and the bacteria 
have a slower doubling time than MGITs™ inoculated from actively growing cultures. 
This strategy is also used by O’Sullivan and colleagues (O'Sullivan et al., 2010) and 
Shorten and colleagues (Shorten et al., 2013). The bacteria in the second MGIT™ 
were harvested during exponential growth as the current study has shown that TTP 
and bacterial doubling time vary depending upon the growth phase of the bacterial 
inoculum. The harvested bacteria were enumerated and then used for further 
experimentation. This method was used for the preparation of all bacteria in the 
current study. 
4.2.2 Enumeration of bacteria 
4.2.2.1 Background 
Mycobacteria were enumerated so that differing inoculum sizes did not cause 
variation between strains when they were tested in a tissue culture model. 
Mycobacteria can form cords, which are large clumps of bacteria that must be 
disrupted in order for accurate quantification to be achieved. 
 
Addition of detergents to bacterial cultures or mechanical disruption methods such as 
sonication can be used to disperse clumps. These procedures may affect the 
bacterial phenotype. Sonication has been shown to remove bacterial cell surface 
lipids, which affects the rate at which bacteria are phagocytosed by macrophages 
(Stokes et al., 2004). A study by Sani and colleagues used cryo-transmission 
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electron microscopy to study the cell envelope of four mycobacterial strains, including 
BCG Copenhagen and M. tuberculosis strain 6020. Sani showed that when 
mycobacteria were grown with 0.05% tween and agitation the outer capsule-like layer 
was partially or completely removed (Sani et al., 2010). Sani also showed that 
removal of the capsule-like layer from BCG reduced binding of the bacteria to human 
MDMs and increased the production of pro-inflammatory cytokines by the 
macrophages. As evidence suggests that removal of cell surface lipids affects the 
interaction of mycobacteria with macrophages, an optimum treatment should to be 
defined to remove clumps whilst preserving the bacterial phenotype. 
4.2.2.2 Hypothesis 
Sonication and addition of Tween 80 to bacterial cultures will eliminate bacterial 
clumps. 
4.2.2.3 Aims 
 To optimise the treatment of mycobacterial cultures in order to remove clumps, 
whilst minimising the manipulation of the bacteria. 
 To determine whether procedures to remove clumps affect bacterial growth in 
vitro 
4.2.2.4 Materials and methods 
Mycobacterial cultures were prepared as described in section 4.2.1.4, and purity was 
confirmed by microscopy using a TB ZN stain kit (Becton Dickinson) according to the 
manufacturer’s instructions. Bacteria were washed and resuspended in 1 ml of RPMI 
with or without 0.05% Tween 80 (v/v) and some suspensions were subjected to two 
30 second bursts of sonication in a bath sonicator. Suspensions were then left to 
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stand for 60 minutes to allow clumps of bacteria to fall out of suspension; the upper 
500 µl was removed and added to 500 µl fresh RPMI. At this point, an aliquot of 
clarified bacteria was removed for auramine staining to assess the number of clumps. 
Staining was carried out using TB fluorescent stain kit (Becton Dickinson) according 
to the manufacturer’s instructions. Bacteria in 10 fields of view were counted and 
categorised as single organisms, clumps of between 2 and 5 organisms, clumps of 6 
and 20 organisms, clumps of 21 and 50 organisms and clumps of over 50 organisms. 
Images were captured using a Leica microscope. Samples were left to stand for a 
further 60 minutes and the upper 500 µl was removed. A sample was removed for 
auramine staining to assess the number of clumps and a further sample was taken 
for counting. The sample of bacteria that was taken for counting was added to an 
equal volume of formalin and incubated at room temperature for 30 minutes to fix the 
bacteria. Fixed bacteria were inoculated into MGITs™ to confirm that bacteria had 
been killed by the formalin treatment. The number of organisms in the fixed sample 
was estimated by counting using a Helber chamber and light microscopy at 50 X 
magnification. Counts were the average of 80 small squares. Counts were used to 
adjust unfixed bacterial suspensions to a density of 5 × 105 bacterial/ml using RPMI 
with or without 0.05% Tween 80 (v/v) and 100 µl was inoculated into a fresh MGIT™. 
In some cases, MGITs™ were inoculated with 100 µl of 5 × 105 bacteria/ml in RPMI 
with 0.5% Tween 80 (v/v). 
4.2.2.5 Results 
Treating a suspension of M. tuberculosis H37Rv with 0.05% (v/v) Tween 80 resulted 
in a 2 fold increase in the number of single organisms (197 ± 10 n=10) when 
compared to untreated bacteria (113 ± 5n=10) (p= 0.002) (Figure 4-5). When bacteria 
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were treated with 0.05% Tween 80 and subjected to sonication it resulted in a 5 fold 
increase in the number of single organisms (534 ± 21 n=10) when compared to 
untreated bacteria (p= 0.00004) and a 3 fold increase when compared to bacteria 
treated with 0.05% Tween 80 (p= 0.0001). 
 
Figure 4-5 Mean number of bacteria in five subgroups after treatment to disperse clumps 
Ten replicate counts were made for each treatment (± SEM). 
 
Addition of 0.05% Tween 80 (v/v) to bacterial suspensions resulted in an increase in 
the number of clumps in all of the categories when compared to untreated bacteria. 
When bacteria were treated with 0.05% Tween 80 (v/v) and sonicated it resulted in 
an increase in the number of smaller clumps, but the larger clumps were eliminated. 
The number of clumps consisting of 2 to 5 organisms was 10 fold higher in cultures 
treated with sonication and 0.05% Tween 80 (v/v) (38 ± 8 n=10) compared to 
untreated bacteria (4 ± 0.3 n=10) (p= 0.01). The number of clumps consisting of 2 to 
5 organisms was 3 fold higher in cultures treated with sonication and 0.05% 
Tween 80 (v/v) (38 ± 8 n=10) compared to bacteria treated with 0.05% Tween 80 
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(v/v) (14 ± 2 n=10) (p= 0.05). The effect of 0.05% Tween 80 (v/v) and sonication on 
the degree of mycobacterial clumping can be seen in Figure 4-6. 
 
MGITs™ inoculated with 5 × 105 H37Rv, had a mean TTP of 119 hours (± 0.3 hours, 
n=3). Addition of 0.05% Tween 80 (v/v) to 5 × 105 H37Rv had no effect on the mean 
TTP (117 ± 1.2 hours, n=3) when compared to cultures with no Tween 80 (p= 0.35). 
Addition of 0.5% Tween 80 (v/v) to 5 × 105 H37Rv caused an increase in mean TTP 
of 28% (150 ± 0.9 hours, n=3) when compared to cultures which had no Tween 80 
added (p= 5 x 10-6) (Figure 4-7). Similar results were seen for BCG (Figure 4-7). 
 
 
Figure 4-6 Effect of 0.05% Tween 80 with and without sonication and sedimentation on the 
degree of clumping in a sample of M. tuberculosis H37Rv as shown by auramine staining 
A0, A1 and A2 were not treated, B0, B1 and B2 were treated with 0.05% Tween 
80, C0, C1 and C2 were treated with 0.05% tween and sonication. Samples 
were removed immediately after treatment (A0, B0, C0), after cultures had 
settled for 1 hour (A1, B1 and C1) or 2 hours (A2, B2 and C2). 
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Figure 4-7 Mean TTP for cultures of H37Rv and BCG after treatment with different 
concentrations of Tween 80 
Error bars depict SEM, (n=3) 
4.2.2.6 Discussion 
The study confirms the importance of sonicating bacteria in addition to treatment with 
detergent for removal of clumps from bacterial preparations. Both methods reduce 
the number of large clumps present in an inoculum and increase the number of 
single organisms, but sonicating the bacteria in addition to treatment with detergent 
destroyed all of the larger clumps and resulted in the largest increase in the number 
of single organisms. 
 
Bacterial suspensions that were not sonicated or treated with detergent have a small 
number of clumps. This is because the cords were not disrupted and remained as 
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large clumps, which settled out of suspension rapidly when cultures were clarified. 
There were very few single organisms present in this preparation, indicating that 
clumps were not dispersed and the majority of the organisms were removed as 
clumps. 
 
The cell envelope of Mycobacterium spp. has three layers, the plasma membrane, 
the cell wall outer membrane (mycomembrane) and the outermost layer (Zuber et al., 
2008; Sani et al., 2010). There are two leaflets to the outer membrane, the inner 
leaflet is composed of mycolic acid residues and the outer leaflet contains large 
amounts of species-specific lipids. The capsule is a mixture of polysaccharides, 
proteins and lipids. Ortalo-Magné and colleagues showed that gentle shaking of 
bacterial clumps with 4 mm diameter glass beads was enough to remove this 
capsule (Ortalo-Magne et al., 1995). 
 
Stokes and colleagues showed that three 30-second bursts of sonication broke up 
clumps, so that 90% of organisms were present as single organisms or clumps of two 
and only 1% of organisms were part of clumps that contained more than 10 
organisms (Stokes et al., 2004). Sonicating bacteria for 5 minutes resulted in a in a 
loss of viability but three bursts of 30 seconds did not alter the integrity or viability of 
the bacterial cells. The surface hydrophobicity of M. tuberculosis was not altered by 
sonication but the appearance of the capsule was dramatically affected. Stokes 
describes the appearance of the capsule from bacteria that had been subjected to 
three 30-second bursts of sonication as loosened and bulging with an increased but 
uneven thickness. Sonication of M. tuberculosis also resulted in an increase in the 
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association of the bacteria with macrophages. The protocol used in the current study 
limited sonication to two bursts of 30 seconds and introduced two clarification steps 
to remove clumps whilst limiting disruption of the capsule. 
 
Addition of 0.05% Tween to bacteria did not alter the in vitro growth as measured by 
the BACTEC™ MGIT™ 960 System, but a higher concentration of detergent resulted 
in a 28% increase in the mean number of hours taken for a MGIT™ to reach a 
positive growth index. Tween 80 is a polyethylene sorbitol ester and when it is 
hydrolysed, it releases traces of oleic acid, which is toxic to M. tuberculosis (Davis 
and Dubos 1948). The higher concentration of Tween 80 may have caused some of 
the bacteria to die, resulting in a smaller inoculum, therefore increasing the time 
taken for the bacteria to respire the oxygen present in the MGIT™. Tween 80 is used 
routinely to cultivate M. tuberculosis in liquid cultures. The addition of BSA to the 
media binds free oleic acid and removes its toxic effect (Wayne, 1994; Middlebrook 
and Dubos, 1948). In the current study Tween 80 was used at a concentration of 
0.05% (v/v) to produce suspensions of single organisms and bacteria were 
suspended in RPMI with 10% fetal bovine serum (FBS) which contains BSA to 
complex with free oleic acid. 
4.2.3 Assessment of bacterial growth 
4.2.3.1 Background 
The number of bacteria in a culture of M. tuberculosis can be estimated by 
performing CFU counts. In order to carry our CFU counts samples are serially diluted 
and put onto agar plates. Agar plates are incubated for between 14 and 30 days and 
the number of colonies that have formed are counted. Colonies of M. tuberculosis 
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have an irregular shape and are pale in colour, which makes them difficult to see on 
agar plates. Estimates of bacterial cell number that are based upon CFU counts may 
be subject to underestimation due to the tendency of M. tuberculosis to form clumps, 
which means that one colony may result from a clump of several organisms. Agar 
plates often become contaminated with other organisms that grow faster than 
M. tuberculosis, meaning that the contaminant covers the plate before the 
mycobacteria have had time to grow. CFU counting is time consuming and it is 
difficult to obtain accurate, reproducible results. 
 
Culturing bacteria in the BACTEC™ MGIT™ 960 System or its predecessor the 
BACTEC™ 460 System and correlating the time taken for a positive growth index to 
be achieved with the number of organisms that were inoculated is an alternative 
method of assessing mycobacterial cell numbers. Enumeration of M. tuberculosis 
using the BACTEC™ systems has been carried out in several studies (Diacon et al., 
2012; Bark et al., 2011; Pheiffer et al., 2008; Cheon et al., 2002; Wallis et al., 1999). 
Culturing bacteria in liquid media is quicker and more sensitive than culturing 
bacteria on solid media. A study carried out on 1,500 sputum specimens by Pfyffer 
and colleagues found that M. tuberculosis complex could be detected in the MGIT™ 
system in an average of 9.9 days whereas detection using solid media took an 
average of 20.2 days (Pfyffer et al., 1997). Idigoras and colleagues found that 
sensitivity of the BACTEC™ MGIT™ 960 System for detection of mycobacterial 
isolates was 75%, whereas the sensitivity of Middlebrook 7H11 agar plates was 51% 
and Löwenstein-Jensen agar slopes was 61% (Idigoras et al., 2000). The addition of 
antibiotics that inhibit non-mycobacterial growth prevents frequent contamination of 
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MGIT™ cultures. Pfyffer and colleagues reported a lower contamination rate for 
MGITs™ than for solid culture methods in two of the three mycobacterial reference 
centres that were used in their study (Pfyffer et al., 1997). MGITs™ contain a 
fluorophore that is liberated by bacterial respiration meaning the presence of clumps 
does not alter the estimate of bacterial number. Assessment of mycobacterial growth 
using the BACTEC™ MGIT™ 960 System gives good reproducibility and the 
automated system assesses the MGITs™ every hour. 
 
In order to utilise the BACTEC™ MGIT™ 960 System for enumeration of bacteria it is 
important to know whether different strains grow at the same rate. Janulionis and 
colleagues assessed the growth rate of 18 clinical isolates and 5 reference strains in 
the BACTEC™ 460 System and found that the strains had different growth rates. 
Janulionis found a 2.45 fold difference between the strain with the fastest growth rate 
and the strain with the slowest growth rate and also noted that reference strains had 
faster growth rates than clinical isolates (Janulionis et al., 2005). Keane and 
colleagues reported that the growth rates for H37Ra and H37Rv in medium were 
similar, although it is not clear whether medium refers to broth or cell culture medium 
(Keane et al., 1997). Sohn and colleagues reported that there was no difference in 
the growth rate in broth of H37Rv and a clinical isolate from the Beijing clade (Sohn 
et al., 2009). Zhang and colleagues found that the growth rate of H37Ra, H37Rv, and 
two clinical isolates in 7H9 media were similar when assessed by CFU counts over 
10 days. As there is conflicting evidence in the literature about the growth rates of 
clinical isolates and the reference strains H37Rv and H37Ra, the growth rates of the 
strains used in the current study were assessed. 
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4.2.3.1 Hypothesis 
The number of bacteria in an inoculum will correlate with the TTP measured using 
the BACTEC™ MGIT™ 960 System. 
4.2.3.2 Aims 
 To calibrate the BACTEC™ MGIT™ 960 System so that the number of hours 
taken for a sample to be declared positive, or the TTP, can be used to 
determine the number of organisms that were present in the inoculum 
4.2.3.3 Materials and methods 
H37Rv was resuspended in RPMI and treated to remove clumps as described in 
4.2.2.4. A sample of the bacterial suspension was fixed and counted and the unfixed 
portion was adjusted to 5 × 105 bacteria/ml as described in 4.2.2.4. Serial dilutions 
were then performed with RPMI. A MGIT™ was inoculated with 100 µl of each 
dilution and the relative fluorescence was recorded from the BACTEC™ MGIT™ 960 
System (BD Biosciences, Oxford, UK) every 24 hours, in some cases more frequent 
readings were taken. It is important to note that although the BACTEC™ MGIT™ 960 
System assesses the fluorescence of each MGIT™ every hour, the information is not 
stored and so has to be manually recorded. The experiment was performed in 
triplicate. The number of hours taken for each MGIT™ to achieve a positive growth 
index was recorded. Positive cultures were confirmed by microscopy. 
 
A further three serial dilutions were prepared from each dilution to aid colony 
counting and 20 μl of each dilution was plated onto Middlebrook 7H10 agar plates 
(Becton Dickinson) in triplicate according to the method of Miles and Misra (Miles et 
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al., 1938). Plates were incubated for 30 days at 37°C and counts were recorded as 
CFU/ml. 
 
Suspensions of clinical isolates were prepared which contained 5 × 105 bacteria/ml. 
Triplicate samples of 100 µl from each of these suspensions were inoculated into 
MGITs™ to assess the TTP of each clinical isolate. Preparation of mycobacterial 
suspensions was repeated on separate occasions. Where applicable, data sets were 
compared in Microsoft Excel using Student’s two-sample t test. 
4.2.3.4 Results 
Figure 4-8 shows that there is an inverse relationship between TTP and log10 CFU/ml 
for cultures of H37Rv. The correlation coefficient is -0.98. There is also an inverse 
relationship between TTP and log10 of the number of bacteria counted using a Helber 
chamber (Figure 4-9); the correlation coefficient is -0.98. 
 
Figure 4-10 shows that when MGITs™ are inoculated with 100 µl of a suspension of 
5 × 105 bacterial/ml the mean TTP for H37Ra (358 ± 6 hours, n=3) is 64% higher 
than for H37Rv (219 ± 3 hours, n=15) (p= 3 x 10-13). The mean TTP for BCG (227 ± 
12 hours, n=15) is similar to that of H37Rv (p= 0.5). The mean TTP for MGITs™ 
inoculated with clinical isolates are between 12% (CE1, 193 ± 6 hours, n=18, p= 5 x 
10-4) and 21% (AE1, 173 ± 2 hours, n=15, p= 8.0 x 10-15) lower than H37Rv. 
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Figure 4-8 Relationship between TTP and log10 H37Rv CFU/ml 
(n=3) 
 
Figure 4-9 Relationship between TTP and log10 number of H37Rv bacteria 
Bacteria were counted using a Helber chamber, n=4, except for 5 × 10
5
 
bacteria, where n=15 
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Figure 4-10 Mean TTP relative to H37Rv for 5 × 10
5
 mycobacteria from six different strains 
Bars above 0 indicate a shorter TTP than H37Rv, bars below 0 indicate a longer 
TTP than H37Rv. Error bars depict SEM, (n=15). 
 
Table 4-8 shows that isolates from the same cluster of disease do not have the same 
TTP. Isolates AE7 and AE6 are from the same epidemiological cluster and have 
identical MIRU-VNTR profiles however the mean TTP for AE6 (225 ± 4 hours, n=3) is 
25% longer than AE7 (178 ± 0.3 hours, n=3) (p= 0.0003). Figure 4-11 shows that 
strains belonging to the CAS clade do not have similar TTPs, although CAS strains 
from epidemiological clusters of disease have shorter TTPs than H37Rv and unique 
CAS isolates have longer TTPs than H37Rv. Figure 4-12 shows that ancient strains 
do not have similar TTPs. Three of the tested strains have a shorter TTP than H37Rv 
and four of the tested strains have a longer TTP than H37Rv. 
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Table 4-8 Mean TTP for M. tuberculosis from different clusters of disease and unique isolates 
Isolate VNTR MIRU 
Cluster of 
disease 
Mean TTP 
(hours) 
(n=3) 
Standard 
error of the 
mean 
CS1  42235 2742516334 N/A 179 8.6 
CS5 42235 2532516333 N/A 233 1.2 
CS6 42235 2642615333 N/A 230 1.5 
CE1  42235 2642517331 CAS cluster 1 193 6.4 
CE2 42235 2642517331 CAS cluster 1 200 5.5 
CE3 42235 2642517331 CAS cluster 1 208 1.7 
AS1  614-6 2632622334 N/A 173 3.2 
AE1  -4465 2422622313 Ancient cluster 1 173 1.6 
AE2 61456 2432622334 Ancient cluster 2 240 1.0 
AE4 61456 2432622334 Ancient cluster 2 233 0.7 
AE5 61456 2432622334 Ancient cluster 2 230 1.9 
AE6 -1456 2432622334 Ancient cluster 3 224 3.8 
AE7 -1456 2432622334 Ancient cluster 3 178 0.3 
N/A = not applicable, CS = CAS single isolate, CE = CAS epidemiological 
isolate, AS = Ancient single isolate, AE = Ancient epidemiological isolate 
 
Figure 4-11 Mean TTP relative to H37Rv for 5 × 10
5
 bacteria from six M. tuberculosis CAS 
strains 
CS1, CS5 and CS6 are all unique isolates, only been identified in the Midlands 
once. CE1, CE2 and CE3 belong to the same disease cluster. Bars above 0 
indicate a shorter TTP and bars below 0 indicate a longer TTP than H37Rv. 
Error bars depict SEM, (n=3) 
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Figure 4-12 Mean TTP relative to H37Rv for 5 × 10
5
 bacteria from six ancient M. tuberculosis 
strains 
AS1 is a unique isolate that has been identified once in the Midlands.AE1 
belongs to cluster of disease 1, AE2, AE4 and AE5 belong cluster of disease 2 
and AE6 and AE7 belong to cluster of disease 3. Bars above 0 indicate a 
shorter TTP than H37Rv, bars below 0 indicate a longer TTP than H37Rv. Error 
bars depict SEM, (n=3). 
4.2.3.5 Discussion 
There is an inverse linear relationship between TTP and log10 CFU/ml, and between 
TTP and log10 of the number of bacteria counted using a Helber chamber for cultures 
of H37Rv. However, TTP was not constant for tested M. tuberculosis clinical isolates, 
which differed from H37Rv by between 12 and 21%. Isolates of M. tuberculosis, 
which had the same MIRU-VNTR, profile and were from the same epidemiological 
cluster of disease did not always have a similar TTP. The TTP of isolates with the 
same MIRU-VNTR profile are heterogeneous so TTP cannot be used as an 
indication of virulence or to identify the spoligotype clade that an isolate belongs to. 
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In order to enumerate mycobacteria from different strains by comparing TTP the 
growth rate for each strain would need to be the same. These experiments indicate 
that this is not the case. If the tissue culture model is to be used for high through put 
screening then it is not possible to construct a calibration curve for each strain to 
allow cell number to be determined from TTP. 
 
In order to assess bacterial growth using the BACTEC™ MGIT™ 960 System the 
TTP is recorded, which is inversely proportional to the number of bacteria in the 
inoculum. A short TTP is therefore indicative of a high bacterial inoculum. By 
culturing bacteria for six days and calculating the percentage change in TTP over 
time for each strain the differences in growth rate between strains will be normalised. 
The percentage change in TTP from day one to day six shows whether bacteria are 
able to grow in culture over six days. A positive percentage change in TTP indicates 
that bacteria have increased in number and a negative percentage change in TTP 
indicates that bacteria have decreased in number. 
4.2.4 The effect of PMA concentration on the differentiation of 
THP-1 cells 
4.2.4.1 Background 
PMA can be used to differentiate THP-1 cells, which causes them to display a 
macrophage like phenotype. PMA is toxic to cells and high concentrations lead to cell 
death. Conversely, low concentrations of PMA preclude full cell differentiation. To 
select an optimal amount of PMA, four concentrations were chosen which represent 
a range of those sited in the literature (see Table 4-6). Differentiated cells have an 
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adherent, non-proliferating phenotype, so cell counts can be used to determine 
whether full differentiation has occurred. 
4.2.4.2 Hypothesis 
Treatment of THP-1 cells with 8 nM PMA for 18 hours will cause the cells to 
differentiate and display an adherent macrophage like phenotype. 
4.2.4.3 Aims 
 To ascertain the optimum concentration of PMA to add to THP-1 cells in order 
to obtain differentiation into a macrophage-like phenotype. 
4.2.4.4 Materials and methods 
THP-1 cells were obtained from the Health Protection Agency (HPA) culture 
collection (catalogue number 88081201, lot number 071001) and cultured in RPMI 
1640 with 2 mM glutamine and 10% FBS (Sigma, UK; lot number 109K3396 was 
used for all experiments) at 37°C in a humidified atmosphere with 5% CO2. Cultures 
were maintained at between 3 and 8 x 104 cells/ml and passaged a maximum of 5 
times. To differentiate cells into a macrophage-like phenotype THP-1 cells were 
seeded at 5 × 105 cells/ml and placed in 96 well tissue culture plates. Phorbol 12-
myristate 13-acetate (PMA) (Sigma) was added to cells at concentrations of 8, 16, 24 
and 32 nM. Cells were incubated at 37°C for 18 hours. Following incubation tissue 
culture plates were centrifuged at 400 × g for 5 minutes, cells were washed with 
warm PBS and then culture medium was replaced with fresh supplemented RPMI 
warmed to 37°C, 24 and 72 hours after addition of PMA. To ascertain the effect of 
nutrient depletion on cell numbers following differentiation, culture medium was 
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replaced 5, 6, 7 and 8 days after PMA treatment, in addition to the usual replacement 
at 24 and 72 hours. 
 
To count the number of viable cells, tissue culture plates were centrifuged at 400 × g 
prior to the removal of culture medium, adherent THP-1 cells were removed by 
addition of TrypLE™ Express (Gibco) for 10 minutes at 37°C. Cells were stained with 
trypan blue and an average of five counts was made using a haemocytometer at 20X 
magnification by light microscopy. Where applicable, data sets were compared in 
Microsoft Excel using Student’s two-sample t test. 
4.2.4.5 Results 
THP-1 cells treated with different concentrations of PMA appeared to have a similar 
morphology at all tested concentrations, as assessed by light microscopy, although 
the degree of confluence was reduced in samples treated with 8 and 32 nM PMA. 
 
An 18 hour treatment of THP-1 cells with PMA resulted in a decrease in the mean 
number of cells from day 0 to day 1 with all concentrations that were tested (Figure 
4-13). There was a dose dependant decline in mean THP-1 cell number. The lowest 
concentration of PMA, 8 nM, caused a 1.7 fold reduction in the mean number of cells 
from day 0 (522,500 ± 20,729) to day 1 (304,000 ± 15,748; p = 1 x 10-6). The highest 
concentration of PMA, 32 nM, caused a 2.7 fold decrease in the mean number of 
cells from day 0 (528,000 ± 14,303) to day 1 (195,000 ± 8,807; p =.1 x 10-11). 
Following the initial decline in mean cell number 1 day after PMA treatment, mean 
cell numbers either stabilised or increased over the subsequent 7 days. 
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Treatment of THP-1 cells with 8 nM PMA caused a 2.4 fold increase in the mean 
number of cells from day 1 (304,000 ± 15,748 cells; n=8) to day 8 (727,000 ± 48,455 
cells; n=6; p = 8 x 10-7). Treatment of cells with 16 nM PMA results in a 1.4 fold 
increase in the mean cell number from day 1 (260,500 ± 13,059 cells; n=8) to day 8 
(353,000 ± 62,554 cells; n=8; p=0.17). Treatment of cells with 24 nM of PMA results 
in a 1.1 fold decrease in the mean number of cells from day 1 (261,000 ± 13,851 
cells; n=8) to day 8 (233,000 ± 10,684 cells; n=8; p= 0.13). Treatment of cells with 32 
nM of PMA causes a 1.2 fold increase in the mean number of cells from day 1 
(195,000± 8,807 cells; n=8) to day 8 (232,000 ± 12,939 cells; n=8; p= 0.03). 
 
Figure 4-13 Mean number of live THP-1 cells in culture over eight days, after treatment with 
different concentrations of PMA 
PMA was added on day 0. Error bars depict SEM, 8 replicate samples were 
counted on each day per concentration 
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The effect of nutrient depletion on cells differentiated for 3 days was tested. To 
prevent nutrient depletion culture medium was replaced every 24 hours, nutrient 
depleted cultures did not have culture medium replaced. The mean number of 
nutrient depleted cells 5 days after treatment with PMA (197,000 ± 9,732 cells, n=8) 
was 1.2 fold lower than the mean number of cells where the culture media was 
replaced every 24 hours (228,000 ± 18,838 cells, n=8; p= 0.17) (Figure 4-14). The 
mean number of nutrient depleted cells 8 days after PMA treatment (229,250 ± 9,180 
cells, n=8) was 1.1 fold lower than the mean number of cells where the culture media 
was replaced every 24 hours (246,500 ± 16,352 cells, n=8; p= 0.4). 
 
Figure 4-14 Effect of replacing culture media on mean number of live THP-1 cells in culture 
after 18 hour treatment with 24 nM PMA 
Blue bars represent cultures where media was replaced on day 1 and day 3, 
red bars represent cultures where media was replaced on day 1, 3, 5, 6, 7 and 
8. Error bars depict SEM, 8 replicate samples were counted on each day per 
concentration 
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4.2.4.6 Discussion 
To ascertain an optimum PMA concentration for THP-1 cell differentiation, a range of 
concentrations was chosen. To overcome the loss of non-adherent cells when culture 
medium was replaced, tissue culture plates were centrifuged prior to the removal of 
the culture media. Tissue culture plates were also centrifuged prior to treatment of 
cells with trypsin, which removes adherent cells from the surface of the culture vessel 
to allow them to be counted. The use of 8 and 16 nM PMA resulted in an increase in 
THP-1 cell number over 8 days, indicating that these concentrations were not 
sufficient to differentiate the cells, as fully differentiated THP-1 cells are adherent and 
unable to undergo cell division. The use of 24 and 32 nM PMA resulted in a stable 
number of cells over 8 days. However, as treatment of cells with 24 nM PMA resulted 
in a smaller decrease in cell number from day 0 to day 1 than 32 nM PMA, 24 nM 
was chosen as the optimum concentration for THP-1 cell differentiation. 
 
Replacing the culture medium every 24 hours after THP-1 cells had been 
differentiated did not appreciably alter the cell number compared to samples where 
the culture medium was not replaced. Therefore, once THP-1 cells had been 
differentiated the culture medium was not replaced again. Retaining the same culture 
medium throughout the experiment is advantageous because it reduces the amount 
of manipulation, which has to be carried out at containment level three, and prevents 
the loss of bacteria from the infection model. 
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4.2.5 Assessment of macrophage viability 
4.2.5.1 Background 
Lactate dehydrogenase (LDH) is a stable cytosolic enzyme that is released by cells 
that have lost their membrane potential, a result of necrotic cell death. Cells in culture 
release LDH into the culture supernatant as they die and so the background level of 
LDH activity in cell culture will be measured. In order to assay the amount of LDH 
that is released from infected cells, the cell supernatant must be sterilised to remove 
the risk of infection with M. tuberculosis. Sterilisation can be achieved by passing cell 
supernatant through a filter with 0.2 µm pores. Lysis of the cells prior to filtration will 
also be performed in order to measure total LDH activity, so that the percentage 
cytotoxicity caused by addition of mycobacteria can be calculated. The filtrate is then 
subjected to an enzyme-linked assay that converts a tetrazolium salt into a red 
formazan product, which can be detected by absorbance at 490 nm. The absorbance 
is proportional to the number of lysed cells (Singer et al., 1999; Miroslav, 1995). 
4.2.5.2 Hypothesis 
LDH can be used as a marker of necrotic cell death and total cell number. 
4.2.5.3 Aims 
 To test filtration of cell supernatant as a method of sterilisation 
 To select a method of cell lysis 
 To ascertain the number of THP-1 cells needed in order to detect LDH 
4.2.5.4 Materials and methods 
In order to determine whether filtration of cell supernatants would preclude the 
detection of LDH activity, THP-1 cells were serially diluted and then differentiated by 
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overnight treatment with 24 nM PMA. Tissue culture plates were centrifuged at 
400 × g for 5 minutes then washed with warm PBS and the culture medium was 
replaced with fresh supplemented RPMI warmed to 37°C at 24, 96 and 120 hours 
after the addition of PMA. Tissue culture plates were centrifuged at 400 × g for 5 
minutes and then the supernatant was removed and in some cases it was filtered 
through a 0.2 μm centrifugal filtration device (Millipore, Hertfordshire), supernatant 
was then assessed for LDH activity. LDH activity was assessed using a CytoTox 96® 
non-radioactive cytotoxicity assay according to the manufacturer’s instructions 
(Promega) and absorbance was measured using a Triturus Automated ELISA 
Workstation (Biomedical Diagnostics). All data were normalised by subtraction of 
background absorbance. 
 
Cell supernatants from THP-1 cells infected with H37Rv at a MOI of 1:1 were passed 
through a 0.2 μm centrifugal filtration device (Millipore, Hertfordshire) and then 
inoculated into MGITs™ to confirm that sterilisation had been achieved. Unfiltered 
cell supernatants from THP-1 cells infected with H37Rv at a MOI of 1:1 were also 
used to inoculate MGITs™ to confirm that the mycobacteria were viable. Finally, 
H37Rv from a positive MGIT™ culture was filtered and 100 µl of H37Rv before and 
after filtration was inoculated into fresh MGITs™. 
 
A method of lysing cells is required in order to measure total LDH activity. THP-1 
cells were seeded at 1.3 × 105 cells/ml and differentiated with 24 nM PMA. 
Differentiated cells were lysed either by addition of Triton X-100 to a final 
concentration of 0.05% (v/v) for 30 minutes at 37°C or by freezing at -80°C for 30 
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minutes followed by thawing at room temperature for 15 minutes. Monolayers were 
viewed by microscopy and if total lysis was not achieved then cells were incubated 
for a further 15 minutes. Once cells had been lysed, the supernatant was centrifuged 
at 400 × g for 5 minutes to remove cell debris, and then filtered before performing the 
LDH assay. It would be advantageous to store samples before the LDH assay is 
carried out so in some cases, samples were split in half. The first half of the sample 
was assayed for LDH activity immediately, the second half was frozen overnight and 
LDH activity was measured the following day. 
 
To ensure that an appropriate number of cells are used for the THP-1 infection model 
THP-1 cells were serially diluted, differentiated with 24 nM PMA and rested for 3 days 
with culture media replacement at 1 and 3 days after PMA treatment. For each 
dilution two samples were prepared, either the supernatant was removed after 
centrifugation of the tissue culture plate at 400 × g for 5 minutes, or the cells were 
lysed by the addition of Triton X-100 to a final concentration of 0.05% (v/v). Each 
sample was passed through a 0.2 μm centrifugal filtration device (Millipore, 
Hertfordshire) and then assayed for LDH activity, and the experiment was performed 
in triplicate. Absorbance values for cell supernatant were divided by absorbance 
values for lysed cells so that the percentage cell death that occurs in untreated 
THP-1 cells could be ascertained. 
4.2.5.5 Results 
Filtration of THP-1 cell lysate through 0.2 µm pores caused a reduction in the 
average absorbance at 490 nm of less than 0.17 for all numbers of cells tested 
(Table 4-9). 
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Table 4-9 Mean absorbance at 490nm (± SEM) caused by LDH in THP-1 cell lysates before and 
after filtration (n=3) 
Number of cells 
Absorbance at 490nm 
Difference (%) 
Filtered Unfiltered 
18,750 0.4 ± 0.07 0.5 ± 0.06 0.01 (2.2) 
37,500 0.7 ± 0.04 0.7 ± 0.04 0.01 (1.4) 
75,000 1.1 ± 0.06 1.2 ± 0.07 0.10 (8.4) 
150,000 1.8 ± 0.08 1.9 ± 0.03 0.09 (4.8) 
300,000 2.7 ± 0.03 2.9 ± 0.03 0.17 (5.9) 
600,000 3.1 ± 0.01 3.2 ± 0.05 0.14 (4.4) 
 
Cell supernatants from THP-1 cells infected with H37Rv at a MOI of 1:1 were passed 
through 0.2 µm filters and then inoculated into MGITs™. After 60 days no growth was 
recorded from any of the filtered samples (n=25). The unfiltered samples achieved a 
positive growth index in an average of 233 hours (n=10, ± 5 hours). Filtered 
supernatant from actively growing H37Rv cultures also failed to grow after 60 days 
incubation, whilst samples of H37Rv which had not been filtered achieved a positive 
growth index in an average of 205 hours (n=10, ± 3 hours). 
 
Figure 4-15 shows that lysis of 1.3 × 105 cells/ml by freeze thaw produced a 3.9 fold 
increase in the mean absorbance (1.032 ± 0.022, n=8) when compared to 
supernatant only (mean absorbance at 490 nm 0.266 ± 0.064, n=3; p= 1 x 10-7). 
Lysis with a final concentration of 0.05% Triton X-100 caused a 3.7 fold increase in 
the mean absorbance reading (0.987 ± 0.029, n=8) compared to supernatant only 
(p= 7 x 10-7). Freeze thaw and lysis with Triton X-100 (0.955 ± 0.005, n=3) produced 
a 3.6 fold increase in absorbance compared to supernatant only (p= 0.0004). 
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Freezing the samples at -20°C overnight before subjecting them to LDH assay 
resulted in a decrease in the mean absorbance for of all the conditions tested. The 
decrease in absorbance that occurred when samples were frozen ranged from a 2.5 
fold decrease for samples that were freeze-thawed (p= 3 x 10-13) to a 4.2 fold 
decrease for samples that were lysed by freeze-thaw and addition of Triton X-100 (p= 
3 x 10-8), compared to samples which were not frozen. 
 
Figure 4-15 Mean absorbance at 490 nm due to LDH activity in cell lysates produced by 
different methods 
Blue bars represent samples that were assayed for LDH activity immediately 
following lysis and red bars represent samples that were stored overnight -20°C 
before the LDH assay was performed. Error bars depict SEM, cells were 
seeded at 130,000 cells/ml 
 
According to the CytoTox 96® non-radioactive cytotoxicity assay instructions the 
absorbance values that are measured from lysed cells should be at least two times 
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the level of absorbance that is recorded from media only in the absence of any cells. 
To establish the appropriate number of cells to use serial dilutions were prepared and 
the absorbance produced by LDH activity was recorded in media only, in supernatant 
from cells and in lysed cells. 
 
Figure 4-16 shows that the level of absorbance caused by LDH in lysed cells was 
less than two times the absorbance caused by media only when 5 × 104 cells/ml or 
less were assayed. When 5 × 105 cells/ml were assayed the absorbance caused by 
LDH from lysed cells was 4.4 fold higher than the absorbance for media only 
(p= 7 X 10-8), and the absorbance from supernatant was 1.7 fold higher (p= 3 X 10-5). 
At 5 × 106 cells/ml the absorbance caused by LDH from lysed cells was 4.6 fold 
higher than the absorbance for media only (p= 1 X 10-9), however the absorbance 
from the supernatant was 4.3 fold higher (Figure 4-16). 
4.2.5.6 Discussion 
Filtration of infected THP-1 cell supernatant was effective in sterilising the samples 
and no mycobacterial growth was detected in liquid culture after 60 days of 
incubation. Filtration of samples did not significantly reduce the level of LDH activity 
from THP-1 cell lysates, indicating that it is a suitable method of sterilising samples to 
enable them to be removed from the containment level three facility and assayed for 
LDH activity. All samples that are assessed for LDH activity will be filtered through 
0.2 µm pores. 
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Figure 4-16 Fold difference in absorbance at 490 nm due to LDH activity in cultures of THP-1 
cells seeded at different cell densities 
Background control samples (blue bars) contained only cell culture media, red 
bars represent the level of spontaneous LDH release by cells and green bars 
represent maximum LDH activity of cells after lysis with Triton X-100. THP-1 
cells were differentiated with PMA for 18 hours, then rested for 3 days prior to 
experimentation Error bars depict SEM, (n=3). 
 
Freeze-thaw was the most effective method for lysing THP-1 cells; however it was 
only 5% more effective than lysis by Triton X-100 and it is more time consuming, so 
lysis will be carried out using Triton X-100. Freezing samples before they were 
assayed for LDH activity resulted in a large drop in absorbance and so samples 
should be assayed as soon as possible after they have been sterilised. 
 
A cell density of 5 × 105 was chosen because the absorbance values due to LDH 
activity in lysed cells were more than two times the level of absorbance that was 
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recorded from media only in the absence of any cells. When the percentage cell 
death in THP-1 cultures seeded at 5 × 105 cells/ml was calculated, it showed that one 
day after the cells had been differentiated 22% (± 0.9%) of the cells were dead. 
When THP-1 cells were seeded at 5 × 106 cells/ ml the absorbance values due to 
LDH in lysed cells were also more than two times higher than the level of absorbance 
that was recorded from media only, but at a density of 5 × 106 cells/ml 92% (± 0.9%) 
of the cells were dead. It is likely that at high cell densities, space and nutrients 
become limited which leads to cell death, producing high levels of LDH in the 
supernatant. 
4.2.6 Selection of an appropriate multiplicity of infection (MOI) 
4.2.6.1 Background 
Before the growth rate of BCG and H37Rv in THP-1 cells can be compared, an MOI 
needs to be chosen. The MOI used in THP-1 cell models reported in the literature 
ranges from one bacterium to ten cells (Castro-Garza et al., 2007) to fifty bacteria per 
cell (Theus et al., 2007b). When a high MOI has been used, investigators have 
incubated cells with bacteria, allowed a period for phagocytosis to occur and then 
cells have been washed to remove bacteria that have not been phagocytosed. It is 
difficult to distinguish between M. tuberculosis that has been phagocytosed and 
M. tuberculosis that is just bound to the surface of the cell. Initial experiments carried 
out in the current study with THP-1 monolayers that had been incubated with BCG, 
formaldehyde fixed and then acid fast stained produced obscured images because 
the stain bound to the formaldehyde matrix, making it difficult to see where the 
bacteria were in relation to the cells. If monolayers were not formaldehyde fixed then 
the acid fast staining destroyed the cells. This means that the length of time to allow 
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phagocytosis to occur could not be determined. Clinical strains of M. tuberculosis 
may have different rates of phagocytosis therefore a low MOI will be used and the 
cells will not be washed, so bacteria which have not been phagocytosed will remain 
in the model. The use of a low MOI is more likely to mimic the initial interaction of 
M. tuberculosis with alveolar macrophages in the human lung than a higher MOI. 
 
Necrosis of THP-1 cells and growth rate of intracellular bacteria have been chosen 
as parameters for identification of virulent M. tuberculosis isolates. It is therefore 
important that the MOI that is chosen causes a difference in the measured 
parameters. 
 
It will be necessary to lyse cells prior to inoculation of MGITs™ for assessment of 
bacterial number (as described in 4.2.3.3) so that the presence of cells or the 
presence of bacteria inside cells does not affect the rate at which oxygen in the 
MGIT™ is used up. The effect of the lysis reagent on bacterial growth will be 
ascertained. 
4.2.6.2 Hypothesis 
When THP-1 cells are infected with one H37Rv bacterium per cell, there will be a 
decrease in the TTP of the bacteria and an increase in THP-1 cell necrosis compared 
to bacteria and cells that have been incubated separately. 
4.2.6.3 Aims 
 To determine an appropriate MOI 
 To assess the effect of Triton X-100 on mycobacterial growth rate 
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4.2.6.4 Materials and methods 
To test which MOI to use, suspensions of single organisms of H37Rv and BCG were 
prepared as described in 4.2.2.4. Bacterial suspensions were diluted so that there 
was 5 × 105 bacteria/ml, 5 × 104 bacteria/ml or 5 × 103 bacteria/ml. THP-1 cells were 
prepared as described in 4.2.4.4 and seeded at 5 × 105 cells/ml. Once the THP-1 
cells had differentiated into a macrophage-like phenotype, the culture medium was 
removed and replaced with 100 µl of bacterial suspension in RMPI with 5% FBS (v/v) 
(Sigma, UK; lot number 109K3396 was used for all experiments). Tissue culture 
plates were covered with AeraSeal gas-permeable sealing films (Alpha labs) and 
then incubated for up to six days at 37°C in a humidified atmosphere with 5% CO2. 
 
THP-1 cell necrosis was measured after 1, 3 and 6 days of infection. To measure 
necrosis caused by mycobacteria the supernatant was removed from infected cells 
and centrifuged at 400 × g for 5 minutes to eliminate whole cells and cell debris. To 
measure total LDH activity Triton X-100 was added to THP-1 cells which had not had 
the supernatant removed to a final concentration of 0.05% (v/v), which caused cell 
lysis. Cell lysate was centrifuged at 400 × g for 5 minutes to remove cell debris. 
Following centrifugation of cell lysate and cell supernatant; 90 µl was removed and 
passed through a 0.2 μm centrifugal filtration device (Millipore, Hertfordshire). 
Filtered cell lysate and filtered cell supernatant were assayed for LDH activity using a 
CytoTox 96® non-radioactive cytotoxicity assay according to the manufacturer’s 
instructions (Promega). Percentage cytotoxicity caused by mycobacteria was 
calculated by dividing the absorbance caused by LDH activity in cell supernatant by 
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LDH activity in lysed cells, multiplied by 100 and the experiment was performed in 
triplicate. 
 
To measure intracellular bacterial growth, infected cells were lysed after 1, 3 and 6 
days by addition of Triton X-100 to a final concentration of 0.05% and the resulting 
lysate was inoculated into a MGIT™, giving a final concentration of 0.00007% Triton 
X-100 (v/v). The experiment was performed in triplicate. 
 
To test the effect of Triton X-100 on bacterial growth a positive MGIT™ of H37Rv and 
BCG was selected and 100 µl aliquots were treated with 0.05%, 0.5% or 1% Triton X-
100 (v/v) or left untreated for 30 minutes at 37°C (bacteria were not counted). 
Following treatment with Triton X-100, bacteria were inoculated into fresh MGITs™; 
the final concentration of Triton X-100 in the MGITs™ was 0%, 0.00007% or 0.007%. 
The TTP for each MGIT™ was recorded and the experiment was performed in 
triplicate. Where applicable, data sets were compared in Microsoft Excel using 
Student’s two-sample t test. 
4.2.6.5 Results 
Cellular necrosis caused by BCG and H37Rv was assessed by measuring LDH 
activity from 5 × 105 THP-1 cells, which had been infected with 5 × 103, 5 × 104 or 
5 × 105 mycobacteria, to give MOIs of 1:1, 1:10 or 1:100 bacteria to cells 
respectively. LDH activity was also measured in cells that had not been infected so 
that the level of spontaneous necrosis in the model could be determined. Figure 4-17 
shows that the amount of necrosis in THP-1 cultures increases over 6 days in both 
infected and uninfected cells. The level of necrosis in uninfected cells increased from 
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10% (± 2%) on day 1, to 27% (± 1%) on day 3 and by day 6 the level of necrosis was 
49% (± 3%). 
 
Infecting THP-1 cells with BCG at MOIs of 1:1, 1:10 or 1:100 did not significantly 
increase the amount of necrosis above that seen in cells that were not infected on 
any of the days tested (Figure 4-17A). After 6 days of infection the level of necrosis in 
THP-1 cells infected with BCG at an MOI of 1:1 was 1% higher than the level of 
necrosis in cells that were not infected (p= 0.9). 
 
Figure 4-17B shows that the amount of necrosis caused by infecting THP-1 cells with 
H37Rv at an MOI of 1:1, one day after infection (21% ± 1.7%) was 7% more than the 
amount of spontaneous necrosis in cells that were not infected (p= 0.06). On day 6 
the amount of necrosis caused by infecting THP-1 cells with H37Rv at an MOI of 1:1 
(52% ± 0.6%) was 8% more than the amount of spontaneous necrosis in cells that 
were not infected (p= 0.01). When THP-1 cells were infected with H37Rv at MOIs of 
1:10 or 1:100, the amount of necrosis was similar to or less than the amount of 
spontaneous necrosis. 
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Figure 4-17 Mean percentage cytoxicity in THP-1 cells infected with different ratios of 
mycobacteria over six days 
THP-1 cells were seeded at 5 x 10
5
 cells/ml. Cytotoxicity was measured using 
an LDH release assay. Blue bars represent an MOI of 1 bacterium to 1 cell 
(1:1), red bars indicate an MOI of 1:10 and purple bars indicate an MOI of 
1:100. Error bars depict SEM, n = 3. 
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Intracellular growth of BCG and H37Rv was assessed by lysing THP-1 cells, which 
had been infected at different MOIs and recording TTP from the lysate. The mean 
TTP for BCG from cells infected for one day at an MOI of 1:1 (175 ± 0.3 hours, n=3) 
was 1.2 fold lower than for BCG from cells infected at an MOI of 1:10 (217 ± 2.3 
hours, n=3; p = 0.00005) (Figure 4-18). The mean TTP for BCG from cells infected 
for one day at an MOI of 1:100 (256 ± 2.6 hours, n=3) was 1.5 fold higher than for an 
MOI of 1:1 (p = 7 x 10-6) (Figure 4-18). Similar results were seen on subsequent days 
and for H37Rv (data not shown). The mean percentage change in TTP from day one 
to day six for BCG was 14% (± 1%) for an MOI of 1:1, 21% (± 1%) for and MOI of 
1:10 and 29% (± 7%) for an MOI of 1:100. 
 
Figure 4-18 Mean TTP for MGITs™ inoculated with BCG after infection of THP-1 cells over 6 
days at different MOIs 
Cells were seeded at 5 × 10
5
 and infected with BCG, blue bars represent an 
MOI of 1 bacterium to 1 cell (1:1), red bars indicate an MOI of 1:10 and green 
bars indicate an MOI of 1:100. Error bars represent SEM, n=3. A decrease in 
TTP corresponds with an increase in the number of bacteria. 
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Figure 4-19 shows that mean TTP for MGITs™ inoculated with bacteria in the 
absence of Triton X-100 was 113 hours for BCG (± 1 hour, n=3) and 117 hours for 
H37Rv (± 1 hour, n=3) (note that bacteria were not counted and so TTPs are not 
comparable with section 4.2.3.4). There was no difference in TTP when 
mycobacteria were treated with 0.05% Triton X-100 (v/v) compared to no treatment. 
The mean TTP for BCG treated with 0.5% Triton X-100 (141 ± 2 hours, n=3; p= 
0.0003) and H37Rv treated with 0.5% Triton X-100 (142 ± 2 hours, n=3; p= 0.0005) 
was 80% higher than for untreated bacteria in both cases. MGITs™ that were 
inoculated with H37Rv or BCG that had been treated with 1% Triton X-100 (v/v) 
failed to reach a positive growth index. 
 
Figure 4-19 Mean TTP for H37Rv or BCG after treatment with different concentrations of Triton 
X-100 
Error bars represent SEM, n=3. 
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4.2.6.6 Discussion 
At an MOI of 1:10 or 1:100, the virulent M. tuberculosis strain H37Rv did not cause 
THP-1 cell necrosis. At an MOI of 1:1, the amount of THP-1 cell necrosis caused by 
H37Rv was greater than the amount of spontaneous necrosis that occurred in 
un-infected THP-1 cells. Therefore, an MOI of 1:1 was chosen for further 
experiments. Higher MOIs were not tested, as this would result in an excess of 
bacteria many of which would be extracellular. A wash step to remove extracellular 
bacteria could be introduced, but the quantity of bacteria that were removed would 
vary between samples and introduce error. An excess of bacteria is also likely to 
cause more cell death and so comparisons over several days could not be made. 
4.2.7 Assessment of bacterial growth in tissue culture media 
4.2.7.1 Background 
In the current study bacteria that have not been phagocytosed by THP-1 cells will 
remain in the infection model. The growth rate of extracellular bacteria will be 
measured to ensure that it does not affect the percentage change in TTP calculated 
for intracellular bacteria. 
 
Paul and colleagues reported that H37Rv and H37Ra were unable to grow in 
cell-free tissue culture medium (Paul et al., 1996). Zhang and colleagues tested 
H37Rv, H37Ra and four clinical isolates and reported that bacteria did not grow in 
RPMI medium with 10% serum, instead the number of CFU declined over 10 days 
(Zhang et al., 1999). Theus and colleagues reported that when 32 clinical isolates 
were tested extracellular growth did not occur (Theus et al., 2005). Armitige and 
colleagues found that heat-inactivated human AB serum does not support 
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M. tuberculosis H37Rv growth, nor does H37Rv grow in RPMI 1640 medium 
containing THP-1 cell lysate and 5% heat-inactivated AB serum (Armitige et al., 
2000). Dobos and colleagues reported that M. tuberculosis Erdman, M. tuberculosis 
CDC1551 and BCG Pasteur were able to grow extracellularly (Dobos et al., 2000). 
Nozawa and Yokota reported M.  kansasii, M.  bovis, and M.  tuberculosis were able 
to grow in F12 tissue culture medium and that growth was improved by the addition 
of 5% FBS and 0.05% Tween 80 (Nozawa and Yokota, 1983). 
4.2.7.2 Hypothesis 
BCG and H37Rv will not replicate in cell culture medium when there are no cells 
present. 
4.2.7.3 Aims 
 To determine whether different strains of mycobacteria are able to grow in 
cell-free tissue culture medium 
4.2.7.4 Materials and methods 
H37Rv and BCG in RPMI with 5% FBS were prepared at 5 × 105 bacteria/ml (as 
described in section 4.2.2) and then 100 µl was placed in tissue culture plates and 
incubated at 37°C. At days 0, 1, 2, 3 and 6 the bacteria were removed from the tissue 
culture plate and inoculated into MGITs™. The experiment was carried out in 
triplicate on five separate occasions. Where applicable, data sets were compared in 
Microsoft Excel using Student’s two-sample t test. 
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4.2.7.5 Results 
Figure 4-20 shows that there was a 28% mean percentage change in TTP for H37Rv 
incubated in tissue culture media in the absence of THP-1 cells (extracellular) from 
day one (245 ± 15 hours) to day six (176 ± 10 hours) (p = 0.2). There was a 7% 
mean percentage change in TTP for extracellular BCG from day one (270 ± 13 hours, 
n=11) to day six (250 ± 9 hours, n=15) (p = 0.0006). 
 
The mean TTP for extracellular H37Rv was 27 hours longer on day one (245 ± 15 
hours, n=14) than on day zero (218 ±3 hours) (p = 0.07). Following the increase in 
mean TTP for extracellular H37Rv on day one, there was a decrease in mean TTP 
on day two and three. This indicated that the bacteria were able to grow in tissue 
culture media in the absence of cells. The mean TTP for extracellular H37Rv was 
shortest on day six (176 ± 10 hours, n=15) indicating that there were more bacteria 
on day six than at any other time point 
 
The mean TTP for extracellular BCG was 37 hours longer on day one (270 ± 13 
hours, n=11) than on day zero (233 ± 10 hours) (p = 0.04). The mean TTP for 
extracellular BCG increased on day two but by day three it had decreased. The mean 
TTP for extracellular BCG on day six (250 ± 9 hours, n=15) was longer than on day 
three but it was shorter than day one and two, indicating that bacteria had begun to 
grow by day 3 but could not continue growing for six days. H37Rv was able to 
replicate more rapidly than BCG in cell-free tissue culture medium at all time points. 
The mean TTP for BCG was 7% longer than H37Rv on day zero, increasing to 9% 
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on day two, 18% on day three and by day six the mean TTP for BCG was 30% 
longer than H37Rv in the absence of cells. 
 
Figure 4-20 Mean TTP for MGITs™ inoculated with 5 × 10
5
 H37Rv/ml or 5 × 10
5
 BCG/ml after 
incubation in cell-free medium over six days 
TTP for mycobacteria was measured by the BACTEC™ MGIT™ 960 System 
after incubation in tissue culture media for up to 6 days. A decrease in TTP 
corresponds to an increase in the number of bacteria. Error bars represent 
SEM. 
4.2.7.6 Discussion 
Results from the current study show that BCG was able to replicate in cell-free media 
for up to three days, and H37Rv was able to replicate in cell-free media for up to six 
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days. These findings are contradictory to the findings of Paul and colleagues (Paul et 
al., 1996), Zhang and colleagues (Zhang et al., 1999), Theus and colleagues (Theus 
et al., 2005) and Armitige and colleagues (Armitige et al., 2000)), all of whom used 
CFU counts to demonstrate that M. tuberculosis strains were not able to grow in 
cell-free tissue culture media. 
 
Dobos and colleagues reported that M. tuberculosis Erdman, M. tuberculosis 
CDC1551 and BCG Pasteur were able to grow extracellularly. Dobos and colleagues 
used CFU counts to demonstrate the increase in the number of extracellular bacteria 
over time in a tissue culture model of infection. However the CFU counts recorded by 
Dobos were taken from cell culture medium that was removed from infected cells so 
the increase in the number of bacteria could be due to an increase in the release of 
bacteria from dead cells, rather than growth of bacteria in tissue culture media 
(Dobos et al., 2000). Nozawa and Yokota demonstrated an increase in the number of 
M. kansasii, M. bovis, and M. tuberculosis in F12 tissue culture medium over time, a 
finding which is in agreement with the results shown in the current study (Nozawa 
and Yokota, 1983). Nozawa and Yokota used turbidity measurements in liquid culture 
rather than CFU enumeration to show increases in mycobacterial numbers. The 
discrepancy in reports of extracellular growth in the current study compared to some 
published models of M. tuberculosis infection may be caused by the increased 
sensitivity of the BACTEC™ MGIT™ 960 System, compared to CFU counts, which 
were performed by Paul, Zhang, Theus and Armatige and are likely to underestimate 
the number of bacteria present in a sample. 
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Results from the current study show that there was a lag effect associated with 
removing bacteria from tissue culture medium and placing them into MGITs as shown 
by the increase in TTP from day zero to day one. This may indicate a reduction in the 
number of viable bacteria. It is also possible that the increase in TTP observed on 
day one, for H37Rv and BCG occurred because mycobacteria had adapted to the 
tissue culture medium and required time to readjust to the new conditions present in 
the MGIT or it could be an artefact introduced by cold shock, which could have 
occurred during handling of the samples. Venkataswamy and colleagues compared 
BCG that was grown in Middlebrook 7H9 broth to BCG that was grown in Sauton’s 
broth and found that BCG grown in Sauton’s broth was more persistent in 
macrophages. BCG that was grown in Sauton’s broth could inhibit apoptosis and 
induce an inflammatory response more effectively than BCG grown in Middlebrook 
7H9 broth (Venkataswamy et al., 2012). This indicates that the media that 
mycobacteria are grown in can affect their behaviour in macrophages and highlights 
the importance of standardising methods so that differences between the virulence of 
M. tuberculosis isolates are discernible. 
 
As the BACTEC™ MGIT™ 960 System is an indirect measure of growth, changes in 
the rate at which the mycobacteria replicate will alter the TTP and could introduce 
error. However because all samples were treated in the same way and a percentage 
change in TTP over six days was calculated, any variation introduced by changes in 
growth rate should be normalised. Extracellular growth of M. tuberculosis in tissue 
culture media will need to be taken into account when THP-1 cells are infected. 
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4.2.8 Infection protocol 
4.2.8.1 Background 
A number of studies have shown that virulent strains of M. tuberculosis have more 
rapid intracellular growth rates than avirulent strains. It has also been demonstrated 
that avirulent strains induce macrophages apoptosis. Macrophage apoptosis results 
in the destruction of virus infected cells and the same mechanism may result in the 
removal of M. tuberculosis infected cells (Roulston et al., 1999). When virulent 
M. tuberculosis strains infect macrophages, apoptosis is not induced and instead the 
cells die by necrosis, releasing the intracellular bacteria which can then infect other 
cells. Virulent strains of M. tuberculosis are able to prevent phagosome-lysosome 
fusion within an infected macrophage whereas avirulent strains are killed within 
mature phagolysosomes. In order to test the THP-1 cell model and ensure that 
differences in virulence can be detected, H37Rv and BCG will be used as examples 
of virulent and avirulent mycobacteria. An LDH release assay will be used to 
determine cytotoxicity and the BACTEC™ MGIT™ 960 System will be used to detect 
changes in bacterial growth. 
4.2.8.2 Hypothesis 
H37Rv will replicate more rapidly than BCG in THP-1 cells, and cause more necrosis. 
4.2.8.3 Aims 
 To compare virulent H37Rv and avirulent BCG in the THP-1 cell model 
4.2.8.4 Materials and methods 
THP-1 cells were differentiated with 24 nM PMA and culture medium was replaced at 
24 and 72 hours as described in 4.2.4.4. Suspensions of 5 × 105 bacteria/ml were 
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prepared in RPMI with 0.5% Tween 80 (v/v) as described in 4.2.3.3. Culture medium 
was removed from THP-1 cells 72 hours after addition of PMA and was replaced with 
bacterial suspensions, or fresh culture medium for non-infected controls. Day zero 
TTP for bacteria were measured by inoculating a fresh MGIT™ with 100 µl of the 
bacterial suspension which was used to infect the THP-1 cells, Triton X-100 was 
added to a final concentration of 0.00007%. Day one, two, three and six TTP were 
measured by treating each tissue culture well with 10 µl Triton X-100 for 15 minutes 
(as described in section 4.2.5.4) and then adding the lysate to a fresh MGIT™. A 
necrosis assay was performed by removing the culture supernatant, centrifuging at 
400 × g for 5 minute to remove any intact cells, then removing 90% of the liquid 
which was sterilised by filtration through 0.2µm pores. Sterilised culture supernatant 
was then assessed for LDH activity using the Promega CytoTox 96® non-radioactive 
cytotoxicity assay. Where applicable, data sets were compared in Microsoft Excel 
using Student’s two-sample t test. 
 
4.2.8.5 Results 
The THP-1 model was infected with BCG and H37RV, to determine which strain has 
the highest intracellular growth rate and which strain causes the most necrosis. 
Values for TTP on day zero were recorded to ensure that the TTP of the bacteria that 
were used to infect the THP-1 cell model, were consistent with previous results. As 
shown in Figure 4-10 previous results found that the mean TTP for BCG is 4% longer 
than for H37Rv. The mean TTP for BCG used to infect the THP-1 model (day 0) (233 
± 10 hours, n=18) was 7% longer than for H37Rv (218 ± 3 hours, n=15; p = 0.2). 
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The mean TTP for H37Rv which had been cultured with THP-1 cells decreased 
gradually over the course of the infection, six 6 days after infection the mean TTP 
(123 ± 10 hours, n=15) had decreased nearly 2 fold from day zero (p = 0.0004). The 
mean TTP for BCG which had been cultured with THP-1 cells decreased on day one, 
two and three, but on day six the mean TTP (186 ± 11 hours, n=15) was the same as 
on day three (Figure 4-21). The mean TTP for intracellular H37Rv was 4% shorter 
than for intracellular BCG on day one and day two after infection. On day three and 
six after infection the mean TTP for H37Rv was shorter than for BCG by 11% and 
34% respectively. 
 
When the mean percentage change in TTP from day one to day six was calculated 
for H37Rv which had been cultured with THP-1 cells it showed that there was a 42% 
(± 2%) change in the TTP (day 1: 213 ± 11 hours, n=14; day 6: 123 ± 10, n=15; p = 
0.000002). There was a 28% (± 3%) change in the mean TTP for H37Rv that was 
cultured in cell-free medium (day 1: 245 ± 15, n=14; day 6: 176 ± 10, n=15; p = 
0.0006) (Figure 4-22). 
 
When the mean percentage change in TTP from day one to day six was calculated 
for BCG which had been cultured with THP-1 cells it showed that there was a 17% (± 
3%) change (day 1: 223 ± 13, n=14; day 6: 186 ± 18, n=12; p = 0.03). There was a 
7% (± 2%) change in the mean TTP for BCG that was cultured in cell-free medium 
(day 1: 270 ± 13 hours, n=11; day 6: 250 ± 9 hours, n=15; p = 0.2) (Figure 4-22). 
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Figure 4-21 Mean TTP for bacteria cultured in cell-free medium or with THP-1 cells over six days 
TTP for mycobacteria was measured by the BACTEC™ MGIT™ 960 System after incubation in tissue culture media 
(extracellular) or incubation with THP-1 cells (intracellular) over 6 days. A decrease in TTP corresponds to an increase in the 
number of bacteria. Cells were infected at an MOI of 1:1. Error bars represent SEM. 
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Figure 4-22 Mean percentage change in TTP over six days for H37Rv and BCG cultured in 
cell-free medium or with THP-1 cells 
TTP for mycobacteria was measured by the BACTEC™ MGIT™ 960 System 
after incubation in tissue culture media (extracellular- red bars) or incubation 
with THP-1 cells (intracellular- blue bars). Cells were infected at an MOI of 1:1. 
Error bars represent SEM, n=15. 
 
 
To account for bacterial growth in cell-free culture medium, the percentage change in 
TTP for extracellular samples was subtracted from the percentage change in TTP for 
intracellular samples (Figure 4-23). The normalised percentage change in TTP is 
14% (± 2%) for H37Rv and 9% (± 2%) for BCG. THP-1 cells caused an increase in 
the growth of both H37Rv and BCG, however H37Rv had a bigger increase in growth 
than BCG (p = 0.008). 
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Figure 4-23 Mean percentage change in TTP over six days for H37Rv and BCG cultured with 
THP-1 cells normalised for extracellular bacterial growth 
Error bars represent SEM, n=15. 
 
The percentage cytotoxicity caused by infection of THP-1 cells with BCG one day 
after infection (22% ± 2%, n=8) was comparable to the amount of spontaneous cell 
death that occurred in uninfected cells (19% ± 2%, n=9; p = 0.4). The percentage 
cytotoxicity caused by infection of THP-1 cells with H37Rv for one day (29% ± 4%, 
n=7) was 1.5 fold higher than the amount of spontaneous cell death that occurred in 
uninfected cells (p = 0.03) (Figure 4-24). 
 
The percentage cytotoxicity caused by infection of THP-1 cells with BCG six days 
after infection (47% ± 2%, n=5) was comparable to the amount of spontaneous cell 
death that occurred in uninfected cells (46% ± 2%, n=6; p = 0.7). The percentage 
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cytotoxicity caused by infection of THP-1 cells with H37Rv for six days (53% ± 2%, 
n=5) was 1.2 fold higher the amount of spontaneous cell death that occurred in 
uninfected cells (p = 0.03) (Figure 4-24). 
 
Figure 4-24 Mean percentage cytotoxicity in uninfected THP-1 cells and THP-1 cells infected 
with H37Rv or BCG at an MOI 1:1 over six days 
Cytotoxicity was measured using an LDH release assay. Blue bars represent an 
Error bars depict SEM, n = 5. 
4.2.8.6 Discussion 
H37Rv is a virulent strain and is able to replicate intracellularly. Rapid intracellular 
growth may cause the cells to burst, accounting for higher cell death when compared 
to BCG. BCG was able to replicate initially, but after three days, the number of 
bacteria began to decline. This indicates that the THP-1 cells were able to contain 
the infection and begin destroying the bacteria. Confirmation of this conclusion is 
given by the fact that necrotic cell death in BCG infected cells did not exceed 
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spontaneous cell death in non-infected control cells. Results from this section have 
validated to use of a THP-1 cell model for assessment of virulence and have shown 
that differences between a virulent mycobacterial strain and an avirulent 
mycobacterial strain can be detected. 
4.2.9 Conclusions for designing a THP-1 cell model to compare 
the virulence of M. tuberculosis strains 
Experiments carried out in section 4.2.1 indicate that the condition of the bacterial 
inoculum can affect the growth rate of subsequent cultures so stock suspensions of 
M. tuberculosis clinical isolates and laboratory reference strains were prepared for 
future experiments. The stock suspensions were stored at -20°C in single use 
aliquots. For all subsequent experiments stock suspensions of M. tuberculosis 
isolates were removed from storage and once thawed 100 µl was inoculated into a 
MGIT™. Once the MGIT™ had achieved a positive growth index, 100 µl was 
removed and used to inoculate a fresh MGIT™ to ensure that bacteria were in an 
exponential growth phase and that growth was not retarded by the effect of storage 
at -20°C. Suspensions of M. tuberculosis clinical isolates were prepared from the 
second positive MGIT™ in 1 ml of RPMI supplemented with 5% FBS (v/v) and 0.05% 
Tween 80 (v/v). The results obtained in section 4.2.2 show that the optimum 
treatment of mycobacterial suspensions to remove clumps was two 30-second pulses 
of bath sonication interspersed with two 60 minute periods of sedimentation, 
following sedimentation two thirds of the volume was removed to a fresh tube. This 
protocol was used to remove clumps from mycobacterial inocula in all subsequent 
experiments. 
 
Section 4.2 
   189 
The optimum conditions for differentiation of THP-1 cells were determined in section 
4.2.4. For all future experiments 5 × 105 THP-1 cells/ml were treated with 24 nM 
phorbol 12-myristate 13-acetate (PMA) for 18 hours. Cells were washed twice with 
PBS and then fresh RPMI supplemented with 5% FBS (v/v) was added 24 and 72 
hours after addition of PMA. 
 
Differentiated THP-1 cells were infected with mycobacteria at an MOI of one 
bacterium to one cell and samples were taken at zero, one and six days for 
assessment of bacterial growth which was carried out using the BACTEC™ MGIT™ 
960 System. The percentage change in TTP over six days was used to determine 
whether the number of bacteria had increased or decreased, as results from section 
4.2.3 indicate that different strains of M. tuberculosis have different TTP. Results from 
section 4.2.7 showed that some strains of bacteria were able to grow in cell-free 
culture medium and so controls for extracellular growth were included in all 
subsequent experiments. 
 
For future experiments to assess the amount of cellular necrosis, THP-1 cell 
supernatants were removed and sterilised by filtration at one and six days after 
infection with mycobacteria. The amount of LDH present in filtered cell supernatants 
was assayed using the Promega CytoTox 96® non-radioactive cytotoxicity assay and 
results were shown as percentage cytotoxicity. 
 
Virulent isolates were identified by their ability to cause THP-1 cell necrosis and their 
ability to replicate in THP-1 cells. 
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4.3 Infection of a THP-1 cell model system with M. tuberculosis 
strains from the CAS and EAI spoligotype clades 
4.3.1 Background 
The M. tuberculosis spoligotype clades CAS and EAI are both prevalent in the ISC. 
CAS is more widespread in the north of India and EAI in the south of India (Arora et 
al., 2009). CAS strains are also prevalent in the Midlands; nearly 40% of 
M. tuberculosis clinical strains isolated from patients in the Midlands between 2007 
and 2008 belonged to the CAS spoligotype clade (Table 3-11). The prevalence of 
EAI in the Midlands is much lower, with only 15% of strains belonging to the EAI 
spoligotype clade. The prevalence of CAS strains in the Midlands compared to EAI 
may be due to specific importation of CAS (Arora et al., 2009). Alternatively, the 
prevalence of CAS in the Midlands could be because CAS is a more successful 
pathogen that is better adapted to spread amongst the population in the Midlands. To 
try to identify the reason for the greater prevalence of CAS strains in the Midlands 
compared to EAI strains, a THP-1 cell model was utilised. This model was used to 
assess the growth rate of different isolates from the CAS and EAI clades and the 
amount of cytotoxicity that they caused, to determine whether CAS strains have 
enhanced properties that have caused them to be more transmissible. 
4.3.2 Hypothesis 
M. tuberculosis isolates belonging to the CAS and EAI spoligotype clades will have 
different growth and cytotoxicity characteristics in THP-1 cells. 
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4.3.3 Aims 
 To compare CAS strains to EAI strains in a THP-1 cell model to identify any 
differences in intracellular growth or cytotoxicity. 
 To compare clinical isolates from epidemiological clusters to unique isolates 
that are not from epidemiological clusters to determine whether there is a 
difference in virulence. 
 To compare isolates from the same cluster of disease to determine whether 
they behave in a similar way in a THP-1 cell model of infection. 
4.3.4 Materials and methods 
4.3.4.1 Bacterial strain selection 
Clinical isolates, which were likely to belong to the CAS or EAI spoligotype clades, 
were selected from amongst all isolates typed by the MRCM between 2003 and 2008 
(5,991). MIRU-VNTR profiles were used to infer the spoligotype of each isolate by 
applying a number of simple rules that were defined using information from the 
literature and data from section 3. Strains that were likely to belong to the CAS 
spoligotype clade were identified by the presence of -223- in the VNTR profile (where 
– represents any number), and were confirmed as modern strains by the possession 
of zero or one copy of MIRU 24. Strains that were likely to belong to the EAI 
spoligotype clade were identified by the presence of two or more copies of MIRU 24, 
which is indicative of ancient TbD1 positive strains. TbD1 positive isolates can belong 
to either the EAI clade or the AFRI clade. EAI and AFRI clades can be distinguished 
by species as EAI strains belong to the M. tuberculosis lineage and AFRI strains 
belong to the M. africanum lineage. 
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Two groups of CAS strains were selected. The first group was selected using 
epidemiological evidence that showed recent transmission had occurred, this group 
will be referred to as CAS epidemiological or CE. All isolates belonging to the same 
cluster had 100% matching MIRU-VNTR profiles. The second group, named CAS 
single or CS, comprised unique isolates that were only been identified once between 
2003 and 2008. Unique isolates were not circulating strains and may represent 
reactivation disease. Culture positive isolates from smear positive sputum samples 
were chosen for further analysis. Two groups of EAI strains were selected using the 
same criteria and groups were referred to as ancient epidemiological or AE and 
ancient single or AS. 
 
There were 34 CE isolates, which were split into 6 clusters, the largest cluster 
contained 14 isolates and the smallest cluster contained 2 isolates. There were 12 
AE isolates split into 3 clusters, the largest contained 7 isolates and the smallest 
contained 2 isolates. There were 81 CS isolates and 7 unique AS isolates. A 
summary of the number of unique and clustered isolates from the CAS and ancient 
M. tuberculosis groups is shown in Figure 4-25. To develop the THP-1 cell model the 
most recent isolate from each of the four groups was selected and the spoligotype of 
these strains was determined experimentally (Table 4-10) as described in section 
3.3.6. The following control organisms were used for comparison; M. tuberculosis 
H37Rv NCTC 7416 and M. tuberculosis H37Ra NCTC 7417 obtained from the 
National Collection of Type Cultures, Colindale, London, UK and M. bovis BCG 
Danish Vaccine strain 1331 obtained from the Statens Serum Institute, Copenhagen. 
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Figure 4-25 Flow chart showing numbers of CAS and ancient isolates selected for analysis in a THP-1 model of infection 
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4.3.4.2 Infection of the THP-1 model 
Suspensions of exponentially growing M. tuberculosis clinical isolates and reference 
strains were prepared as described in section 4.2.1.4. Purity of all cultures was 
confirmed by microscopy using TB ZN stain kit (Becton Dickinson) according to the 
manufacturer’s instructions. Mycobacteria were resuspended in RPMI, treated with 
Tween 80 and sonicated to remove clumps as described in 4.2.2.4. Suspensions of 
5 × 105 bacteria/ml were prepared in RPMI with 0.5% Tween 80 (v/v) as described in 
4.2.3.3. 
 
THP-1 cells seeded at 5 × 105 cells/ml were differentiated with 24 nM PMA and 
culture medium was replaced at 24 and 72 hours as described in 4.2.4.4. Culture 
medium was removed from THP-1 cells 72 hours after addition of PMA and replaced 
with bacterial suspensions at an MOI of 1:1, or fresh culture medium. Samples were 
taken one, four and six days after infection for assessment of bacterial growth as 
described in section 4.2.8.4 and assessment of necrosis as described in 4.2.8.4. 
4.3.4.3 Statistical analysis 
Where applicable, data sets were compared in Microsoft Excel using Student’s 
two-sample t test. 
4.3.5 Results 
Comparison of experimentally derived spoligotype patterns from the four selected 
clinical isolates (CE1, CS1, AE1 ad AS1) to SITVIT showed that both isolates that 
were part of epidemiological clusters (CE1 and AE1) belonged to a SIT (Table 4-10). 
The two unique isolates (CS1 and AS1) were not part of a SIT and these profiles 
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were not present in the SpolDB4 database confirming that they are orphan profiles. A 
newer version of the international spoligotype database (SITVITWEB) was published 
(Demay et al., 2012) and can be queried online (http://www.pasteur-
guadeloupe.fr:8081/SITVIT_ONLINE/). Comparison of the experimentally derived 
spoligotypes of the four selected strains to SITVITWEB (accessed January 2013) 
resulted in the additional identification of AS1, which matched to an orphan profile 
from the EAI5 clade. Using MIRU-VNTRplus to identify strains that are related to CS1 
and AS1 showed that CS1 was most similar to a CAS1_Dehli strain from SIT 1092 
and AS1 was most similar to EAI strains from SIT 11 and SIT 138. This confirms that 
the rules that were used to select the isolates were accurate. 
Table 4-10 Genotyping data for test strains 
     
Comparison with 
SpolDB4 
Comparison with 
SITVITWEB 
Sample 
Year 
isolated 
VNTR MIRU Spoligotype 
Shared 
type 
Clade 
Shared 
type 
Clade 
CE1 2008 42235 2642517331 703777400003771 485 CAS 485 CAS 
CS1 2008 42235 2742516334 700777740003711     
AE1 2008 -4465 2422622313 077777777413731 6 EAI1_SOM 6 EAI1_SOM 
AS1* 2008 614-6 2632622334 477777777413001   N/A EAI5 
N/A indicates that a shared type was not identified as the isolate matched to an 
orphan profile belonging to the EAI5 clade, which was isolated in the UK. 
 
When growth of the four M. tuberculosis clinical isolates, and three reference strains 
was assessed the mean percentage change in TTP from day one to day six for 
bacteria cultured with THP-1 cells ranged from 17% for BCG to 55% for AS1 (Figure 
4-26). All strains were able to replicate in cell-free media, BCG had the smallest 
mean percentage change in TTP (7% ± 2%) in cell-free media and AS1 had the 
largest mean percentage change in TTP (37% ± 2%) in cell-free media (Figure 4-26). 
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When the mean percentage change in TTP was normalised to take account of 
extracellular growth AE1 had the largest mean percentage change in TTP, an 
increase of 23% ± 4%, which was 9% more than H37Rv (14% ± 2) (p = 0.01) (Figure 
4-27). The mean percentage change in TTP for AE1 was not significantly higher than 
for any of the other clinical isolates. All of the clinical isolates had a greater mean 
percentage change in TTP than H37Rv, although the difference was not significant 
(compared to H37Rv; CS1 p=0.7, CE1 p=0.1, AS1 p=0.1). H37Ra and BCG had the 
smallest percentage change in TTP and were both 5% less than H37Rv (compared 
to H37Rv; H37Ra p = 0.02 and BCG p=0.01). The normalised percentage changes in 
TTP for CS1 (14.6% ± 1%) and CE1 (15.3 ± 4%) were not significantly different (p = 
0.2). The normalised percentage change in TTP for AS1 (17.7% ± 2%) and AE1 
(23.3 ± 4%) were also not significantly different (p = 0.3). 
 
The percentage cytotoxicity one day after infection of THP-1 cells with BCG 
(22% ± 2%, n=8) or H37Ra (20% ± 2%, n=3) was comparable to the amount of 
spontaneous cell death that occurred in uninfected cells (19% ± 2%, n=9; 
BCG p = 0.4, H37Ra p = 0.7, when compared to uninfected cells). The percentage 
cytotoxicity caused by infection of THP-1 cells with H37Rv for one day (29% ± 4%, 
n=7) was 1.5 fold higher than the amount of spontaneous cell death that occurred in 
uninfected cells (p = 0.03). The percentage cytotoxicity in THP-1 cells infected for 
one day with CE1, AE1 and AS1 was similar to the amount of necrosis caused by 
BCG, however the amount of necrosis caused by infection with CS1 was 1.4 fold 
higher than the amount of spontaneous cell death that occurred in uninfected cells 
(p  = 0.07). 
Section 4.3 
   197 
 
Figure 4-26 Mean percentage change in TTP for different strains of mycobacteria over six days 
cultured with (intracellular) and without (extracellular) THP-1 cells 
** denotes p< 0.01 when comparing percentage change in TTP for intracellular 
and extracellular bacteria. Error bars represent SEM, n=15. 
 
The percentage cytotoxicity six days after infection of THP-1 cells with BCG 
(47% ± 2%, n=5) or H37Ra (47% ± 2%, n=3) was not significantly different to the 
amount of spontaneous cell death that occurred in uninfected cells (46% ± 2%, n=6; 
BCG p = 0.7, H37Ra p = 0.9 when compared to uninfected cells) (Figure 4-28). The 
percentage cytotoxicity caused by infection of THP-1 cells with H37Rv for six days 
(53% ± 2%, n=5) was 1.2 fold higher the amount of spontaneous cell death that 
occurred in uninfected cells (p = 0.03). The percentage cytotoxicity in THP-1 cells 
infected for six days with CE1, CS1, AE1 and AS1 was similar to the amount of 
cytotoxicity caused by H37Rv. 
 
These results indicate that there is no difference in the ability of CAS and ancient 
strains to cause cytotoxicity in THP-1 cells. The growth of CAS and ancient strains in 
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THP-1 cells was also similar, although the growth of the AE isolate was significantly 
greater than the growth of H37Rv. The growth of all of the clinical isolates was 
greater than the growth of the avirulent strains H37Ra and BCG. 
 
Figure 4-27 Mean percentage change in TTP for different strains of mycobacteria over six days 
cultured with THP-1 cells, normalised for extracellular growth 
* denotes p < 0.05 and ** denotes p< 0.01 when compared to H37Rv, # denotes 
p < 0.05 and # # denotes p< 0.01 when compared to BCG. Error bars represent 
SEM, n=15. 
 
To determine whether all isolates of M. tuberculosis from the CAS clade have the 
same virulence characteristics, six different CAS isolates were selected. 
Epidemiological evidence showing that recent transmission had occurred was used 
to select three isolates; CE1, CE2 and CE3. Three strains were selected that have 
been isolated once between 2003 and 2008, indicating that they are not circulating 
strains; CS1, CS5 and CS6. All six CAS isolates were able to replicate in cell-free 
media (Figure 4-29). When the mean percentage change in TTP from day one to day 
six was normalised for extracellular growth, CE1 and CS1 had the largest mean 
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percentage change in TTP. CS6 had the smallest percentage change, an increase of 
7% ± 0.6% (Figure 4-30). 
 
 
Figure 4-28 Mean percentage cytotoxicity in uninfected THP-1 cells and THP-1 cells infected 
with different strains of mycobacteria over six days 
An MOI of 1:1 was used and cytotoxicity was measured using an LDH release 
assay. * denotes p < 0.05 when compared to no infection. Error bars represent 
SEM, n=15. 
 
The growth of CE1, CE2 and CE3 in THP-1 cells (normalised for extracellular growth) 
was not significantly different. CE1, CE2 and CE3 all belonged to the same 
epidemiological cluster of disease (Figure 4-30). The growth of CS1 was not 
significantly different from the growth of CS5, but the growth of CS6 was significantly 
different from CE1 (p=0.03) and highly significantly different from CS1 (p=0.0001). 
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Figure 4-29 Mean percentage change in TTP for clinical isolates of M. tuberculosis from the 
CAS clade over six days cultured with (intracellular) and without (extracellular) THP-1 cells 
* denotes p < 0.05 and ** denotes p< 0.01 when comparing percentage change 
in TTP for intracellular and extracellular bacteria. Error bars represent SEM, 
n=3, except for CE1 and CS1 where n=15. 
 
Figure 4-30 Mean percentage change in TTP for clinical isolates from the CAS clade over six 
days cultured with THP-1 cells, normalised for extracellular growth 
* denotes p < 0.05 and ** denotes p< 0.01 when compared to CE1, # denotes 
p < 0.05 when compared to CS1. Error bars represent SEM, n=3, except for 
CE1 and CS1 where n=15. 
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The level of THP-1 cell cytotoxicity caused by all isolates from the CAS clade was 
higher than in non-infected cells after one day and six days of infection (Figure 4-31). 
CS5 caused the most cytotoxicity on day one (32% ± 3%, n=3, p=0.01 compared to 
uninfected cells) and on day six (57% ± 2%, n=3, p=0.02 compared to uninfected 
cells). CE1 caused the lowest percentage THP-1 cell cytotoxicity on day one 
(22% ± 3%, n=6, p=0.5 compared to uninfected cells) and on day six (50% ± 3%, 
n=6; p = 0.3 compared to uninfected cells) (Figure 4-31). When the average 
percentage cytotoxicity caused after six days by CAS strains from epidemiological 
clusters (51% ± 0.5%, n=3) was compared to the average percentage cytotoxicity for 
unique CAS isolates (56% ± 0.7%, n=3) there was a significant difference (p=0.05), 
with unique isolates causing the most cytotoxicity. 
 
Figure 4-31 Mean percentage cytotoxicity in uninfected THP-1 cells and THP-1 cells infected 
with clinical isolates from the CAS clade over six days  
An MOI of 1:1 was used and cytotoxicity was measured using an LDH release 
assay. * denotes p < 0.05 when compared to no infection. Error bars represent 
SEM, n=3. Except for CE1 and CS1 where n=6. 
Section 4.3 
   202 
4.3.6 Discussion 
The ancient isolate from epidemiological cluster 1 (AE1) had the highest intracellular 
growth of all the strains tested in the current study. Growth rate did not correlate 
exactly with cytotoxicity as the CAS orphan strain CS1 caused the most THP-1 cell 
necrosis. This chapter shows that all of the tested clinical isolates were able to grow 
in THP-1 cells more rapidly than the virulent reference strain H37Rv and the avirulent 
reference strains H37Ra and BCG. Although the AE1 isolate had the highest 
intracellular growth, it was not significantly higher when compared to the other clinical 
isolates. All the clinical isolates caused more THP-1 cell necrosis than BCG and 
H37Ra. After six days of infection, CS1 was the only clinical isolate that had caused 
more THP-1 cell necrosis than H37Rv, but the amount of necrosis caused by CS1 
was not significantly greater than any of the other clinical isolates. 
 
Previous studies have shown that high intracellular growth rates in THP-1 cells 
correlate with the ability of a strain to kill macrophages in vitro, cause disease in 
animals, or to spread amongst humans. It was therefore hypothesised that ancient 
isolates, which are not prevalent in the Midlands, would have a lower growth rate in 
THP-1 cells and cause less cytotoxicity than isolates belonging to the CAS 
spoligotype clade, which are prevalent in the Midlands and are evolutionarily modern 
strains. However, the results from the THP-1 infection model used in the current 
study did not fully confirm this hypothesis. 
 
The intracellular growth rates of M. tuberculosis strains in THP-1 cells began to differ 
after three days, showing that THP-1 cells need to be infected for at least three days 
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before differences between strains can be detected. Theus also showed that 
intracellular growth rates for different isolates of M. tuberculosis began to differ after 
three days of incubation with THP-1 cells (Theus et al., 2005). Sharma and 
colleagues found no difference in the intracellular growth rate of H37Ra, H37Rv and 
a clinical isolate after infection of THP-1 cells for three days (Sharma et al., 2008); 
however, data from the current study has shown that H37Ra and H37Rv have 
different intracellular growth rates after three days. Sharma and colleagues 
suggested that the length of time that their experiments were carried out for could 
have prevented differences in the growth of H37Ra and H37Rv from being detected, 
which is consistent with data from the current study. 
 
The current study found that differences in intracellular growth between strains 
occurred after three days, and differences were still discernible after six days. Kanji 
and colleagues assessed the growth of H37Rv and 21 clinical isolates from the 
CAS1_Dehli spoligotype clade (SIT26) in broth and in THP-1 cells (Kanji et al., 
2011b). The authors found that differences in intracellular growth between strains 
were most evident after three days, but after five days, differences were no longer 
significant. Theus showed that growth of unique clinical isolates and isolates from 
epidemiological clusters of disease were significantly different in THP-1 cells after 
seven days of infection, growth of unique isolates was lowest (Theus et al., 2005). 
 
The BACTEC™ MGIT™ 960 System was used to enumerate M. tuberculosis in the 
current study, whereas the studies by Kanji and colleagues and Theus and 
colleagues used CFU to enumerate bacteria. The BACTEC™ MGIT™ 960 System 
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uses liquid culture media for enumeration of M. tuberculosis and is highly sensitive 
(Diacon et al., 2010; Dhillon et al., 2004). 
 
Dhillon and colleagues have demonstrated that there are populations of bacteria 
present in stationary phase, micro-aerophilic adapted cultures, which can grow in 
liquid culture media but are not able to grow on solid culture media (which is used for 
CFU enumeration). The same population of bacteria are present in the lungs and 
spleen of chronically infected mice, which led the authors to suggest that the growth 
difference between solid and liquid media could be caused by the presence of a 
sub-population of non-replicating or dormant bacteria (Dhillon et al., 2004). 
 
The gene expression profile of M. tuberculosis in micro-aerophilic culture conditions 
had similarities to the gene expression profile of M. tuberculosis from the lungs of 
infected mice (Voskuil et al., 2003) and M. tuberculosis from murine bone 
marrow-derived macrophages (Schnappinger et al., 2003). These observations 
suggest that a dormant population of M. tuberculosis could be present when THP-1 
cells are used to model infection. If dormant bacteria can only grow in liquid medium 
this could account for why differences in growth between CAS strains were not 
significant after five days in the study carried out by Kanji, where solid media was 
used for bacterial enumeration. 
 
The study by Theus and colleagues also used CFU counts to enumerate bacteria. 
However, the THP-1 cells used in Theus’s study were treated with PMA and IFN-γ, in 
contrast to the current study, which only used PMA. Addition of IFN-γ activates the 
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THP-1 causing them to destroy M. tuberculosis more efficiently than non-activated 
cells. Activation of the THP-1 cells may have prevented the bacteria from entering 
dormancy, accounting for the significant differences in growth rate found after six 
days in the study by Theus, which were not seen in the study by Kanji, despite both 
studies using the same method of bacterial enumeration. 
 
The current study has shown that there was no significant difference in the 
intracellular growth rate of three isolates from the same epidemiological cluster of 
disease (CE1, CE2 and CE3) in THP-1 cells. The intracellular growth rate of two 
unique strains (CS1 and CS5) was not significantly different to the growth of CE1; 
however, growth of one of the unique isolates (CS6) was significantly lower than the 
growth of CE1 and CS1. 
 
Kanji and colleagues investigated reasons for differences in intracellular growth rates 
of CAS1_Dehli strains in THP-1 cells by analysing the distribution of two genomic 
regions in 133 clinical isolates from Pakistan. They found deletion of RD149 occurred 
in 40% of isolates and deletion of both RD149 and RD152 occurred in 19% of 
isolates (Kanji et al., 2011a). In a subsequent study, Kanji and colleagues observed 
statistically significant variation in growth rates for different CAS isolates and they 
attempted to examine possible genetic causes for this (Kanji et al., 2011b). Kanji and 
colleagues suggested that absence of RD149 from 40% of the CAS1_Dehli clinical 
isolates that they studied contributed to slower growth in broth and in THP-1 cells 
than H37Rv; however absence of RD149 and RD152 did not produce the same 
effect. 
Section 4.3 
   206 
The function of the RD149 and RD152 regions are not known but RD149 contains 
possible phage proteins (Tsolaki et al., 2005) and RD152 includes putative 
transposases and phospholipase-C gene D (plcD) which has been proposed as a 
virulence factor (Yang et al., 2005). Kanji and colleagues also noted that CAS1_Delhi 
strains with RD149 deletions that were isolated from extrapulmonary sites grew faster 
and induced lower levels of TNF-α and IL10 than isolates with the same deletion that 
were from pulmonary sites. 
 
Theus and colleagues tested 15 clinical isolates that belonged to the Beijing 
spoligotype clade using a THP-1 cell model of infection and found that intracellular 
growth rate varied significantly amongst the isolates (Theus et al., 2007a). This 
suggests that the growth of isolates that belong to the same spoligotype clade can 
vary considerably in THP-1 cells. 
 
The current study showed that isolates from the same cluster of disease had a similar 
growth rate, however high intracellular growth rate did not correlate with high 
induction of cytotoxicity. It has been reported that isolates belonging to a cluster of 
disease have higher intracellular growth rates and produce more cytotoxicity than 
single isolates that were not part of disease clusters. However, in the current study, 
only one of the three unique isolates that were tested had a significantly lower 
intracellular growth rate compared to strains that belonged to a cluster of disease, 
and the unique isolates caused more cytotoxicity than the isolates from disease 
clusters. 
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Theus and colleagues found that H37Rv and a clinical isolate belonging to the Beijing 
spoligotype clade, which was from a cluster of disease had a higher intracellular 
growth rate than a unique clinical isolate which had an orphan spoligotype profile 
(Theus et al., 2004). Theus followed up the work on the unique isolate and clustered 
isolate by testing a further 32 clinical isolates, and again found that higher 
intracellular growth correlated with the ability of a strain to spread in the community 
(Theus et al., 2005). However, work carried out in the current study only showed a 
significant difference between the intracellular growth of one unique isolate when 
compared to isolates that belonged to a disease cluster. The discrepancies between 
the current study and the study carried out by Theus may be caused by the small 
sample size; only three unique and three cluster isolates were tested in the current 
study. The differences could also have been caused by different methodology, Theus 
and colleagues used activated THP-1 cells infected with 50 mycobacteria per cell 
whereas the current study used non-activated THP-1 infected with one 
mycobacterium per cell. 
 
In the current study, only the CAS orphan strain CS1 was able to cause more 
necrosis than H37Rv. However, after seven days in culture almost half of the THP-1 
cells had died spontaneously in the absence of mycobacteria. The high degree of cell 
death in THP-1 cultures in the current study may have prevented subtle differences 
in the amount of necrosis caused by different M. tuberculosis isolates from being 
detected. Castro-Garza and colleagues (Castro-Garza et al., 2007) and Sohn and 
colleagues (Sohn et al., 2009) were able to show that clinical isolates of 
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M. tuberculosis caused more necrosis in a THP-1 cell model of infection than the 
reference strain H37Rv. 
 
The high level of THP-1 cell death occurring in the absence of infection in the current 
study contrasts with the study carried out by Theus and colleagues which reported 
that the percentage of viable THP-1 cells was constant over seven days of incubation 
with mycobacterial isolates and did not vary between isolates. Theus and colleagues 
did not report the amount of cell death occurring in uninfected cells (Theus et al., 
2005). THP-1 cells used in the current study were passaged for a maximum of five 
times, as it is known that the phenotype of THP-1 cells can alter after repeated 
passage (Tominaga et al., 1998). The THP-1 cells used in the study by Theus were 
passaged every three days and there is no mention of whether passage number was 
restricted. 
 
The concentration of PMA used to differentiate THP-1 cells in the current study was 
four times lower that the concentration used by Theus and colleagues. The 
concentration of PMA chosen for THP-1 cell differentiation was optimised in section 
4.2.4, and higher concentrations were shown to result in cell death. PMA is sensitive 
to light as well as to acid and alkali conditions and is insoluble in water. Differences in 
the preparation and storage of PMA in the current study and the study carried out by 
Theus and colleagues may have occurred. 
 
THP-1 cell viability in the current study was assessed using a highly sensitive LDH 
release assay. The study by Theus and colleagues assessed cell viability using 
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trypan blue staining of cells that had been removed from their culture vessel using 
trypsin (Theus et al., 2005). The different techniques could account for the variation 
seen in cell death between the two studies. 
 
After reviewing other published studies, a number of improvements were made so 
that the current study would be standardised. The passage number of the THP-1 
cells was controlled, bacterial enumeration was carried out using the BACTEC™ 
MGIT™ 960 System rather than CFU counting and cell viability was tested using an 
LDH release assay. Despite these improvements, M. tuberculosis isolates that 
belong to the CAS spoligotype clade did not appear to be more virulent in a THP-1 
cell model than ancient isolates from the EAI spoligotype clade. In addition, isolates 
that belonged to an epidemiological cluster of disease were not more virulent than 
isolates that did not belong to an epidemiological cluster. High M. tuberculosis 
intracellular growth rates in THP-1 cells did not absolutely correlate with increased 
cytotoxicity. However, the amount of spontaneous cell death that occurred in the 
THP-1 cell model in the absence of infection may have precluded the observation of 
subtle differences in cytotoxicity. The current study has provided insight into the 
complex relationship between macrophages and different strains of M. tuberculosis. 
Growth rates and cytotoxicity do not fully account for potential differences in disease 
pathogenesis. Immune evasion is likely to be an important factor in the virulence of 
M. tuberculosis, however the TB-host interaction is complex and the exact 
mechanism of immune evasion is yet to be fully elucidated (McEvoy et al., 2012; 
Comas et al., 2010). To determine whether similarity in the amount of necrosis 
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caused by M. tuberculosis strains in the current study was due to high spontaneous 
cell death, the strains were tested in a MDM model, described in section 4.4. 
4.4 Infection of human MDMs with M. tuberculosis strains from 
the CAS and EAI spoligotype clades 
4.4.1 Background 
THP-1 cells differ from MDMs in their expression of surface receptors, such as the 
lectin-like receptors (Stokes and Doxsee, 1999). Macrophages are a heterogeneous 
population of cells that can exist in different states, which are referred to as M1 and 
M2. Although THP-1 cells can be polarised towards an M1 or an M2 phenotype, this 
is not commonly done as the PMA treatment that is required to convert THP-1 cells 
into macrophage-like cells already programs them to some extent. Therefore, most 
studies looking at the effects of macrophage polarisation and M. tuberculosis 
infection are conducted with MDMs. There is evidence to suggest that 
M. tuberculosis can alter the polarisation of macrophages in human lungs (Redente 
et al., 2010; Ho and Lape e Silva, 2010; Almeida et al., 2009; Chacon-Salinas et al., 
2005) but the ability of polarised macrophages to control the growth of 
M. tuberculosis, especially clinical isolates has not been studied in detail. MDMs were 
polarised towards an M1 or an M2 phenotype in order to assess the growth of the 
virulent reference strain H37Rv and the avirulent reference strains H37Ra and BCG, 
as well as the four clinical isolates studied in section 4.3. 
 
As discussed in section 3 there is evidence, which indicates that the global origin of a 
TB patient is associated with the lineage of M. tuberculosis that they become infected 
with, even when the person has immigrated to a different country. In the current 
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study, it was shown that 60% of the TB patients with ISC ethnicity in the Midlands, 
UK were infected with the CAS spoligotype clade (which is a modern TbD1 negative 
lineage) and 10% were infected with the EAI spoligotype clade (which is an ancient, 
TbD1 positive lineage), both of which are prevalent in the ISC. To investigate this 
association further, monocytes were obtained from Asian and Caucasian donors and 
used to assess whether host ethnicity affects the ability of different strains of 
M. tuberculosis to replicate within or kill macrophages. 
4.4.2 Hypothesis 
M. tuberculosis isolates belonging to the CAS and EAI spoligotype clades will have 
different growth and cytotoxicity characteristics in a human MDM model of infection. 
4.4.3 Aims 
 To compare an MDM model of M. tuberculosis infection with the THP-1 cell 
model used in section 4.3. 
 To compare CAS strains with EAI strains in a human MDM cell model to 
identify any differences in virulence. 
 To compare clinical isolates from epidemiological clusters to isolates that are 
not from epidemiological clusters to determine whether isolates responsible for 
a cluster of disease are more virulent than unique isolates. 
 To compare the effect of M1 and M2 macrophage polarisation on the 
intracellular growth rate and cytotoxicity of CAS and EAI strains 
 To compare the effect of blood donor ethnicity on the intracellular growth rate 
and cytotoxicity of CAS and EAI strains in MDMs. 
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4.4.4 Materials and methods 
Human peripheral blood mononuclear cells (PBMCs) from eight healthy anonymous 
donors were isolated from buffy coats processed by the National Blood Services, 
Birmingham, UK. For work related to the effect of ethnicity on macrophage function 
fresh heparinized (10 U/ml) blood was collected from six healthy male donors who 
had been vaccinated with BCG (three Asian donors and three Caucasian donors). 
PBMCs were prepared on a Ficoll-Paque density gradient (GE Healthcare) by 
centrifugation (400 × g, 30 min at room temperature). The cells at the interphase 
were collected and washed four times in RPMI (Life Technologies, UK). Monocytes 
were purified using magnetic cell sorting with anti-CD14-MicroBeads (Miltenyi Biotec, 
Bergisch Gladbach, Germany) in a miniMACS, according to the manufacturer’s 
instructions (Hanley et al., 2004). Cells were seeded at a density of 5 x 105 cells/ml 
and divided into two aliquots. The first aliquot was treated with10 ng/ml GM-CSF 
(PeproTech, Rocky Hill, NJ) and the second aliquot was treated with 50 ng/ml M-CSF 
(PeproTech, Rocky Hill, NJ) to generate M1 and M2 MDMs, respectively (Verreck et 
al., 2004). Cells were incubated in 96-well tissue culture plates for 48 hours in RPMI 
medium supplemented with 10% FBS (Sigma, UK; lot number 109K3396 was used 
for all experiments) at 37°C in a humidified atmosphere with 5% CO2. Following 
incubation half of the culture medium was removed and replaced with fresh media 
containing 20 ng/ml GM–CSF or 100 ng/ml M–CSF. Cells were incubated for a 
further four days, they were then washed with warm RPMI before fresh, cytokine-free 
media was added (RPMI with 10% FBS), cells were then used for infection studies. 
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Suspensions of exponentially growing M. tuberculosis clinical isolates and reference 
strains were prepared as described in section 4.2.1.4 and purity was confirmed by 
microscopy using a TB ZN stain kit (Becton Dickinson) according to the 
manufacturer’s instructions. Mycobacteria were resuspended in RPMI and treated 
with Tween 80 and sonication to remove clumps as described in 4.2.2.4. 
Suspensions of 5 × 105 bacteria/ml were prepared in RPMI with 0.5% Tween 80 (v/v) 
as described in 4.2.3.3. Culture medium was removed from M1 and M2 MDMs and 
replaced with bacterial suspensions at an MOI of 1:1, or fresh culture medium. 
Samples were taken at one, four and six days after infection for assessment of 
bacterial growth and cell necrosis as described in 4.2.8.4. Measurements for each 
blood donor were carried out in duplicate. Where applicable, data sets were 
compared in Microsoft Excel using Student’s two-sample t test. 
4.4.5 Results 
4.4.5.1 Growth of M. tuberculosis isolates in cell-free tissue culture medium 
The reference strains H37Ra and H37Rv and four clinical M. tuberculosis isolates 
were able to grow in cell-free tissue culture media for six days (data not shown). 
M. bovis BCG was able to grow in cell-free culture media for three days but after this, 
the number of bacteria began to fall. The initial increase in the number of BCG 
followed by a decrease causes a lower percentage change in TTP from day one to 
day six compared to strains that were able to continue growing in cell-free culture 
media for six days. The growth of BCG in cell-free culture media was consistent with 
data obtained in section 4.2.7, as BCG had the smallest mean percentage change in 
TTP in cell-free media (10% ± 5%). The growth of AE1 in cell free media was the 
highest in the MDM model (39% ± 2%), whereas in THP-1 cells the growth of AS1 
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(37% ± 2%) was the highest (Figure 4-32). BCG was the only bacterial strain that 
could not grow in cell free tissue culture medium for six days 
4.4.5.2 Growth of M. tuberculosis isolates in THP-1 cells compared to their 
growth in human MDMs 
All of the strains that were tested in the THP-1 model had a higher percentage 
change in TTP when cultured with cells compared to cell-free media, indicating that 
THP-1 cells provide a more favourable environment for mycobacterial growth than 
media alone. However, when the strains were tested in M1 and M2 human MDMs the 
percentage change in TTP for some strains was lower when cultured with cells 
compared to cell-free media, indicating that the macrophages were inhibiting the 
growth of the bacteria (Figure 4-32). BCG, H37Rv, CE1 and CS1 were able to grow 
more in M1 cells than in cell-free media; the growth of H37Ra, AS1 and AE1 was 
lower in M1 cells than it was in cell-free media. The same pattern was seen in M2 
cells, they supported higher growth of BGC, H37Rv, CE1 and CS1 compared to 
cell-free media. 
 
The behaviour of BCG and H37Rv in M1 and M2 macrophages was similar to their 
behaviour in THP-1 cells. The percentage change in TTP from day one to day six for 
H37Rv cultured with THP-1 cells (42% ± 2%) was similar to the percentage change in 
M1 (40% ± 3%) and M2 cells (45% ± 5%). However, the clinical isolates behaved 
differently in M1 and M2 cells compared to THP-1 cells (Figure 4-32). For example 
the percentage change in TTP from day one to day six for AE1 cultured with THP-1 
cells (47% ± 3%) was greater than the percentage change in TTP when AE1 was 
cultured with M1 cells (37% ± 2; p = 0.03) and M2 cells (33% ± 3%; p = 0.04). AE1 
Section 4.4 
   215 
was able to grow more in THP-1 cells than in cell free culture medium, but in M1 and 
M2 cells AE1 grew less than it did in cell-free media. 
 
BCG had the second lowest percentage change in TTP when it was cultured with M1 
or M2 cells compared to the other six strains that were tested. However, when 
percentage change in TTP from day one to day six was normalised to account for 
extracellular growth, BCG had the largest mean percentage change in TTP in M1 
cells and the second largest change in M2 cells. The percentage change in TTP from 
day one to day six is lower for extracellular BCG than it is for other strains, as BCG 
was not able to continue growing in cell-free media for 6 days. Therefore when 
percentage change in TTP for extracellular BCG is subtracted from percentage 
change in TTP for intracellular BCG the normalised value is elevated, an artefact 
which only occurs when bacteria are not able to continue growing in cell-free media 
for six days. 
4.4.5.3 Growth of M. tuberculosis isolates in M1 and M2 macrophages 
M2 MDMs provide a more favourable environment for the growth of virulent strains of 
M. tuberculosis than M1 macrophages; however, M2 macrophages inhibit the growth 
of avirulent strains more than M1 macrophages. When percentage change in TTP 
from day one to day six was normalised to account for extracellular growth, CE1 from 
M2 cells had the largest mean percentage change in TTP, an increase of 14% ± 4%. 
The normalised percentage change in TTP for CE1 in M1 cells (4% ± 4%) was 3.5 
fold lower than for M2 cells. H37Rv and CS1 also grew more in M2 cells than they did 
in M1 cells (Figure 4-33). 
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Figure 4-32 Mean percentage change in TTP for different mycobacterial strains cultured with 
and without different cells over six days 
Mycobacteria were cultured with (intracellular) and without (extracellular) 
different types of cells, A) THP-1 cells (n=15), B) M1 MDMs (n=8) or C) M2 
MDMs (n=8).* denotes p < 0.05 and ** denotes p< 0.01 when comparing 
percentage change in TTP for intracellular and extracellular bacteria. The data 
in panel A (THP-1 cells) is also shown in Figure 4-26. Error bars represent 
SEM.  
Section 4.4 
   217 
H37Ra was able to grow in THP-1 cells better than in cell-free media but both M1 
and M2 MDMs were able to inhibit the growth of H37Ra. When percentage change in 
TTP from day one to day six was normalised for extracellular growth there was a 
small negative change in TTP for H37Ra incubated with M1 cells (-4% ± 4%), but 
there was a much larger negative change in TTP for H37Ra incubated with M2 cells 
(-24% ± 4%). The ancient strains AE1 and AS1 grew in THP-1 cells but their growth 
was inhibited by M1 and M2 cells, inhibition was greatest in M2 cells. 
4.4.5.4 Spontaneous cell death in the THP-1 and human MDM models of 
M. tuberculosis infection 
There was a higher level of spontaneous cell death in the THP-1 cell model of 
M. tuberculosis infection than there was in human MDMs. Nearly a fifth of the cells in 
the THP-1 cell model had died after one day in culture in the absence of bacteria 
(percentage cytotoxicity 19% ± 2%, n=9); less than 1% of M1 cells had died under 
the same constions (percentage cytotoxicity 0.8% ± 0.2%, n=21) and the same result 
was seen for M2 cells (percentage cytotoxicity 0.9% ± 0.3%, n=21) (Figure 4-34). 
After six days in culture, nearly half of the uninfected THP-1 cells were dead (46% ± 
2%), whereas only 2% (± 0.6%) of M1 cells and 3% (± 0.9%) of M2 cells had died. 
 
After six days of infection, the percentage cytotoxicity in THP-1 cells ranged from 
4 fold higher than M1 cells when infected with AS1 or CE1 to 11 fold higher when 
infected with H37Ra or BCG. BCG and H37Ra cause the lowest cytotoxicity in THP-1 
cells, M1 cells and M2 cells; however, the amount of cytotoxicity caused by infection 
with the clinical isolates differed between the three cell types. 
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Figure 4-33 Mean percentage change in TTP for different mycobacterial strains cultured with 
different cells over six days normalised for extracellular growth 
Mycobacteria were cultured with A) THP-1 cells (n=15), B) M1 MDMs (n=8) or 
C) M2 MDMs (n=8). Error bars represent SEM, n=8. The data in panel A 
(THP-1 cells) is also shown in Figure 4-27. Error bars represent SEM. 
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Figure 4-34 Mean percentage cytotoxicity in different cells caused by different strains of 
mycobacteria over six days 
Mycobacteria were cultured with A) THP-1 cell, B) M1 polarised MDMs or C) M2 
polarised MDMs. * denotes p < 0.05, ** denotes p < 0.01 compared to no 
infection. Error bars represent SEM, n=8. 
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Table 4-11 Mean percentage cytotoxicity in M1 and M2 cells six days after infection with 
mycobacterial strains 
Cell 
phenotype 
Bacterial 
phenotype 
Mean 
percentage 
cytotoxicity 
SEM 
p value 
compared 
to CAS 
p value 
compared 
to ancient 
p value 
compared 
to 
virulent 
p value 
compared 
to 
avirulent 
M1 
CAS 13 2 - 0.08 0.8 0.0009 
Ancient 9 1 
 
- 0.005 0.02 
Virulent 13 1 
  
- 0.000001 
Avirulent 5 1 
   
- 
M2 
CAS 16 2 - 0.02 0.6 0.000009 
Ancient 10 1  - 0.003 0.0002 
Virulent 17 2   - 0.0000004 
Avirulent 4 1   
 
- 
 
The CAS strains caused the same amount of necrosis as the virulent laboratory 
strain H37Rv. Ancient strains caused more necrosis than the avirulent laboratory 
strains H37Ra and BCG, but less than the virulent strain H37Rv. 
 
There was no significant difference in the intracellular growth or the amount of 
cellular necrosis that occurred when unique M. tuberculosis isolates (CS1 and AS1) 
were compared to isolates from epidemiologically linked clusters of disease (CE1 
and AE1). 
4.4.5.5 The effect of blood donor ethnicity on the ability of MDMs to inhibit 
the growth of M. tuberculosis 
MDMs were generated from three UK-born Caucasian blood donors and three 
UK-born Asian blood donors to assess whether ethnicity of the blood donor affected 
the ability of MDMs to inhibit mycobacterial growth. Growth of H37Rv and the CAS 
strains (CE1 and CS1) was better in MDMs originating from Asians than it was in 
MDMs originating from Caucasians. Growth of H37Rv in Asian M1 MDMs was nearly 
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20 fold higher than in Caucasian M1 MDMs, growth of CE1 was 1.5 fold higher and 
growth of CS1 was 1.2 fold higher (Figure 4-35, Figure 4-36). 
 
MDMs from Caucasians were able to suppress the growth of H37Ra more than 
MDMs from Asians, with M2 MDMs being more effective than M1 MDMs at inhibition 
of H37Ra growth. Growth of H37Ra in Caucasian M1 MDMs was 6 fold lower than in 
Asian M1 MDMs and 9 fold lower in M2 MDMs (Figure 4-35, Figure 4-36). The 
growth of the AE1 isolate did not vary according to the ethnicity of the macrophage 
donor, M1 MDMs from Caucasians and Asians were able to suppress the growth of 
AE1, but AE1 was able to grow in M2 MDMs from Caucasians and Asians. 
 
M1 and M2 macrophages from Caucasians suppressed the growth of the AS1 
isolate; growth suppression was greatest in M2 cells. Conversely, the AS1 isolate 
grew in M1 and M2 MDMs from Asians, highest growth occurred in M2 cells. Growth 
of BCG was 2.3 fold higher in M1 MDMs from Caucasians compared to Asians, but in 
M2 MDMs, growth of BCG was 1.5 fold higher in cells derived from Asians (Figure 
4-35, Figure 4-36). 
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Figure 4-35 Mean percentage change in TTP for M. tuberculosis strains cultured for six days with MDMs generated from people of different 
ethnicity 
Mycobacteria were cultured with (intracellular) and without (extracellular) A) M1 MDMs from three Caucasian donors, B) M2 
MDMs from three Caucasian donors, C) M1 MDMs from three Asian donors or D) M2 MDMs from three Asian donors. Error bars 
represent SEM. 
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Figure 4-36 Mean percentage change in TTP for M. tuberculosis strains cultured for six days with MDMs generated from people of different 
ethnicity, normalised for extracellular growth 
Mycobacteria were cultured with A) M1 MDMs from three Caucasian donors, B) M2 MDMs from three Caucasian donors, C) M1 
MDMs from three Asian donors or D) M2 MDMs from three Asian donors. Error bars represent SEM. 
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4.4.5.6 The effect of blood donor ethnicity on the ability of M. tuberculosis to 
cause necrosis in MDMs 
The amount of necrosis that occurred in MDMs infected with different mycobacterial 
strains did not differ significantly according to the ethnicity of the blood donor (Figure 
4-37). There was a similar level of necrosis in Asian M1 cells and Caucasian M1 cells 
infected with the same mycobacterial strain, the same was true of M2 cells (Table 
4-12). 
 
Table 4-12 Mean percentage cytotoxicity in M1 and M2 MDMs from Asian and Caucasian blood 
donors six days after infection with mycobacterial strains 
Cell 
phenotype 
Bacterial 
phenotype 
Mean percentage 
cytotoxicity (SEM) p 
value* 
Asian Caucasian 
M1 
CAS 10 (0.8) 14 (2.3) 0.2 
Ancient 7 (0.8) 8 (0.3) 0.2 
Virulent 14 (2.3) 16 (0.5) 0.6 
Avirulent 2 (1.1) 6 (1.7) 0.1 
M2 
CAS 13 (3.5) 20 (2.3) 0.1 
Ancient 10 (1.6) 13 (2.2) 0.3 
Virulent 18 (0.5) 21 (1.9) 0.2 
Avirulent 3 (0.5) 4 (1.3) 0.4 
* p values were calculated by comparing mean percentage cytotoxicity for Asian 
and Caucasian cells, there were three donors from each ethnic group and 
experiments were carried out in duplicate for each blood donor. 
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Figure 4-37 Mean percentage cytotoxicity in MDMs generated from people of different ethnicity caused by M. tuberculosis strains over six 
days 
Mycobacteria were cultured with A) M1 MDMs from three Caucasian donors, B) M2 MDMs from three Caucasian donors, C) M1 
MDMs from three Asian donors or D) M2 MDMs from three Asian donors. Error bars represent SEM. 
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4.4.6 Discussion 
Results from the current study suggest that an MDM model of M. tuberculosis 
infection is more appropriate than a THP-1 cell model, especially for assessing 
differences in cytotoxicity caused by clinical isolates. Growth of all the M. tuberculosis 
clinical isolates and reference strains was higher in THP-1 cells than it was in MDMs. 
There was also a higher level of necrosis in the THP-1 cell model compared to 
MDMs. However, nearly 50% of THP-1 cells were dead after six days in culture in the 
absence of infection, whereas only 2% of MDMs died in the same conditions. The 
high level of spontaneous cell death in the THP-1 cell model may mask the 
observation of differences in the amount of cytotoxicity caused by distinct 
M. tuberculosis strains. The overall pattern of intracellular growth and cell necrosis 
produced by the reference strains BCG and H37Rv was similar in the THP-1 model 
and the MDM model but the behaviour of the clinical isolates differed between the 
two models. However, it is also important to note the effect of extracellular bacterial 
growth on the normalisation used to determine growth ratios in the current study. For 
example, BCG was the only strain that was not able to grow in cell-free media for six 
days. Therefore when percentage change in TTP for extracellular BCG was 
subtracted from percentage change in TTP for intracellular BCG the normalised 
value was elevated, an artefact which only occurs when bacteria are not able to 
continue growing in cell-free media for six days. 
 
The THP-1 model has been widely used to assess the virulence of M. tuberculosis 
strains and THP-1 cells have been described as a good substitute for MDMs 
(Daigneault et al., 2010; Stokes and Doxsee, 1999; Auwerx, 1991). Riendeau and 
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colleagues also reported that PMA differentiated THP-1 cells undergo apoptosis in 
response to infection with avirulent M. tuberculosis in a manner that is similar to 
human alveolar macrophages (Riendeau and Kornfeld, 2003). Riendeau and 
colleagues carried out their study using four strains, wild-type M bovis, M. bovis BCG, 
M. tuberculosis H37Ra and H37Rv. However, the only direct comparison of the 
response of THP-1 cells and MDMs to infection with M. tuberculosis was published 
by Stokes and colleagues and it used just one mycobacterial strain; M. tuberculosis 
strain Erdman (ATCC 35801) (Stokes and Doxsee, 1999). Stokes and colleagues 
concluded that the capacity of both models to bind M. tuberculosis strain Erdman 
was the same and after seven days of infection. Stokes showed a 15-fold increase in 
the number of mycobacteria in MDMs and a 20-fold increase in the number of 
mycobacteria in THP-1 cells. Data from the current study shows that whilst the THP-1 
cell model is a good substitute for infection of MDMs with laboratory reference strains 
such as H37Rv and BCG, the behaviour of clinical isolates is not the same in THP-1 
cells and MDMs. 
 
The current study shows that modern CAS strains are more virulent than ancient 
M. tuberculosis strains in an MDM model as CAS strains are able to cause more cell 
necrosis and to grow more than ancient strains. The differences between strains are 
more evident when macrophages are polarised towards an M2 phenotype. When a 
THP-1 cell model was used to assess virulence, it appeared that ancient strains were 
able to grow more than CAS strains, but the amount of cell necrosis that occurred 
was similar for CAS and ancient strains. In the MDM model of infection, CAS strains 
had similar growth characteristics to the virulent reference strain H37Rv, whereas the 
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growth of ancient strains resembled that of the avirulent reference strain H37Ra. In 
addition, CAS strains and H37Rv caused a similar level of cytotoxicity, whereas 
ancient strains caused less cytotoxicity than H37Rv. 
 
The lower intracellular growth rate of ancient strains and decreased levels of necrosis 
in MDMs indicates that they were less virulent than the CAS strains that were tested 
in the current study. Portevin and colleagues showed that ancient strains of 
M. tuberculosis produced a pro-inflammatory phenotype in human M1 MDMs, 
whereas modern strains produced a lower inflammatory response (Portevin et al., 
2011). If modern strains were more virulent than ancient strains it could be expected 
that ancient strains would not be isolated as frequently as modern strains. However, 
data from India suggest that ancient strains are still prevalent, for example, a study 
carried out in Andhra Pradesh, India showed that 40% of M. tuberculosis isolates 
belonged to the modern CAS spoligotype clade and 38% belonged to the ancient EAI 
clade (Thomas et al., 2011). 
 
Differences in intracellular growth rate and cytokine profiles elicited by modern and 
ancient strains could be indications of different virulence strategies, rather than an 
indication of the superior virulence of modern strains (Portevin et al., 2011). 
However, it is possible that a low intracellular growth rate and the induction of a 
pro-inflammatory host response could have conferred a selective advantage on 
ancient strains in the past. Rather than evading the host immune system, until large 
numbers of bacteria have accumulated, ancient strains may enter a dormant state. 
The induction of dormancy allows the pathogen to exist for decades without killing 
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the host, reactivation may then occur when the host immune system weakens during 
old age, providing the pathogen with the opportunity to infect the next generation. 
Dormancy could therefore be considered as an adaptation to low host population 
density, which occurred during the pre-Neolithic era. Eshed and colleagues report 
that increased population density due to the shift from hunter-gatherer societies 
towards farming coincided with an increase in infectious disease during the Neolithic 
period (Eshed et al., 2010). The high intracellular growth rate of modern strains and 
induction of a low inflammatory response mean that modern strains are more likely to 
cause early, progressive TB. The rapid onset of clinical disease, which could lead to 
death of the host, also increases the chance of transmission. When the human 
population density is high and the probability of transmission is also high, the survival 
of the strain no longer depends on survival of an individual host so induction of 
primary TB could have conferred a selective advantage on modern strains, by 
allowing them spread to more hosts (Ahmed et al., 2009). 
 
The virulent reference strain H37Rv and the modern CAS strains tested in this study 
caused more necrosis in an MDM model than the ancient strains. The amount of 
necrosis caused by avirulent H37Ra and attenuated BCG was the same as in 
uninfected cells. High cellular necrosis has been reported to correlate with high 
mycobacterial intracellular growth rates, which Park and colleagues suggested were 
M. tuberculosis virulence factors (Park et al., 2006). Induction of macrophage 
apoptosis has been described as a feature of avirulent M. tuberculosis strains 
whereas virulent strains are able to prevent macrophage apoptosis (Keane et al., 
2000). The mode of macrophage cell death affects the fate of the infecting 
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mycobacteria, apoptotic cell death is bactericidal, but necrotic cell death releases the 
bacteria allowing them disseminate. However, the inhibition of macrophage apoptosis 
by virulent M. tuberculosis is a complex system that has not been fully elucidated. 
 
There are contrasting reports of virulent strains of M. tuberculosis stimulating 
macrophage apoptosis and avirulent strains inhibiting macrophage apoptosis. 
O'Sullivan and colleagues compared the effect of infection with H37Ra and H37Rv 
on cell death using THP-1 cells and human MDMs. The authors showed that when 
cells were infected with a low MOI of 1 to 2 bacilli per cell only H37Ra induced 
apoptosis. When cells were infected with 10 to 20 bacilli per cell both H37Ra and 
H37Rv induced apoptosis, although the authors described the mode of cell death as 
apoptosis-like because it was caspase-independent (O'Sullivan et al., 2007b). Lee 
and colleagues showed that at MOIs of 25 bacilli per cell M. tuberculosis Erdman 
induced more apoptosis than BCG in murine bone-marrow derived macrophages. 
The authors also described the mode of cell death as caspase independent and 
showed that cell death did not cause a reduction in mycobacterial viability, which the 
authors explained was because apoptotic cells quickly became necrotic (Lee et al., 
2006). Derrick and Morris showed that ESAT-6, which is a protein secreted by 
virulent M. tuberculosis strains, but not by BCG, was able to induce apoptosis in 
THP-1 cells. Apoptosis was also induced in a dose-dependent manner by infection of 
THP-1 cells with H37Rv at MOIs of 1 bacilli per cell and 10 bacilli per cell. Using the 
same MOIs apoptosis was shown not to occur when the RD-1 locus, which encodes 
nine genes including the ESAT-6 gene, was deleted from H37Rv (Derrick and Morris, 
2007). In addition, alveolar macrophages isolated by bronchoalveolar lavage from TB 
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patients with active disease have been reported to show increased apoptosis 
compared to macrophages collected from healthy people (Placido et al., 1997; 
Klingler et al., 1997). 
 
Butler and colleagues created two M. tuberculosis transposon mutants from an 
isolate belonging to the Beijing lineage (Butler et al., 2012). In contrast to the parent 
isolate, the mutants could not cause disease in mice or grow in macrophages and 
had lost the ability to prevent phagosomal maturation. Butler and colleagues showed 
that the virulent parent strain caused more cell death in a murine macrophage-like 
cell line than the avirulent mutants did. However, although the total cell death caused 
by the virulent parent strain exceeded the amount of cell death caused by the 
avirulent mutants, the mode of cell death, that is apoptosis or necrosis, was not 
related to the virulence of the strain. The percentage of total cell death caused by 
necrosis was higher for the avirulent mutants than for the parent strain, which was 
unexpected, as induction of necrotic cell death has been described as a feature 
associated with mycobacterial virulence. 
 
The disparity between various studies describing the mode of cell death induced by 
virulent and avirulent M. tuberculosis strains may be explained by the use of different 
MOI. Inhibition of macrophage apoptosis has been shown to depend on MOI in a 
dose dependant manner as well on the virulence of the M. tuberculosis strain (Lee et 
al., 2006). A low MOI of one bacterium per cell was used in the current study, in 
order to model the initial stages of macrophage infection with M. tuberculosis. Butler 
and colleagues showed that MOI and the length of time that macrophages were 
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infected for both affected the induction of apoptosis (Butler et al., 2012). The authors 
concluded that isolated measurements at different time points or with different MOIs 
would have affected the conclusion as to whether virulent or avirulent M. tuberculosis 
induced more or less apoptosis. Butler and colleagues also pointed out that 
secondary necrosis can occur after the induction of apoptosis, which makes 
comparison between virulent and avirulent strains more complicated and emphasises 
the need to take carefully timed samples. Secondary necrosis occurs when apoptotic 
bodies are not phagocytosed by other cells. 
 
However, Butler and colleagues were aware of the effect of time and MOI on the 
induction of apoptosis, so this does not explain their finding that avirulent 
M. tuberculosis mutants caused a higher percentage of necrosis than the virulent 
parent strain. They suggest that the mechanisms that directly stimulate necrosis are 
independent of apoptosis inhibition and concluded that virulence determines the level 
of cytotoxicity, but not the mechanism of cell death (Butler et al., 2012). Some viruses 
are able to prevent cells from undergoing apoptosis, which allows viral replication to 
occur. When the cell is replete and viral replication cannot continue the cell becomes 
necrotic providing the virus with an exit from the cell (Busca et al., 2009). 
M. tuberculosis may employ a similar strategy to replicate within and then escape 
from macrophages. This could also account for the high level of apoptosis in 
macrophages obtained by bronchoalveolar lavage from TB patients with active 
disease reported by Placido and colleagues (Placido et al., 1997). The mode of 
macrophage cell death should therefore be measured using different methods in 
order to make accurate comparisons between strains so that the mechanisms used 
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by M. tuberculosis to achieve intracellular growth and transmission to other cells 
whilst avoiding destruction by the immune system can be better understood. Several 
methods can be employed to differentiate between apoptotic and necrotic cell death. 
The morphology of the cells can be assessed using microscopy or flow cytometry. 
There are also numerous biochemical techniques that identify the presence of cell 
surface markers, fragmented DNA, protein cleavage or activation of specific enzymes 
such as the caspases, which are indicative of different modes of cell death (Krysko et 
al., 2008). 
 
There is evidence to suggest that M. tuberculosis is able to alter macrophage 
polarisation (Redente et al., 2010; Ho and Lape e Silva, 2010; Almeida et al., 2009; 
Chacon-Salinas et al., 2005), however the infection of polarised macrophages with 
clinical isolates of M. tuberculosis has not been described previously. In the current 
study, M2 macrophages permitted higher growth of H37Rv and two clinical isolates 
from the modern CAS spoligotype clade compared to M1 macrophages. This is 
consistent with a study carried out by Denis, which found that growth of H37Rv was 
higher in M2 macrophages than it was in M1 macrophages (Denis, 1991). The 
current study also showed that M2 macrophages inhibited the growth of H37Ra and 
two clinical isolates from the ancient EAI spoligotype clade more than M1 
macrophages. H37Ra is an avirulent strain and it was expected that M1 
macrophages would be able to inhibit its growth more effectively than M2 
macrophages. A recent study has shown that clearance of early apoptotic cells is 
more efficient in a subset of M2 macrophages (Zizzo et al., 2012). It has been 
reported that avirulent strains of M. tuberculosis induce macrophage apoptosis. It is 
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conceivable that H37Ra and the ancient clinical isolates induced macrophage 
apoptosis, clearance of the cells undergoing apoptosis by other macrophages in the 
culture may therefore explain the enhanced capacity of M2 cells to inhibit the growth 
of H37Ra and the ancient strains compared to M1 cells. The enhanced growth of 
CAS M. tuberculosis isolates in M1 and M2 macrophages compared to ancient 
isolates has provided further support for the theory that modern CAS strains are 
more virulent that ancient strains in an MDM model of infection. This may help to 
explain why the CAS strain is prevalent in the Midlands and ancient strains are not 
prevalent, despite both clades being prevalent in the ISC. 
 
When MDMs from Asian and Caucasian donors were compared, it was shown that 
CAS isolates grew preferentially in M2 cells from Asian donors. Growth of 
M. tuberculosis isolates in M1 cells was broadly similar for Asian and Caucasian 
donors, although H37Rv grew better in in Asian M1 cells and AS1 was inhibited more 
by Caucasian cells. Despite mounting evidence describing the association of 
M. tuberculosis lineages with the geographical origin of TB patients (Rodwell et al., 
2012; Brown et al., 2010; Reed et al., 2009; Gagneux et al., 2006), the mechanism 
behind this association has not been as well studied. Pareek and colleagues have 
shown that certain M. tuberculosis lineages are more likely to cause extrapulmonary 
TB than others; however, the clinical phenotype of the disease was strongly 
associated with the ethnicity of the patient. Pareek concluded that the ethnicity of the 
host was a more important determinant of clinical disease than the M. tuberculosis 
lineage (Pareek et al., 2013). Click and colleagues have also shown that 
M. tuberculosis lineage is associated with disease phenotype but they found that the 
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association between ethnicity and disease phenotype was only weak (Click et al., 
2012). There have not been any other studies that have looked for an association 
between M. tuberculosis lineage and disease phenotype, which have taken the 
ethnicity of the host into account. Pareek and colleagues suggested that the 
difference in the effect of ethnicity on disease phenotype between their study and the 
study carried out by Click and colleagues may be due in part to different population 
structures; there was a much lower proportion of people with ISC ethnicity in the 
study carried out by Click and colleagues. There are a number of studies that have 
described human gene polymorphisms, which cause certain ethnic groups to have a 
higher susceptibility to M. tuberculosis than others (Zhang et al., 2012; Arji et al., 
2012; Larcombe et al., 2008; Fernando et al., 2007; Hsu et al., 2006; Stead et al., 
1990). However, the response of human MDMs from people belonging to different 
ethnic groups to infection with the same strains of M. tuberculosis has not been 
described. Reports that natural resistance-associated macrophage protein 1 (Nramp-
1) gene polymorphisms cause susceptibility to mycobacterial infections indicate that 
innate immunity of the macrophage can influence disease outcome (Hackam et al., 
1998). Given the co-evolution of M. tuberculosis with human populations that is 
assumed to have given rise to the distinct families of strains that are seen to be 
closely associated with different global regions, it is plausible that M. tuberculosis 
strains may have adapted to differences in macrophage phenotype in specific human 
populations (Chapman and Hill, 2012). This could explain the observation made in 
the current study that growth of CAS strains was higher in M2 MDMs from Asian 
blood donors, than it was in M2 MDMs from Caucasian blood donors. 
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The observation that CAS clinical isolates of M. tuberculosis grow preferentially in M2 
MDMs from Asian donors supports the idea that M. tuberculosis has co-evolved with 
humans leading to distinct phylogeographical lineages of M. tuberculosis. However, 
the observation of macrophage polarisation in humans and the propensity for 
M. tuberculosis to induce a switch in macrophage polarisation means that identifying 
determinants of virulence in M. tuberculosis strains is further complicated. A properly 
powered, age matched study should be conducted in order to confirm the hypothesis 
that was generated in this study by assessing the response of macrophages from 
three Asian and three Caucasian donors to infection with different lineages of 
M. tuberculosis. 
 
The current study showed variation in virulence between M. tuberculosis isolates 
belonging to the same spoligotype clade, which adds to the increasing evidence that 
suggests there is significant heterogeneity in the virulence of strains belonging to the 
same spoligotype clade. Garcίa de Viedma and colleagues identified three TB 
patients who were infected with two genotypically distinct strains of M. tuberculosis at 
the same time (Garcia de Viedma et al., 2006). One of the strains remained in the 
lungs whereas the other strain had disseminated to extrapulmonary sites. Garcίa de 
Viedma found that extrapulmonary strains infected macrophages more efficiently 
when cells were inoculated with an equal ratio of the pulmonary and extrapulmonary 
isolates. The authors studied the isolates from one patient in further detail, both 
isolates belonged to the LAM spoligotype clade, the pulmonary isolate was a LAM2 
strain from SIT 17 and the extrapulmonary isolate was a LAM3 strain from SIT 33. 
The survival of SCID (severe combined immunodeficiency) mice was significantly 
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lower when infected with the extrapulmonary strain (average survival, 29 days), 
compared to the respiratory strain (average survival, 37 days). The authors 
concluded that there was a correlation between extrapulmonary dissemination and 
infectivity in vivo (Garcia de Viedma et al., 2005b). 
 
Data from the current study and several others indicates that members of the same 
spoligotype can have different virulence properties (Kanji et al., 2011b; Theus et al., 
2007a; Garcia de Viedma et al., 2005b). The observation that LSPs such as RD-149 
deletion (discussed in section 4.3.6) in isolates from the CAS1_Dehli spoligotype 
clade can affect intracellular growth suggests that strain subsets exist within different 
spoligotype clades that have different virulence characteristics (Kanji et al., 2011b).  
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5 FUTURE WORK 
Significant heterogeneity has been identified in the intracellular growth rate of CAS 
isolates in THP-1 cells, including differences identified between isolates from the 
same epidemiological cluster of disease. The study should be expanded to include a 
greater number of CAS and ancient isolates, which should also be tested in the MDM 
cell model. MDMs should be isolated from a greater number of people, who should 
be age matched so that putative differences in the response of MDMs from people of 
different ethnicities can be confirmed or refuted. M. tuberculosis isolates from other 
clades should also be included, and where possible examples of sympatric and 
allopatric infections should be studied in macrophage models of infection. 
 
LSP profiling of CAS strains should be carried out to confirm whether the absence of 
specific RDs contributes to the virulence of subsets of CAS isolates in order to 
confirm the observation made by Kanji and colleagues that absence of RD149 
causes slower intracellular growth rates amongst CAS isolates (Kanji et al., 2011b). 
 
The mode of cell death caused by infection of macrophages with CAS strains should 
be assessed as Butler and colleagues have shown that the mechanisms that directly 
stimulate necrosis are independent of apoptosis inhibition (Butler et al., 2012). 
Commercially available apoptosis and necrosis kits are now available which use 
fluorescent stains to identify live and dead cells in the same sample and can also 
distinguish between apoptotic and necrotic cells. These assays could be used to give 
more information about the cause of macrophage death and could allow a time 
course to be constructed, so that the type of cell death induced could be accurately 
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correlated with intracellular bacterial numbers. This would give more information 
about the virulence of different members of the CAS clade and allow more accurate 
comparisons to be made with strains from different clades. 
 
Some bacterial pathogens manipulate macrophage polarisation in order to 
down-regulate the bactericidal activity of the host cell. Kyrova and colleagues 
showed that Salmonella enterica serotype Typhimurium promoted M2 macrophage 
polarisation leading to enhanced intracellular growth (Kyrova et al., 2012). The ability 
of different M. tuberculosis strains to alter the phenotype of M1 and M2 polarised 
macrophages should be assessed (Chanput et al., 2012). 
 
There are significant data to suggest that virulence of M. tuberculosis can be 
determined by the immune response that is elicited in the host. To that end culture 
supernatants from all the experiments in the current study have been filter sterilised 
and stored at -80°C so that multiplex cytokine assays can be performed. 
 
This study does not prove a causal relationship for the increased incidence of strains 
from the CAS spoligotype clade in the Midlands. However, it does provide a rationale 
for future studies aimed at identifying the virulence of different M. tuberculosis 
strains.
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